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Introduction
Urinary incontinence is a common problem among adult women. The Health Council of the 
Netherlands estimated that yearly 64.000 new patients, of whom 96% women, consult their 
general practitioner because of urinary incontinence.1 
Urinary incontinence is commonly divided into three types based on symptoms; stress, urgency 
and mixed urinary incontinence. Stress urinary incontinence (SUI) is defined as the complaint of 
involuntary loss of urine on effort, physical exertion, on coughing or sneezing.2 This is usually due 
to anatomical defects in the structures that support the bladder and urethra, and/or dysfunction of 
the neuromuscular components that help to control urethral pressure. The urodynamic diagnosis 
of SUI is based on the fact that the intravesical pressure exceeds the urethral pressure, in the 
absence of detrusor muscle contraction. Urgency urinary incontinence is defined as the involuntary 
leakage of urine accompanied by or immediately preceded by urgency.2 This usually results from 
involuntary increase in the bladder pressure due to detrusor activity. The symptoms of SUI are 
often coexisting with overactive bladder symptoms. The overactive bladder syndrome is defined 
as urinary urgency, often accompanied by frequency and nocturia, with or without urgency 
urinary incontinence, in the absence of urinary tract infection or other obvious pathology.2 When 
the complaint of involuntary loss of urine is associated with effort, physical exertion, sneezing or 
coughing and also with urgency symptoms, it is called mixed urinary incontinence.2 
Of the women consulting a general practitioner, 45-50% has complaints of SUI and a further 
36-44% of mixed urinary incontinence.3,4 Urinary incontinence is not a life-threatening disease, 
but the symptoms may seriously influence the physical, psychological and social well being of 
the affected women.5 Moderate to severe restriction of activity of daily living caused by urinary 
incontinence occurs in 13%; above the age of 60 years this can increase up to 46-65%.3,6 
Determination of the type of incontinence is important since it determines the treatment and 
predicts its expected success and complications. Important treatment options for SUI are pelvic 
floor physiotherapy and surgery. For women in which conservative measures are not successful, 
the most common surgical therapy is the midurethral sling procedure. These slings have an 
average success rate of 90%.7 
To assess the presence and the bother of lower urinary tract dysfunction, a history is carefully taken 
and it is recommended to use validated questionnaires on urogenital dysfunction and health-
related quality of life. In the Netherlands, questionnaires such as the Urogenital Distress Inventory 
and the Incontinence Impact Questionnaire have been translated, validated and are advised by 
the Working Party on Pelvic Floor and Urogynaecology of the Dutch Society of Obstetrics and 
Gynaecology.8 
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Routine physical examination should include abdominal, pelvic, and perineal examinations. The 
presence of a pelvic organ prolapse or urogenital atrophy must be assessed and a stress test 
should be performed. 
Urodynamic investigation
Urodynamic investigation was introduced around 1970.9 It is used to investigate people who have 
urinary incontinence or other lower urinary tract symptoms in order to make a definitive objective 
diagnosis. Urodynamics are used to assess the neuromuscular function and dysfunction of the 
urinary tract and depict the storage and evacuation function of the lower urinary tract.
Different techniques have been developed to allow the synchronous measurement of bladder 
pressures and flow rates, namely single-channel, multi-channel, ambulatory and video 
urodynamics. 
In single-channel cystometry only the intra-vesical pressure is measured. This technique is not 
accurate because it assumes that the detrusor pressure approximates to the intra-vesical pressure. 
However a significant proportion of the pressure measured in the bladder emanates from intra-
abdominal pressure and not from the detrusor muscle itself.10 
In ambulatory urodynamics, pressures and other physiological parameters from the patient are 
registered into a small, body-worn recorder and the patient is able to carry out normal activities. 
Advantages of ambulatory urodynamics are the natural bladder filling, the longer period 
of registration and the fact that the patient is able to perform everyday activities, including 
provocative actions. Disadvantages are that it is time-consuming to perform and it requires regular 
monitoring to ensure that the catheters have not become displaced. To date, the technique has 
not been standardised and the measurement parameters have not been adequately defined.7 
Video urodynamics is the combination of cystometry with simultaneous X-ray of the lower urinary 
tract during the filling and voiding phase. An important disadvantage of this type of urodynamics 
is the exposition to radiation.11-13 This investigation is mainly used in the management of children 
and neurogenic patients.7 
The most common used technique for the evaluation of women with complaints of SUI, is the 
multi-channel urodynamic investigation. It is an invasive investigation which involves a pressure 
catheter being placed in the bladder transurethrally, and another pressure catheter placed rectally 
or vaginally to measure the abdominal pressure. Subtracting the abdominal pressure from the 
pressure measured inside the bladder gives a representation of the true pressure changes due 
to the action of the detrusor smooth muscle. Action potentials of the pelvic floor muscles are 
registered by surface electrodes. During the investigation, the bladder is usually filled with saline 
solution, either through a separate catheter placed transurethrally or through the filling channel 
of a dual lumen catheter. A normal filling rate is 50 millilitres per minute, which is much faster than 
physiological bladder filling. 
12
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A multi-channel urodynamic investigation composes of different tests. During uroflowmetry, 
maximum flow rate and the form of the flow curve are determined. Postvoid residual volume 
can be measured afterwards by ultrasound or catheterisation. During filling cystometry, the 
pressure inside the bladder is assessed in relation to volume and time, and reflects the storage 
function. It enhances detrusor compliance, bladder capacity and measurement of the strength 
of involuntary detrusor contractions during provocation (e.g. by coughing). During provocation, 
The upper line represents the intra-abdominal pressure (Pabd), the second line the intra-vesical 
pressure (Pves) and the third line represents the subtracted detrusor pressure (Pdet). The urinary 
flow rate (Qura) is displayed in the fourth row. In the lowest row the electromyography (EMG) and 
the infused volume (Vin) are displayed. Different cough tests (indicated with Stress) are performed 
during filling to ensure a correct position and registration of the pressure catheters and to observe 
stress urinary incontinence. Bladder sensations are indicated with first sensation (when the patient 
first becomes aware of the bladder filling), normal desire (the feeling that would lead the patient to 
pass urine at the next convenient moment, but the voiding could be delayed if necessary) and strong 
desire (the persistent desire to void without the fear of leakage). Leak point indicates the intra-vesical 
pressure when leakage of urine occurs due to increased abdominal pressure by a Valsalva manoeuvre, 
in the absence of a detrusor contraction. The right part of the trace represents the voiding phase, the 
detrusor contracts and the urine is expelled. 
Figure 1 Urodynamic trace during filling and voiding phase (pressure/flow cystometry)
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urodynamic stress urinary incontinence can also be observed. Pressure-flow studies measure the 
voiding mechanism. During emptying of the bladder, flow rate in relation to detrusor pressure is 
determined. In patients with symptoms of voiding dysfunction, a distinction between urethral 
obstruction and/or detrusor contractility disorders can be made. Figure 1 shows an example of an 
urodynamic trace during the filling and voiding phase. 
During resting urethral pressure profilometry, the pressure along the length of the urethra 
relative to the pressure in the bladder is measured by withdrawing a pressure catheter along the 
urethra. The maximum pressure forms an indication of the closure mechanism of the urethra. 
The abdominal pressure transmission to the urethra is thought to keep the normal urethra closed 
during stress. During a stress urethral pressure profile, by increasing the abdominal pressure 
(e.g. coughing or Valsalva), the pressure transmission rate is determined. Electromyography is an 
indirect measure of pelvic floor and sphincter muscle contractility.
The main risks of urodynamics are those associated with urethral catheterisation, such as dysuria 
and urinary tract infection.14,15 Furthermore, many women find it a painful or embarrassing 
investigation.16,17 
In general, urodynamics try to enhance the understanding of lower urinary tract functioning and 
reveal the underlying pathology that cause patients complaints. It is regarded as an extension 
of the patient history and physical examination in an unphysiological setting. The information 
gained from urodynamics may confirm or alter the clinical diagnosis or may influence the choice 
of intervention. 
Controversies on the utility of preoperative urodynamics for stress urinary incontinence
Although urodynamic tests are widely used, their place in the diagnostic work-up and treatment 
selection of women with SUI remains controversial. The value of an accurate diagnosis depends 
on the availability and effectiveness of appropriate treatment. If urodynamics could distinguish 
between a group for whom surgery is effective and another group for whom it is not effective 
or management needs to be altered in a specific way, urodynamics could attribute to an optimal 
treatment selection and accurate counselling.18 However, different observational studies on the 
predictive value of urodynamics did not show evidence for better outcomes after treatment 
in women who underwent preoperative urodynamics.19-23 Moreover, urodynamics are time 
consuming and costly. In Europe, approximately 100.000 midurethral sling operation are performed 
yearly.24 At expected costs of about 335 euro per test25, urodynamics account for over 50 million 
euro health insurance charges, leaving non-surgical treated patients out of consideration. 
Several national and international guidelines of professional organizations and authorities advise 
to perform urodynamics prior to invasive treatment for SUI.26-28 The National Institute for Clinical 
Excellence (NICE) recommends since 2006 that “the use of multi-channel cystometry is not 
routinely recommended before surgery in women with a clearly defined clinical diagnosis of 
14
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pure SUI. The test is recommended for women with a clinical suspicion of detrusor overactivity, 
symptoms suggestive of voiding dysfunction, or in those with previous surgery for SUI or anterior 
compartment prolapse”.29 The International Consultation on Incontinence (ICI) advocates the use 
of urodynamics in complicated cases of urinary incontinence, uncertain pathophysiology, and the 
presence of neurogenic voiding dysfunction.7 These statements are, however, largely based on 
expert opinion rather than solid evidence.18 
There is a considerable discrepancy between patient’s symptoms and the urodynamic 
diagnosis.30-32 The need for preoperative urodynamics is often justified by the consideration 
that pre-existing detrusor overactivity may be either a contra-indication for surgery or at least 
carries a poorer prognosis.33-35 Detrusor overactivity can however be cured in over 50% of women 
with a colposuspension or a midurethral slings.36,37 Furthermore, 92% of women in whom stress 
induced urgency urinary incontinence is found are cured with a midurethral sling procedures.38 
Therefore, the preoperative diagnosis of detrusor overactivity could attribute to the counselling of 
patients on the perspectives, but it is unsure whether detrusor overactivity should influence the 
management to a major extent. 
Surgery for SUI can lead to postoperative voiding dysfunction including retention of urine, which 
occurs in 7-36%, depending on the definition used.39-43 A high preoperative postvoid residual 
volume and a low maximum flow velocity (<15ml/s) have been correlated to voiding dysfunction 
postoperatively in some studies42,44,45 although other studies contradict that voiding dysfunction 
could be predicted by urodynamic parameters.43,46 The flow pattern may be assessed by free 
uroflowmetry, which is a non-invasive investigation without catheters. The determination of the 
postvoid residual volume may sufficiently accurate be assessed by ultrasound.47 Urodynamics are 
not obligatory for the measurement of these parameters. Furthermore, a single postvoid residual 
volume measurement seemed to be unreliable, since an incidence of a postvoid residual >100 ml 
of 14% declined to 1.3% after repeated measurements.48
According to the standardisation report of the International Continence Society (ICS) and 
International Urogynaecological Association (IUGA), dysfunctional voiding is characterised by 
an intermittent flow due to involuntary contractions of the pelvic floor muscles or as a result 
of an acontractile detrusor (abdominal voiding). The distinction between these two conditions 
needs to be made with voiding cystometry including electromyography registration. However, 
during voiding with catheters in situ, there is a high risk of artefacts. One study detected in 28% 
of women with SUI, dysfunctional voiding during urodynamics.49 Objective cure and the global 
index of Patient Global Impression of Improvement (PGI-I) after surgery for SUI did however not 
differ between patients with and without dysfunctional voiding. Also, a nomogram to diagnose 
bladder outlet obstruction in woman was developed. Bladder outlet obstruction was associated 
with higher prevalence of a large postoperative postvoid residual.50 However, in another study 
the nomogram gave an unlikely high prevalence of obstruction and showed no correlation with 
15
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symptoms measured with the Urogenital Distress Inventory.51 Consensus on what constitutes 
voiding dysfunction, and the predictive value of voiding cystometry for anticipation of 
postoperative voiding difficulty has not been established. 
Conceptually, urodynamics differentiate between two forms of SUI: SUI based on urethral 
hypermobility and SUI based on intrinsic sphincter deficiency. The differentiation between the 
two conditions could be important with regard to the choice of operation and the prognosis for 
the individual patient. However, the value of distinguishing between intrinsic sphincter deficiency 
and urethral hypermobility has not been proven. Intrinsic sphincter deficiency is not well defined, 
but is related to low Valsalva leak point pressures (<60 cmH2O) and/or to a low maximum urethral 
closure pressure (<20cmH2O). Hypermobility is associated with the loss of vaginal support of the 
urethra, however hypermobility is poorly defined and no gold standard for this diagnosis exists. 
In practice, this differentiation is not absolute and a large part of the patients have signs of both. 
Low urethral closure pressures, as well as less mobile urethras, seem to correlate with impaired 
success of treatment.52-57 Bladder neck suspensions, such as the Burch colposuspension, were 
historically regarded as suitable for the hypermobile urethra, whereas intrinsic sphincter deficiency 
was best treated with a pubovaginal autologous fascial sling. Since the introduction of the less 
invasive tension-free vaginal tape in 1995 by Ulmsten, the current gold standard for surgical 
management of SUI is the midurethral sling (retropubic or transobturator).58 For women with poor 
intrinsic urethral sphincteric function, as assessed by low closure pressures, a retropubic approach 
may result in better continence rates than the transobturator sling, as these are potentially more 
obstructive.59-62 However, recent evidence-based recommendations for the treatment of stress 
incontinence do not utilize intrinsic sphincter deficiency and bladder neck hypermobility as 
primary determinants in the selection of the type of sling.63 
Thesis “The value of urodynamics prior to surgery for stress urinary incontinence”
The role of urodynamics in the evaluation of SUI in women is questionable and very much 
under debate.64 The value of the urodynamic investigation depends on the additional retrieved 
information in relation to symptoms and signs, the quality and reliability of the investigation, 
the consequences of urodynamic findings in treatment selection and on the predictive value 
with regard to outcome. In this thesis, these various aspects of the role of urodynamics in the 
diagnostic work-up of women with complaints of pure or predominant SUI were studied. The 
results of the studies described in this thesis may guide future management of women with SUI.
16
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The aims of this thesis are:
•	 To provide an overview of the agreement with regard to classification into the different 
types of incontinence between the clinical and the urodynamic diagnosis of incontinence 
(Chapter 2). 
•	 To determine the current use and the opinion of gynaecologists and urologist with special 
interest in stress urinary incontinence on preoperative urodynamics in women with stress 
urinary incontinence (Chapter 3). 
•	 To assess the technical quality and the interobserver reliability with regard to classification 
into concordant or discordant outcomes of urodynamic investigations (Chapter 4).
•	 To assess whether the additional information gained by urodynamics influences clinical 
decision making and improves clinical outcome in women with stress urinary incontinence 
(Chapter 5, 6 and 7). 
•	 To identify urodynamics factors which could predict success of treatment (Chapter 7).
•	 To provide recommendations for the use of urodynamics in patients with complaints of 
stress urinary incontinence in daily clinical practice (Chapter 5, 7 and 8).
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Abstract 
Introduction
The aim of this study was to determine the reclassification rate of clinically diagnosed stress, mixed 
and urgency urinary incontinence after urodynamic investigation. 
Methods
We performed a systematic review of the published literature in MEDLINE and EMBASE of clinical 
trials among women with urinary incontinence. Studies were included in case the diagnosis based 
on symptoms and/or signs was compared with the diagnosis after urodynamic investigation.
 
Results 
Twenty-three papers involving 6.282 women with urinary incontinence met the inclusion criteria. 
A clinical diagnosis of stress urinary incontinence was reclassified into mixed urinary incontinence 
in 9% of women and into detrusor overactivity in 7% of cases. The pooled reclassification rate was 
highest among patients with symptoms of mixed urinary incontinence, where 46% of the patients 
had stress urinary incontinence and 21% had detrusor overactivity on urodynamic investigation. 
The available literature does not allow the identification of the additional value of non-invasive 
test, such as stress test and bladder diary, accessory to symptoms. None of the studies had 
therapeutic effects as an outcome measure.
Conclusions 
This review of clinical studies shows that the level of agreement between classification based 
on clinical evaluation and based on urodynamic investigation is poor. Urodynamic observations 
are regarded as gold standard, but based on the poor correlation, this assumption should be 
questioned.
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Introduction
Urinary incontinence in women is generally divided into stress (SUI), urgency and mixed urinary 
incontinence (MUI). Determination of the type of incontinence is important since it determines the 
type of treatment and predicts its expected success and complications. The patient’s history and 
clinical examination are important aspects in the assessment of patients with urinary incontinence. 
Urodynamic investigation is widely considered as the gold standard for determining the type of 
incontinence. It is performed to confirm or reject the clinical diagnosis based on symptoms and 
signs and is the final verdict for the therapeutic strategy. Findings on urodynamics may however 
occur with different symptoms and signs, or in the absence of any symptoms or signs.1
The information gained from urodynamic investigation may determine the choice of intervention. 
Until now, it is not known whether urodynamics are necessary in women with a diagnosis that 
seems obvious from their history, physical examination and bladder diary, and the additional value 
of urodynamic investigation in individual cases to improve success rates and avoid complications 
remains unclear.2
Several studies have evaluated the accuracy of history taking relative to findings on urodynamics 
in women with urinary incontinence and showed a wide variation of the results. Most of these 
studies have been included in two previous reviews.3,4 These two reviews reported that history 
taking for diagnosing urodynamic stress incontinence in women has sensitivity – specificity 
combinations of 0.92 – 0.56 and 0.66 – 0.83, respectively. For diagnosing urodynamic detrusor 
overactivity (DO) they reported sensitivity – specificity combinations of 0.61 – 0.87 and 0.45 – 0.96, 
respectively. The National Institute for Health and Clinical Excellence (NICE) guideline has reported 
that urodynamics has a sensitivity of 0.68 and specificity of 0.77 in diagnosing urodynamic mixed 
incontinence.4 
Besides the fact that the reviews did not include similar studies, the reported sensitivity and 
specificity differ between the reviews since Martin et al. have assessed stress and mixed 
incontinence as one category were the NICE guideline assessed the results for stress and mixed 
incontinence separately. Although the data of these two reviews enhance understanding of 
the agreement between history and urodynamic investigation, the clinical consequences of 
disagreement remained unclear. In other words, it has not been investigated into which types 
of urinary incontinence women were classified after urodynamic investigation and what the 
consequences were for the choice of treatment. 
The objective of this systematic review was to determine the reclassification rate among the three 
types of urinary incontinence after urodynamic investigation in females with urinary incontinence. 
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Materials and Methods 
Literature search
We searched the electronic databases MEDLINE and EMBASE from inception until December 2009. 
Language restrictions or restrictions on publication date were not applied. The used search terms 
were adapted for each database accordingly, and generally referred to the different terms for 
“incontinence” and “urodynamics”. References of relevant retrieved studies were cross-checked for 
additional studies. The entire string of search terms, including Medical Subject Headings (MESH) 
and Thesaurus terms, are depicted in the Appendices A and B.
All articles were systematically assessed by title and abstract according to the inclusion and 
exclusion criteria by two of the authors (SvL, JHO). When considered necessary, the full text articles 
were read. 
Studies were included when they compared the diagnosis of the type of urinary incontinence 
after history taking (with or without clinical examination) to the diagnosis after multi-channel 
urodynamic investigation in women. In order to be included, a study had to provide sufficient 
data to calculate a reclassification rate for at least one type of incontinence. Urodynamics had to 
include at least provocative filling cystometry and pressure flow study. Authors of studies with 
insufficient data for inclusion were contacted by email and asked for further details. 
Studies were excluded if data from women could not be distinguished from men, the mean age 
was below 18 years, a population with specific comorbidity (e.g. diabetes mellitus, neurologic 
disease), or a population with lower urinary tract symptoms (LUTS) in whom incontinence could 
not be distinguished from other symptoms.
Quality assessment and data abstraction
Data were independently extracted by the same two reviewers with the use of a score form, 
including the QUADAS (quality assessment of diagnostic accuracy studies) criteria.5 Disagreement 
was resolved in consensus meetings with a third author (KK). 
Data on study population, study design, used definition of incontinence, previous incontinence 
surgery, stage of pelvic organ prolapse, methods of incontinence symptom assessment (use of 
questionnaires) and the tests of which the urodynamic investigation included were collected. 
Data were subgrouped for the primary diagnosis stress, mixed and urgency urinary incontinence. 
Subsequently, accuracy data were used to construct a cross-tabulation in which diagnosis based 
on signs and symptoms to urodynamic diagnosis were related.
Data analysis
From the cross-tabulation, the reclassification rates were calculated. Note that the confirmation of 
the clinical diagnosis on urodynamics corresponds to the positive predictive value. Subsequently, 
25
Correlation between clinical and urodynamic diagnosisChapter 2
2
the mean reclassification rates, weighted for the sample size of the study, were calculated. The 
sensitivity and specificity for symptoms and signs of overactive bladder in predicting urodynamic 
detrusor overactivity were determined for the studies which provided information on the 
urodynamic diagnosis of all clinical types of urinary incontinence. 
It was assessed whether the trials provided any data on the consequences (regarding treatment 
and outcome) of reclassification of type of urinary incontinence after multi-channel urodynamics. 
Figure 1. Identif ication of studies who compared the clinical diagnosis of the type of urinary 
incontinence to the diagnosis after multi-channel urodynamic investigation in women
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Excluded 
• No comparison clinical and urodynamic diagnosis   31 
• Review, letter, commentary or editorial    37 
• Insufficient date to calculate reclassification rate   16 
• Single-channel urodynamics/         9 
only urethral pressure profile     
• Patients with lower urinary tract symptoms,    10 
incontinence not distinguishable     
• Male or mixed population          8 
• Children          2 
• Specific comorbidity        4 
• Other reason     6 
Duplicates removed 
N = 4522 
Identified by literature  Identified by literature 
search in EMBASE search in MEDLINE 
N = 3238 N = 2368
Potentially relevant after 
reading title and abstract Additional articles by cross-checking 
reference lists.  N = 126 
Further data retrieved from emails to 
authors.   
N = 0 
Primary studies included in systematic review
N = 23 
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Results
In total, 3.238 papers in MEDLINE and 2.368 papers in EMBASE were identified by the literature 
search. Of these articles, 126 were considered potentially relevant for this review after reading title 
and abstract and were read by full text. No additional articles were identified by cross-checking 
the reference lists, and no further data were retrieved from emails to the authors. Finally, 23 
articles were included in the review (see Figure 1).6-28 All studies met de following QUADAS criteria; 
appropriate patient spectrum, appropriate reference test, avoidance of partial and differential 
verification and availability of clinical data. Studies scored poorly in terms of adequate descriptions 
of selection criteria and index test, blind assessment of the reference test and description of the 
interval between index and reference test. The study characteristics of the selected studies are 
shown in Table 1. The 23 studies included data from 6.282 women with urinary incontinence. 
The clinical symptoms indicated pure SUI in 2.659, MUI in 3.142 women and urgency urinary 
incontinence in 481 women. The number of articles which have used International Continence 
Society (ICS) definitions to classify the clinical and urodynamic type of incontinence was 19 of 23 
papers (83%). 
Table 2a-2c show the results on positive predictive value and reclassification of the type of 
incontinence after urodynamic investigation, subgrouped for the clinical diagnosis of stress, 
mixed and urgency incontinence respectively. Table 3 shows the sensitivity and specificity 
for symptoms and signs of overactive bladder in predicting urodynamic DO. Note that only 
studies which provided information on the urodynamic diagnosis of all clinical types of urinary 
incontinence were included in this table. In Figure 2, the receiver operating characteristics (ROC) 
curve presents the pooled and single accuracy estimates for symptoms and signs of overactive 
bladder in predicting DO in women with urinary incontinence.
The mean percentage in which a clinical diagnosis of SUI was confirmed by urodynamics was 
75% (range 0.41-0.95). The diagnosis of SUI was reclassified for 9% in MUI and for 7% in DO with or 
without incontinence. The mean proportion of women with symptoms and signs of SUI but with 
normal findings on urodynamic investigation was 8% (range 0-32%). 
In the MUI group, the percentage in which the clinical diagnosis was confirmed by urodynamics 
was lower as compared with SUI: pooled mean 21% (range 12%-54%). The diagnosis of MUI was 
reclassified into SUI in 46% and in DO (with or without incontinence) in 21%. The mean proportion 
of women with a clinical diagnosis of MUI, but with normal findings on urodynamic investigation 
was 10% (range 0-24%). 
In 58% (range 22%-100%) of patients with the clinical diagnosis of urgency urinary incontinence, 
urodynamic investigation revealed DO. In 12% urgency urinary incontinence was reclassified 
into SUI after urodynamics and in 12% into MUI. This implies that in 70% of women, DO (with or 
without any type of incontinence) was found on urodynamics in patients with urgency urinary 
incontinence.
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The index tests in the included papers to make the clinical diagnosis, consisted of different non-
invasive tests (see Table 1). The reclassification rate in articles with a clinical diagnosis based on 
symptoms only was not different from those articles where symptoms and signs (such as stress 
test or bladder diary) were compared with urodynamic findings. 
None of the publications studied the effect of reclassification on the following treatment or the 
effect on clinical outcomes after treatment. 
Table 2a. Urodynamic findings in women with the clinical diagnosis of stress urinary incontinence 
 
Author N Urodynamic SUI DO Urodynamic MUI Other Normal 
 
Agur6 324 241 (74%) 15 (5%) 29 (9%) 4 (1%)* 35 (11%) 
Bergman7 97 78 (80%) 14 (14%) 0 4 (4%)** 1 (1%) 
Busch8 153 136 (89%) 11 (7%) 6 (4%) - 0 
Byrne9 61 54 (89%) 5 (3%) 2 (8%) - 0 
Cundiff10 180 156 (87%) 7 (4%) 17 (9%) - 0 
De Muylder11 170 69 (41%) 36 (21%) 53 (41%) - 12 (7%) 
Digesu13 308 241 (78%) 23 (3%) 9 (7%) - 35 (11%) 
Diokno14 132 92 (70%) 3 (2%) 15 (11%) 10 (8%)*** 12 (9%) 
Fitzgerald15 38 25 (66%) 2 (5%) 3 (8%) - 8 (21%) 
Holtedahl16 23 15 (65%) 2 (9%) 2 (9%) - 4 (17%) 
Iosif17 179 137 (77%) 2 (1%) 5 (3%) - 35 (19%) 
Ishiko18 110 104 (95%) 2 (2%) 4 (4%) - 0 
Korda19 272 176 (65%) 32 (12%) 43 (16%) - 21 (8%) 
Lagro-Janssen20 54 47 (87%) 1 (2%) 4 (7%) - 2 (4%) 
Maes21 43 24 (56%) 0 1 (2%) 5 (12%)† 13 (30%) 
Phua22 22 11 (50%) 4 (18%) 0 - 7 (32%) 
Pinto23 77 67 (87%) 0 5 (6,5%) 5 (6%)†† 0 
Sand24 43 25 (58%) 7 (16%) 8 (19%) - 3 (7%) 
Sandvik25 97 84 (87%) 1 (1%) 7 (7%) 5  (5%)††† - 
Sunshine26 65 61 (94%) 4 (6%) 0 - 0 
Videla27 74 61 (82%) 1 (1%) 11 (15%) - 1 (1%) 
Voigt28 137 90 (66%) 15 (11%) 9 (7%) - 23 (17%) 
Median (range) 2659 78% (41%-95%) 6% (0%-21%) 8% (0%-41%)  7% (0%-32%) 
Pooled [95% CI] 75% [0.73-0.77] 7% [0.06-0.08] 9% [0.08-0.10]  8% [0.07-0.09] 
 
 
Note that the confirmation of the clinical diagnosis by the presence of urodynamic stress urinary incontinence corresponds to the 
positive predictive value.  
N, number of patients; SUI, stress urinary incontinence; DO, detrusor overactivity; MUI, mixed urinary incontinence; CI, confidence 
interval; * Postvoid residual >100 ml; ** Urethral diverticulum; *** Reduced bladder sensation or overflow incontinence (9), increased 
bladder sensation (1); † Strain to void (3), underactive detrusor (2); † Increased bladder sensation (4), underactive detrusor (1) all with 
SUI; ††† Not reported.  
 
29
Correlation between clinical and urodynamic diagnosisChapter 2
2
Table 2b. Urodynamic findings in women with the clinical diagnosis of mixed urinary incontinence
 
Author N Urodynamic MUI Urodynamic SUI DO Other Normal 
 
Busch8 3 1 (33%) 2 (67%) 0 - 0 
Cundiff10 296 56 (19%) 187 (63%) 53 (18%) - 0 
De Muylder11 116 45 (39%) 61 (53%) 10 (9%) - 0 
Digesu12 1626 299 (18%) 665 (41%) 414 (25%) - 248 (15%) 
Diokno14 53 14 (26%) 24 (45%) 8 (15%) 5 (9%)*** 2 (4%) 
Fitzgerald15 200 52 (26%) 107 (53%) 25 (12%) - 16 (8%) 
Holtedahl16 17 8 (47%) 3 (18%) 3 (18%) - 3 (18%) 
Iosif17 199 35 (18%) 76 (38%) 29 (15%) 31 (16%)‡ 28 (14%) 
Ishiko18 46 25 (54%) 19 (41%) 1 (2%) 1 (2%)‡‡ 0 
Korda19 218 30 (14%) 113 (52%) 67 (31%) - 8 (4%) 
Lagro-Janssen20 31 13 (42%) 12 (39%) 5 (16%) - 1 (3%) 
Maes21 42 5 (12%) 13 (31%) 4 (9%) 10 (24%)‡‡‡ 10 (24%) 
Pinto23 33 5 (15%) 18 (54%) 4 (12%) 6 (18%) ^ 0 
Sand24 132 30 (23%) 89 (67%) 13 (10%) - 0 
Sandvik25 108 47 (44%) 41 (38%) 17 (16%) 3 (3%) ††† 0 
Sunshine26 22 4 (18%) 15 (68%) 0 3 (14%)^^ 0 
Median (range) 3142 25% (12%-54%) 49% (18%-68%) 14% (0%-31%)  1% (0%-24%) 
Pooled [95% CI] 21% [0.20-0.23] 46% [0.44-0.48] 21% [0.19-0.22]  10% [0.09-0.11] 
 
 
Note that the confirmation of the clinical diagnosis by the presence of urodynamic mixed urinary incontinence corresponds to the 
positive predictive value. 
N, number of patients; MUI, mixed urinary incontinence; SUI, stress urinary incontinence; DO, detrusor overactivity; CI, confidence 
interval; *** Reduced bladder sensation or overflow incontinence (9), increased bladder sensation (1); ‡ Urgency/frequency (16), 
neurogenic bladder (6), uncertain aetiology (9); ‡‡ Overflow incontinence; ‡‡‡ Low-compliance bladder (3), underactive detrusor (6), 
unstable urethra (1); ^ Increased bladder sensation (6); ††† Not reported; ^^ Abnormal urethral electromyography. 
 
 
 
Author N DO Urodynamic SUI Urodynamic MUI Other Normal 
 
Bergman7 25 11 (44%) 0 0 3 (12%)^^^ 11 (44%) 
Busch8 19 16 (84%) 3 (16%) 0 - 0 
Cundiff10 59 42 (71%) 8 (14%) 9 (15%) - 0 
De Muylder11 122 86 (70%) 8 (6%) 6 (5%) - 22 (18%) 
Diokno14 8 2 (25%) 3 (37%) 2 (25%) 1 (12%)‡‡ 0 
Fitzgerald15 31 10 (32%) 5 (16%) 5 (16%) - 11 (35%) 
Holtedahl16 2 2 (100%) 0 0 - 0 
Iosif17 23 17 (74%) 1 (4%) 1 (4%) 4 (17%)° 0 
Ishiko18 31 25 (81%) 1 (3%) 5 (16%) - 0 
Lagro-Janssen20 15 11 (73%) 0 2 (13%) - 2 (13%) 
Maes21 9 2 (22%) 0 1 (11%) 3 (33%)°° 3 (33%) 
Sand24 13 10 (77%) 0 0 - 3 (23%) 
Sandvik25 31 23 (74%) 2 (6%) 2 (6%) 4 (13%)††† 0 
Sunshine26 13 3 (23%) 0 0 10 (77%)^^ 0 
Voigt28 80 21 (26%) 27 (34%) 27 (34%) - 5 (6%) 
Median (range) 481 71% (22%-100%) 4% (0%-37%) 6% (0%-34%)  1% (0%-44%) 
Pooled [95% CI] 58% [0.53-0.62] 12% [0.09-0.15] 12% [0.10-0.16]  12% [0.09-0.15] 
 
Note that the confirmation of the clinical diagnosis by the presence of detrusor overactivity corresponds to the positive predictive value.  
N, number of patients; DO, detrusor overactivity; SUI, stress urinary incontinence; MUI, mixed urinary incontinence; CI, confidence 
interval; ^^^ Unstable urethra (3); ‡‡ Overflow incontinence; ° Urgency/frequency (4; 1 also unstable urethra); °°Underactive detrusor (2), 
unstable urethra (1); ††† Not reported; ^^ Abnormal urethral electromyography. 
 
Table 2c. Urodynamic findings in women with the clinical diagnosis of urgency urinary incontinence
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Figure 2. Receiver operating characteristics curve showing accuracy estimates for symptoms and 
signs of overactive bladder in predicting detrusor overactivity in women with urinary incontinence 
 
Note that the x axis shows reversed specificity. The closer the index values are to the upper left corner 
of each graph, the greater the accuracy of the test. Sensitivity for predicting urodynamic detrusor 
overactivity in women with symptoms and signs of an overactive bladder was acceptable (0.76), but 
the specificity was only moderate (0.57).
Appendix A. Syntax MEDLINE 
(conventional procedures[Title/abstract] OR cystometry[Title/abstract] OR urethrocystometry[Title/abstract] 
OR cystomanometric[Title/abstract] OR urodynamic*[Title/abstract] OR “urodynamics”[MeSH Terms]) AND 
(“urinary incontinence”[MeSH Terms] OR “incontinence”[Title/abstract]) AND (diagnosis[Title/abstract] OR 
“diagnosis”[MeSH Terms] OR diagnostic*[Title/abstract] OR diagnoses[Title/abstract])
Appendix B. Syntax EMBASE 
(urine incontinence/ or mixed incontinence/ or stress incontinence/ or urge* incontinence/ or incontinence.
ti,ab.) AND (exp diagnosis/ or (diagnosis or diagnostic* or diagnoses).ti,ab.) AND ((cystometry or 
urethrocystometry or cystomanometric or urodynamic* or urodynamics).ti,ab. OR cystometry/ OR 
urethrocystometry/ or uroflowmetry/ OR urodynamics/)
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Discussion
In this review, clinical studies were summarised in order to investigate the potential role of 
urodynamics in the clinical decision making in women with urinary incontinence. We confirmed 
that the level of agreement between classification of women with incontinence based on 
clinical evaluation and based on urodynamic investigation is poor. What this review adds is that 
reclassification of type of incontinence was especially high among women with symptoms of MUI, 
where the diagnosis was altered after urodynamics in two thirds of these patients. This seems 
a relevant finding with possible clinical implications. Most women with MUI had pure SUI on 
urodynamics. The effects of urodynamics on the clinical outcomes after treatment have, however, 
not been studied. 
One study has made subgroups in the group of patients with MUI according to their predominant 
symptom.12 As expected, in the patients with stress predominant MUI symptoms there was 
a higher reclassification rate into urodynamic SUI (64%) compared with patients with urgency 
predominant MUI (18%). Thus, this division according to the predominant symptom in patients 
presenting with MUI seems helpful in the decision making for clinical management. 
A shortcoming of the available studies is that most studies used the patient’s symptoms as index 
test (61%), and not a combination with signs. In this review, the reclassification after urodynamics 
was, furthermore, very high and probably unacceptable. In our opinion, however, a decrease in 
  
 
 
Author N TP FP FN TN 
Sensitivity 
[95% CI] 
Specificity 
[95% CI] 
PPV 
[95% CI] 
NPV 
[95% CI] 
 
Busch8 175 17 5 17 136 0.50 [0.32, 0.68] 0.96 [0.92, 0.99] 0.77 [0.55, 0.92] 
 
0.89 [0.83, 0.93] 
Cundiff10 535 160 195 24 156 0.87 [0.81, 0.91] 0.44 [0.39, 0.50] 0.45 [0.40, 0.50] 0.87 [0.81, 0.91] 
De muylder11 408 147 91 89 81 0.62 [0.56, 0.68] 0.47 [0.39, 0.55] 0.62 [0.55, 0.68] 0.48 [0.40, 0.55] 
Diokno14 193 26 35 18 114 0.59 [0.43, 0.74] 0.77 [0.69, 0.83] 0.43 [0.30, 0.56] 0.86 [0.79, 0.92] 
Fitzgerald15 269 92 139 5 33 0.95 [0.88, 0.98] 0.19 [0.14, 0.26] 0.40 [0.33, 0.46] 0.87 [0.72, 0.96] 
Holtedahl16 42 13 6 4 19 0.76 [0.50, 0.93] 0.76 [0.55, 0.91] 0.68 [0.43, 0.87] 0.83 [0.61, 0.95] 
Iosif17 401 82 140 7 172 0.92 [0.84, 0.97] 0.55 [0.49, 0.61] 0.37 [0.31, 0.44] 0.96 [0.92, 0.98] 
Ishiko18 187 56 21 6 104 0.90 [0.80, 0.96] 0.83 [0.75, 0.89] 0.73 [0.61, 0.82] 0.95 [0.89, 0.98] 
Korda19 533 118 143 75 197 0.61 [0.54, 0.68] 0.58 [0.52, 0.63] 0.45 [0.39, 0.51] 0.72 [0.67, 0.78] 
Lagro-Jansen20 100 31 15 5 49 0.86 [0.71, 0.95] 0.77 [0.64, 0.86] 0.67 [0.52, 0.80] 0.91 [0.80, 0.97] 
Maes21 94 12 39 1 42 0.92 [0.64, 1.00] 0.52 [0.40, 0.63] 0.24 [0.13, 0.37] 0.98 [0.88, 1.00] 
Sand24 188 53 92 15 28 0.78 [0.66, 0.87] 0.23 [0.16, 0.32] 0.37 [0.29, 0.45] 0.65 [0.49, 0.79] 
Sandvik25 236 89 50 8 89 0.92 [0.84, 0.96] 0.64 [0.55, 0.72] 0.64 [0.55, 0.72] 0.92 [0.84, 0.96] 
Sunshine26 100 7 28 4 61 0.64 [0.31, 0.89] 0.69 [0.58, 0.78] 0.20 [0.08, 0.37] 0.94 [0.85, 0.98] 
Voigt28 217 48 32 24 113 0.67 [0.55, 0.77] 0.78 [0.70, 0.84] 0.60 [0.48, 0.71] 0.82 [0.75, 0.88] 
Pooled 3678 951 1031 302 1394 0.76 [0.73, 0.78] 0.57 [0.55, 0.59] 0.48 [0.46, 0.50] 0.82 [0.80, 0.84] 
 
N, number; TP, true positive; FP, false positive; FN, false negative; TN, true negative; CI, confidence interval; PPV, positive predictive value;  
NPV,  negative predictive value. 
 
Table 3. Single and pooled estimates for symptoms and signs of overactive bladder in predicting 
detrusor overactivity in women with urinary incontinence 
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reclassification may be expected when more non-invasive tests, such as a stress test and bladder 
diary, would be used to affirm the symptoms. In another study, sensitivity and specificity of a 
clinical diagnosis based on questionnaires and a bladder diary, compared with urodynamics 
in diagnosing DO, were 0.88 and 0.83 respectively.29 The clinical stress test compared to multi-
channel urodynamics for the diagnosis of SUI has a sensitivity - specificity combination of 0.85 
(95% CI 0.78-0.91) – 0.83 (95% CI 0.74-0.90), respectively.30 A diagnosis based on the combination 
of symptoms from the patient’s history and various non-invasive tests is probably more near to the 
workflow in daily practice, and is likely to show better agreement with urodynamics. Unfortunately, 
in our study, the data were insufficient to show difference between the reclassification rate based 
on symptoms only and based on the combination of symptoms and signs.  
In the included studies, it was mostly not clear whether women with an advanced pelvic organ 
prolapse had been excluded. Moreover, in those studies that included women with a pelvic 
organ prolapse, it remained unclear whether there was a correlation between a prolapse and the 
agreement between history and urodynamics. In the further available literature there were no data 
concerning diagnostic performance of urodynamic investigation in patients with and without a 
pelvic organ prolapse, and with and without redression of the prolapse during urodynamics. It 
was not possible to do subgroup analyses with and without a pelvic organ prolapse, and therefore 
all papers were analysed as one group in the present study.
As has been reported previously31, this study showed that DO was present in 16% of women without 
symptoms of an overactive bladder. One previous study has reported worse treatment outcomes 
in patients without symptoms of overactive bladder but with DO on urodynamics who underwent 
a Burch colposuspension.32 That study indicated the need for urodynamics in all women in whom 
incontinence surgery is considered, even without overactive bladder symptoms. In our review, in 
only 7% of women, the clinical diagnosis of pure SUI was reclassified into DO after urodynamic 
investigation. Two studies provided detailed information on patients with urodynamic DO and a 
history of pure SUI.7,9 In 63% of cases, it appeared to concern stress induced urgency incontinence. 
It has been published that midurethral sling procedure cured 92% of patients with this specific 
type of incontinence.33 For this reason, in patients with stress induced urgency incontinence, 
urodynamics are unlikely to improve the effectiveness of treatment. Urodynamic investigation has 
the risk of delay or inadequate treatment, because these patients may be treated for DO instead of 
an incompetent closure mechanism. This risk needs to be offset against the risk to overlook pure 
DO in women with symptoms of pure SUI planned to undergo surgery for SUI. 
Besides classification of the incontinence, urodynamics can potentially attribute to the detection 
of preoperative factors that influence the effectiveness of surgery for SUI and complication rate 
such as voiding dysfunction. In this review, the percentage of “other findings” on urodynamics 
varied between 0 en 77%. Whether these findings had any clinical consequences is not known. 
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Likewise, the effect on clinical outcome of a discordant classification between clinical and 
urodynamic diagnosis has not been determined in any of the included studies.
Despite the absence of evidence regarding the value of urodynamic investigation, urodynamics 
are generally considered to be superior to a clinical diagnosis. Various retrospective cohort studies 
have concluded that findings on urodynamics do not predict the outcomes after surgery for SUI 
in women, whereas there are no studies available that have shown the benefit.34,35 The results 
of a multicentre randomised controlled trial with validated questionnaires and standardised 
urodynamics would provide evidence on the effect of urodynamics on treatment outcome.36 
Conclusions
In conclusion, the reclassification rate among clinical stress, mixed and urgency urinary incontinence 
after urodynamic investigation is high. Especially in women with MUI, pure urodynamic SUI is 
common. Whether the more wide use of non-invasive tests in the clinical diagnosis would improve 
the agreement is likely, but not proven yet. The effects of urodynamic observations on the choice 
for various treatments and the effects on treatment outcomes need further investigation. 
34
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Abstract
Introduction
The aim of this study was to assess variations in practice in the use of preoperative urodynamics 
in women with stress urinary incontinence.
Methods
We performed an E-survey among all Dutch gynaecologists and urologists who have stress 
urinary incontinence as focus in daily practice. The questions concerned the common policy and 
preferred policy. Descriptive statistics were used.
Results
Of the 260 targeted specialists, 163 (63%) responded. We found that 37% of the respondents 
performed standard preoperative urodynamics; in the preferred practice, this would reduce to 
only 18%. Eighty percent indicated that they would operate a patient without urodynamic stress 
urinary incontinence but with a positive stress test, whereas 21% would do this in case the clinical 
stress test was negative. Only 9% of the respondents indicated that they adapted the choice of the 
type of sling based on urethral pressure profilometry parameters.
Conclusions
Urodynamics are not routinely performed and outcomes hardly influence the choice of treatment. 
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Introduction
Stress urinary incontinence (SUI) is a frequently occurring problem. The Health Council of the 
Netherlands estimated that yearly 64.000 women consult their general practitioner because of 
urinary incontinence.1 When conservative treatment fails, patients can opt for surgical therapy. The 
most common procedure for SUI is the midurethral sling procedure. These slings have an average 
success rate of 90%.2 The introduction of these minimally invasive techniques for SUI therapy has 
led to an enormous increase in the number of operations in the Netherlands.3
At present, there is an ongoing discussion among gynaecologists and urologists regarding the need 
for urodynamics in the preoperative work-up in women with (predominant) SUI. Urodynamics are 
an extension of signs and symptoms in an unphysiological setting. The information gained from 
urodynamic investigation may confirm or alter the clinical diagnosis or may influence the choice 
of intervention. When performing urodynamics, the assumption is that the urodynamic setting 
is capable of making a distinction between several pathophysiological mechanisms causing the 
same micturition symptoms. However, the urodynamic investigations that differentiate between 
several types of urinary incontinence and specify for the type of treatment, lack validation and 
predictive value in individual cases.4 Moreover, since the introduction of easy to administer 
midurethral polypropylene slings, a simplified reasoning has found ground that states that every 
type of SUI is treated in the same way, and therefore, no urodynamic investigation would be 
needed. 
The National Institute for Clinical Excellence (NICE) recommends since 2006 that the use of multi-
channel cystometry is not routinely needed before surgery in women with a clearly defined 
clinical diagnosis of pure SUI. The test is recommended for women with a clinical suspicion of 
detrusor overactivity (DO), symptoms suggestive of voiding dysfunction, or in those with previous 
surgery for SUI or anterior compartment prolapse.5 In the Netherlands, the guidelines still advise to 
perform urodynamics in all patients prior to surgery to confirm the diagnosis of SUI and to detect 
factors which can influence the effectiveness of surgery and the probability of complications.6-8
The implementation of these guidelines in clinical practice seems to be limited9 and probably 
decreasing. During the set up of a randomised trial, we found that presently there is no uniform 
standard work-up for women with SUI in clinical practice. There seems to be a wide variety in the 
diagnostic work-up, ranging from women who are evaluated and treated in primary care settings 
without an extensive diagnostic evaluation till women who are directly referred to undergo 
urodynamics even before seeing the specialist. 
The objective of this study was to determine the use of urodynamics in current practice and the 
opinion about the need to perform preoperative urodynamic investigation in patients with SUI 
according to gynaecologists and urologists with special interest in SUI.
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Materials and Methods
The target populations of this survey were gynaecologists and urologists who have treatment for 
SUI as focus in daily practice. A specific mailing list of these specialists was not available. Therefore, 
the questionnaire was emailed to all gynaecologists and urologists in the Netherlands who are 
member of the Dutch Society of Obstetrics and Gynaecology or the Dutch Urological Association. 
The member records consist of approximately 98% of the Dutch practitioners. The number of 
target specialists was estimated at 190 gynaecologists and 70 urologists based on information of 
the professional organisations. 
The link to the survey was provided in an email. The answers were web-based collected by a 
digital E-survey. Name and hospital were checked for duplicates. In case the survey was answered 
anonymously, internet protocol (IP) address and completion time were checked. A reminder was 
sent after 3 weeks in order to enlarge the response rate.
The survey included a short letter to explain the purpose of the survey. In total, the questionnaire 
contained 26 questions and can be obtained on request from the corresponding author. The 
questions concerned the common policy and the preferred policy. The preferred policy refers to 
the ideal work-up according to the respondents, regardless common practice in their hospital. 
All questions focused on women with SUI after conservative treatment but without prior 
incontinence surgery and without advanced pelvic organ prolapse (beyond Pelvic Organ Prolapse 
Quantification (POP-Q) stage 2). Various discordant findings on urodynamics were proposed, and 
respondents were asked what effect on their choice for treatment these findings would have. 
Multiple choice questions with the possibility to make a comment were designed to encourage 
complete answers. General questions regarding the number of anti-incontinence surgery 
performed yearly in the affiliated hospital and by the respondent, the number of urodynamics 
performed yearly and the frequency of assessment of urodynamic curves by the respondent were 
also included.
Data are presented as percentage and mean percentage. Data were analysed by using Statistical 
Package for the Social Sciences (SPSS) version 16.0. We used descriptive statistics.
A summary of the survey details according to the Checklist for Reporting Results of Internet 
E-Surveys guidelines is shown in Appendix A.10
Results
The survey was conducted in January 2010. We received 253 responses, of which five duplicates 
based on name or IP address were removed. Residents and non-practitioners were excluded from 
assay. The analysis was confined to 103 gynaecologists and 60 urologists who indicated to have 
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treatment of SUI as focus in daily practice. The response rate among the target specialists was 65% 
(163/260; 54% for gynaecologists and 86% for urologists). The characteristics of the respondents 
are shown in Table 1. From 80 out of the 94 hospitals (85%) in the Netherlands, at least one 
response was received. All eight Dutch university medical centres were represented. 
Table 2 shows the performance of preoperative urodynamics in the actual and preferred work-up. 
The factors which were considered as indications to perform urodynamic investigation are shown 
in Table 3. In case SUI cannot be demonstrated on urodynamic investigation but the stress test is 
positive on clinical examination, 83 gynaecologists (81%) and 47 urologists (78%) would operate 
Table 1. Characteristics of respondents 
 
 
 
Gynaecologists Urologists Total 
N =103 N = 60 N = 163 
Type of hospital Academic 8 (8%) 8 (13%) 16 (10%) 
 Teaching 49 (48%) 32 (53%) 81 (50%) 
 Non-teaching 34 (33%) 18 (30%) 52 (32%) 
  Unknown 12 (12%) 2 (3%) 14 (9%) 
MUS yearly in own hospital 0-10 6 (6%) 3 (5%) 9 (5%) 
 0-50 58 (56%) 37 (62%) 95 (58%) 
 >50 35 (34%) 20 (33%) 55 (34%) 
  ? 4 (4%) 0  4 (2%) 
Operations yearly by specialist 0-10 20 (19%) 18 (30%) 38 (23%) 
0-50 76 (74%) 36 (60%) 112 (69%) 
 >50 4 (4%) 3 (5%) 7 (4%) 
  ? 3 (3%) 3 (5%) 6 (4%) 
Urodynamics results 
interpreted by investigator 
Always 43 (42%) 27 (45%) 70 (43%) 
Often 21 (20%) 7 (12%) 28 (17%) 
 Sometimes 12 (12%) 9 (15%) 21 (13%) 
 Never 20 (19%) 17 (28%) 37 (23%) 
  ? 7 (7%) 0  7 (4%) 
Able to read urodynamics Yes 55 (53%) 55 (92%) 110 (67%) 
 No 42 (41%) 3 (5%) 45 (28%) 
  ? 6 (6%) 2 (3%) 8 (5%) 
    Mean (range) Mean (range) Mean (range) 
Type of procedure Retropubic sling 20% (0-100) 22% (0-100) 21% (0-100) 
 Transobturator sling 69% (0-100) 65% (0-100) 70% (0-100) 
 Minisling 4% (0-95) 9% (0-100) 6% (0-100) 
 Burch 1% (0-15) 3% (0-80) 1% (0-80) 
 Bulk injections 1% (0-20) 1% (0-10) 1% (0-20) 
 Other 0% (0-2) 1% (0-20) 1% (0-20) 
 
  
MUS, midurethral sling; ? Respondent answered ‘I don’t know’.   
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on the patient. In case the SUI could not be demonstrated during physical examination nor at 
urodynamics, only 22 gynaecologists (21%) and 11 urologists (18%) would operate. 
A history of overactive bladder symptoms with suspected DO, e.g. urgency symptoms or 
a micturition frequency of more than seven times a day, was the most common indication to 
perform preoperative urodynamics. DO on urodynamics was an important reason not to perform 
an operation. In case urodynamic investigation showed detrusor overactivity, 13 gynaecologists 
(13%) and 12 urologists (20%) would perform surgery and only in case of complaints afterwards 
would start anticholinergics. Ninety gynaecologists (87%) and 48 urologists (80%) would renounce 
or reconsider the operation for SUI and start a treatment aimed at controlling DO first. 
Ninety-three respondents (57%) indicated that a urethral pressure profile is part of a standard 
urodynamic investigation. Only 15 respondents (9%), however, would choose the type and 
technique of surgery based on urethral pressure profile outcome, especially the maximum urethral 
closure pressure. Only three respondents (2%) mentioned to use the maximum urethral closure 
pressure when counselling on success rates. Sixty-eight respondents (42%) indicated that a Valsalva 
leak point pressure is part of a standard urodynamic investigation. Fifty-two respondents (32%) 
indicated that neither an urethral pressure profile nor a Valsalva leak point pressure is performed 
during urodynamics.
One hundred and seventeen respondents (72%) indicated to use only one type of sling in more 
than 90% of all anti-incontinence procedures; in 55% a transobturator tape, in 15% a retropubic 
sling and in 2% a single incision sling is used in more than 90% of cases. Seventy-two respondents 
(44%) indicated to use only one type of sling in all procedures.
The interpretation of the urodynamic investigation is in 43% always performed by the specialist 
that orders the investigation. Forty-two gynaecologists (41%) indicated to be unable to interpret 
the curves of an urodynamic investigation themselves, versus only two urologists (3%).
Discussion
This is a report on practice variation and the perceived value of preoperative urodynamics 
according to gynaecologists and urologists with special interest in treatment of SUI in the 
Netherlands. Although urodynamics are widely used, it still needs to show evidence that 
performing urodynamics does improve the outcome of anti-incontinence procedures.11 Despite 
this, guidelines recommend that women undergoing surgery for SUI should have a urodynamic 
investigation prior to treatment.6-8 This study shows that existing guidelines are very poorly 
implemented. Only in one third of the respondents, the standard work-up before surgery for SUI 
includes an urodynamic investigation, and in the preferred setting, this would be only in one 
fifth. The majority prefers to perform urodynamics only when there is an indication during history 
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taking, bladder diary or clinical examination. The indications, as well the related consequences of 
urodynamic findings, vary widely.
The respondents seem to attribute substantial relevance to the stress test during clinical 
examination. The cough stress test has a reported sensitivity of 0.85 (0.78-0.91) and specificity 
of 0.83 (0.74-0.90) for the diagnosis of urodynamic SUI in women compared with multi-channel 
urodynamics.12 A correlation between the result of the stress test during clinical examination and 
clinical outcome is however not reported. One study showed higher, albeit not significant, overall 
success in women with a positive stress test during both clinical examination and urodynamic SUI, 
as compared to women with a positive stress test during clinical examination only.13
The perceived value of the stress test during clinical examination illustrates that in clinical 
practice, urodynamics are mostly not used as confirmation of the diagnosis of an incompetent 
sphincter mechanism. The revealed information on the risk of failure and complications like de 
novo urgency or aggravation of urgency and urinary retention was considered more important. 
This management is in line with previous studies which have shown less successful treatment 
outcomes in patients with DO, voiding dysfunction or intrinsic sphincter deficiency.14-17
However, when urodynamics are only performed in patients with symptoms or signs, many 
patients would be misdiagnosed. In patients without overactive bladder complaints, in 20% 
detrusor overactivity was found.18 The majority indicated to renounce of a primarily surgical 
treatment when preoperative DO is found.
Although there is a lack of controlled studies available on whether urodynamics predict stress 
continence outcome, it is reported that the subjective cure rate of SUI after surgical treatment 
decreases in case of preoperative DO.9,19,20 However, it has been shown as well that complaints of 
stress and urgency urinary incontinence can be cured in 50-85% of women with mixed urinary 
incontinence after colposuspension and midurethral sling.21-23 Therefore, the preoperative 
diagnosis of DO could attribute to the counselling of patients about the perspectives of surgery, 
but it is a question whether it should influence the choice of treatment. 
A recent meta-analysis of randomised controlled trials, as well as a randomised equivalence trial, 
on the effectiveness of the transobturator tape (TOT) compared to the retropubic tape (TVT) in 
women with SUI, revealed that the classic TVT appeared to be followed by higher objective cure 
rates than the TOT but with no difference in subjective cure rates and at the cost of higher risks 
of operative complications, voiding dysfunction and storage lower urinary tract symptoms.22,24,25 
For women with a maximum urethral closure pressure less than 20 cm H2O, the TVT appears 
to be a better option because it is more obstructive.24,26-28 After a longer period of follow-up, 
women with SUI and maximum urethral closure pressure less than 20 cm H2O are significantly 
less likely to require further surgery for SUI with the TVT than the TOT.29 Therefore, the use of the 
urethral pressure profile could attribute to the determination of the most effective type of sling 
in individuals. However, in Dutch practice, the choice of sling was rarely especially based on this 
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measurement. Possibly, this is due to surgeon’s experience and familiarity with only one type of 
sling procedures (TOT or TVT) or to a poor understanding of the interpretation of the urethral 
pressure profile. Two third of the respondents indicated to use one particular sling in more than 
90% of procedures, and almost half of them use only one type of sling in all of their patients. 
This study shows that the expertise, of especially gynaecologists, in the interpretation of 
urodynamic curves is poor. This is despite the fact that the final qualifications of the training to 
gynaecologists contain the objective to be capable to interpret the results of urodynamics.30 Our 
target population consisted of gynaecologists with special interest in SUI; it is reasonable they 
should have a good understanding of urodynamic theory and practice. In case the interpretation 
of urodynamic curves or written results is performed without complete understanding, the results 
will not be reliable and less valuable.
The limitations of the conclusions offered by this survey include the shortcomings of web surveys 
in general and the moderate response rate. However, bias was avoided by exclusion of residents 
and specialist not treating women for urinary incontinence in the analysis. Also, multiple entries 
from the same individual were avoided. All kinds of hospitals were represented (academic, teaching 
and non-teaching hospitals). Therefore, the included responses are thought to be representative 
for the Dutch specialists treating SUI in daily practice. 
The variety in use of preoperative urodynamics indicates the necessity of conclusive evidence 
on patient groups in whom a preoperative urodynamic investigation is valuable. As suggested 
in previous reports, a randomised controlled trial in this specific patient group can show which 
patients would benefit from preoperative urodynamics.11,31 This might lead to adaptation 
of guidelines and a more uniform work-up. In case predictive information retrieved from 
urodynamics does however not lead to an adjustment of treatment strategy, a potential positive 
value of urodynamics would still be lost.
Conclusions
Guidelines on indications for urodynamics are not widely implemented, resulting in practice 
variation in the preoperative work-up in women with (predominant) SUI. Urodynamics are not 
routinely performed as indicated, and the outcomes hardly influence the choice of treatment. 
The practice variability indicates the necessity of conclusive evidence on the patients in 
whom to perform preoperative urodynamic investigation, and a consequent modification and 
implementation of the guideline in order to create a more uniform work-up. 
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Appendix A. Summary of the survey details according to the Checklist for Reporting Results of 
Internet E-Surveys guidelines
D
es
ig
n
Survey Design The target populations of this survey are gynaecologists and urologists 
who have treatment of SUI as focus in daily practice. The survey was 
emailed to all members of the Dutch Urological Association and the 
Dutch Society of Obstetrics and Gynaecology to reach as most as possible 
of the target specialists. The number of target specialists was estimated 
at 190 gynaecologists and 70 urologists based on information of the 
professional organizations.
IR
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st
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l R
ev
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w
 B
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pp
ro
va
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rm
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 c
on
se
nt
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ss
IRB Approval IRB approval was not needed. 
Informed Consent The participants were informed on the fact that their responses would be 
used only for the purpose of this study.
Data Protection The following commercial web survey provider was used: emailenquete.nl. 
All data were hosted by emailenquete.nl. An e-link to the survey was 
created, the web survey provider did not dispose of email addresses. 
Names and IP addresses were checked for duplicates. After removal of the 
duplicates, the responses were analysed anonymously.
D
ev
el
op
m
en
t 
an
d 
pr
et
es
tin
g Development and testing The questions were composed by an expert panel of 3 subspecialists. The 
web survey was tested before the start of the study.
Re
cr
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t p
ro
ce
ss
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nd
 th
e 
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 th
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sa
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ng
 a
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es
s 
to
Open survey versus 
closed survey
It was a closed survey. The survey tool automatically created a link that 
allowed access to the online survey. This link was emailed to the 
respondents and not published online.
Contact Mode The target population received an email explaining the goals and 
purposes of the survey and asked for their participation. This email 
included the link to the online survey. Three weeks after the first email, 
one reminder email was sent.
Advertising the survey No advertising was used.
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Su
rv
ey
 A
dm
in
is
tr
at
io
n
Web / email The link to the survey was provided in an email. Respondents could only 
get access to the web-based survey by clicking on the link. The data were 
collected automatically after their submission.
Context Not applicable.
Mandatory/voluntary Responding to the survey was voluntary. 
Time/date The survey was conducted in January 2010.
Randomisation of items 
or questionnaires
No items or questionnaires were randomised.
Adaptive questioning Adaptive questioning was mostly used. Only two questions were 
conditional. Based on the answer, respondents were directed to an 
additional question or to the next question.
Number of Items At the end of each division of the survey, the progression was displayed in 
a percentage of completeness. In total 26 questions were pointed.
Number of screens 
(pages)
Only one question was displayed on a screen. After answering the 
question, a new question was displayed on a new screen. 
Completeness check Each submitted response was checked for completeness. This functionality 
was available in the survey instrument by making all of the questions 
mandatory. All questions contained the answer ‘I don’t know’. 
Review step Respondents were able to go back to previous pages and update existing 
answers until the survey was finished or until they have closed the survey. 
After the survey was finished, the respondents were not able to re-enter 
the survey.
Re
sp
on
se
 ra
te
s
Unique site visitor Unique visitor was determined by name and affiliated hospital and, in case 
missing, by IP address. 
View rate There were 253 completed responses of 248 unique site visitors. The 
response rate of the target population was 63% (163/260).
Participation rate All unique visitors completed the full survey.
Completion rate All unique visitors completed the full survey.
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Cookies used Not used
IP check In case the name and affiliated hospital were not completed, the 
IP address of the client computer was used to identify potential 
duplicate entries from the same user. In case the survey was completed 
anonymous, in combination with a duplicate IP address, the last 
responses was kept for analysis. Two entries were removed before 
analysis based on a duplicate IP address. 
Log file analysis No log file analysis was performed.
Registration Voluntary completion of name and affiliated hospital.
A
na
ly
si
s
Handling of incomplete 
questionnaires
Only completed surveys could be submitted. Therefore no incomplete 
surveys were included in the analysis. 
Questionnaires 
submitted with an 
atypical timestamp
Not applicable
Statistical correction Not applicable
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Abstract 
Introduction 
The value of information obtained with urodynamics depends on the quality of testing techniques, 
reports and interpretation. These factors may differ among centres and practitioners in multicentre 
trials. The aim of this study was to assess the technical quality of the urodynamic investigations 
and the interobserver agreement of its interpretation between local and central researcher. 
Methods 
We studied consecutive women with complaints of stress urinary incontinence who were included 
in a multicentre randomised controlled trial entitled ‘the Value of Urodynamics prior to Stress 
Incontinence Surgery 2 study’. All participants underwent multi-channel urodynamics. All traces 
were re-reviewed blindly by one central reviewer and assessed for quality using a standardised 
checklist based on the guideline on ‘Good Urodynamic Practice’. Furthermore the interrater 
reliability between local and central researcher was analysed using the kappa statistic and overall 
agreement for various discordant urodynamic findings. 
Results
We studied the urodynamic traces of 543 patients. In most traces (>99%) pressure catheters were 
appropriate positioned and during all investigations a cough test was performed. The traces scored 
poorly in terms of the use of annotations for leakage (57%) and adequate frequency of coughs to 
ensure right positions (25%). The interrater reliability between local and central researcher for the 
diagnosis of urodynamic stress incontinence was found to be very good with kappa = 0.81 (95% 
CI 0.76-0.86, raw agreement 91%) and moderate for the observation of detrusor overactivity kappa 
= 0.52 (95% CI 0.38-0.66, raw agreement 94%). 
Conclusions 
Although the guideline on ‘Good Urodynamic Practice’ was not strictly adhered to, the quality 
of most traces was sufficient to assess the presence of urodynamic stress incontinence, detrusor 
overactivity and voiding pattern. The reproducibility on diagnosis of the absence for urodynamic 
stress incontinence was almost perfect, but moderate for detrusor overactivity. Other discordant 
findings with the patient’s history were often not identified but raw agreement was good.
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Introduction
Stress urinary incontinence (SUI) is a common problem among adult women, with an overall 
prevalence of 25-57%.1 For women in which conservative measures were not successful, the 
most common surgical therapy is the midurethral sling procedure. Preoperative urodynamics 
are advised to confirm the diagnosis of SUI and to detect factors which may influence the 
effectiveness of surgery and the probability of complications.2-4 However, no prospective study 
exists that has determined the value of urodynamics prior to surgery for SUI. The reliability and 
reproducibility of urodynamic data depends on standardised testing techniques, adequate 
reports and interpretation.5 These factors may differ among centres and practitioners, and may 
both influence clinical decision making and scientific results. 
In recent years, several guidelines have been published to improve standards and the 
comparability of urodynamic studies internationally.6-8 In 2002, the International Continence 
Society (ICS) developed a guideline on ‘Good Urodynamic Practice’ (GUP).9 This document covers 
recommendations on technical requirements for catheters, equipment, calibration, zeroing, signal 
quality control and plausibility, that are useful for standardising urodynamics across centres. In 
addition, the Urinary Incontinence Treatment Network (UITN) established interpretation guidelines 
to assist local reviewers in assessing urodynamic studies in a multicentre trial, therefore a central 
review process of all traces would not be necessary to obtain reliable measurements.10 It has been 
shown that careful implementation of these guidelines realised adequate interrater reliability for 
numerical cystometry variables in a multicentre trial of incontinence surgery.11 
Several studies have evaluated the interobserver variability of urodynamics. Interobserver 
agreement has been reported to be substantial for urodynamic SUI with a kappa of 0.74.12 For 
detrusor function the interobserver agreement is moderate to substantial with kappa of 0.59-0.80 
and raw agreement of 78%-91%.11,12 
Reproducibility of the potential clinical consequences has, however, not been well determined. 
The objective of this study was to review the technical quality of urodynamic traces, the adherence 
to the guideline on GUP, and to assess the agreement on the classification as concordant or 
discordant between local and central researchers. This study was performed among all women 
included in a multicentre trial on the effectiveness of urodynamic investigation among women 
with symptoms of SUI.13 
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Materials and Methods
We performed a multicentre, diagnostic cohort study involving a non-inferiority randomised 
controlled trial (‘the Value of Urodynamics prior to Stress Incontinence Surgery (VUSIS) 2’ study). 
This trial was conducted in 6 academic and 24 non-academic hospitals in the Netherlands. 
The study was embedded within the Dutch Urogynaecology Consortium, which is a research 
collaboration network in The Netherlands (www.studies-obsgyn.nl). 
Ethical approval for this study has been obtained from the institutional review board of the 
Radboud University Nijmegen Medical Centre on 02-10-2008 (2006/197). All participating 
centres approved local feasibility of the study. All patients gave written informed consent before 
enrolment. This study was registered in clinicaltrials.gov, number NCT00814749.
Details of the enrolment criteria and the study design have been published previously.13 Women 
were eligible for the study in case they had SUI or mixed urinary incontinence with predominant 
symptoms of SUI. To be included, conservative therapy had to have failed and patients had to be 
indicated for surgical treatment. Furthermore, incontinence had to be demonstrated on physical 
examination and/or bladder diary. Patients with previous incontinence surgery, a pelvic organ 
prolapse >1 centimetre beyond the level of the hymen (stage 3 or more), and/or with postvoid 
residual urine (PVR) of more than 150 ml on ultrasound or catheterisation were excluded. 
All women underwent a urodynamic investigation at inclusion (baseline). The study protocol 
stated that urodynamics should be performed according to the International Continence 
Society (ICS) standards, it was not determined before the trial whether guidelines were locally 
applied. Urodynamics should consist of a free flow and measurement of PVR, a provocative filling 
cystometry and a pressure flow study. A urethral pressure profilometry in rest and during stress 
was optional.9 The specifications of the performance of urodynamics are shown in Table 1.
Urodynamics were called discordant in case they did not confirm the clinical diagnosis of SUI 
or showed relative contra-indications for an operation, e.g. in case of detrusor overactivity (DO), 
Table 1. Additional information on urodynamic equipment and performance for the 30 participating 
centres 
 
Trademark: Andromeda 5  Medtronic 2  MMS  23 
Position (Filling & Voiding): Sitting 30  Standing 0  Supine 0 
Type catheter: Air-charged 13  Fluid 15  Microtip  2 
Size catheter: ≤7 Fr 24  8 Fr 4  9 Fr  2 
Prophylactic antibiotics: Yes 5  No 25    
Cystoscopy: Yes 10  No 20    
 
 
MMS, Medical Measurement Systems; FR, french.  
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reduced bladder sensation, small cystometric maximum capacity, weak flow, large PVR or voiding 
dysfunction. Cutoff levels for normal and abnormal values were not provided, but were left to the 
discretion of the observer. 
Urodynamic traces were assessed and classified by the local specialists of the participating hospitals 
using a standard case record form. Copies of the urodynamic traces were collected. Quality criteria 
as described below were defined prior to reassessment (SL, JH). All available urodynamic traces 
were blindly reviewed by one central reviewer (SL) and discussed in a consensus meeting in 
case necessary (JH). Used definitions of parameters and conditions were in accordance to the 
report on the terminology for female pelvic floor dysfunction of the ICS and the International 
Urogynaecological Association (IUGA).6
Quality control
For the purpose of this study, a quality criteria list which was mainly based on the guideline on GUP 
8,13, was developed and consisted of the following items; appropriate filling speed (≤ 50ml/min), 
zero to atmospheric pressure (sitting 15-40 cmH2O 
9), correct position of abdominal and vesical 
pressure catheters, frequent coughs to ensure right position (at least 1x/min or 1x/50ml), filling till 
500 ml or to functional capacity (measured by bladder diary), use of annotations (cough, leakage, 
sensation), voiding command, electromyography connected, vesical catheter remains in place 
throughout void, determination and registration of residual volume. The position of the catheters 
was considered correct in case the signals of the abdominal and the intravesical pressure line 
responded equally during coughs, this assessment was independent of the frequency of coughs 
and of the baseline pressures. Coughs were identified by characteristic narrow upward spikes on 
the intravesical and the intra-abdominal pressure line. For total filling, a volume over 600ml or 
more than 10% deviation from functional capacity scored negatively on quality. Displacement of 
the intravesical pressure line after voiding was identified by a sudden and continuous decrease 
of the intravesical pressure. The free flow was assessed by using the Liverpool diagram, a velocity 
below p10 was considered as weak flow.14 A free flow volume of at least 150 ml was considered as 
a sufficient volume to be representative.8 
The following five quality items were considered as most clinically relevant for the study 
population: correct position of the catheters during the filling and voiding phase, the presence of 
cough tests to check position and to observe urodynamic stress urinary incontinence (USUI), the 
use of a marker for leakage and determination of the PVR after urodynamics or free flow. 
Analysis
All data were combined in one database. Data were analysed by using the Statistical Package for 
the Social Sciences (SPSS) version 18.0. An interrater reliability analysis using the kappa statistic and 
level of agreement was performed to determine consistency between local and central assessor 
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for urodynamic SUI, DO, compliance, poor flow, PVR, and obstructive voiding. Kappa is an index 
of agreement beyond chance. Kappa ranges 0.8-1.0 0.6-0.8 0.4-0.6 0.2-0.4, 0.00-0.2 and less than 
0.00 were interpreted as almost perfect, substantial, moderate, fair, slight or poor agreement, 
respectively.15 The measure of raw agreement indicates the number of instances in which raters 
agree exactly, relative to the total number of judgments. Positive agreement estimates the 
conditional probability, given that one of the raters, randomly selected, makes a positive rating, 
the other rater will also do so. Negative agreement estimates this for a negative rating.
 
Results
Between January 2009 and November 2010, 607 women were approached to participate in the 
VUSIS 2 study. Twenty-nine patients were excluded from the trial since they did not fulfil the in- 
and exclusion criteria or did not undergo an urodynamic investigation. Figure 1 shows the study 
profile. In total, 543 copies out of 578 urodynamic traces (94%) were available for the present study. 
Thirty-six traces were excluded from the voiding phase analysis due to the inability to void with a 
catheter. The characteristics of all included patients are presented in Table 2.
Table 3 presents the results of the quality assessment. The traces scored poorly in terms of the 
use of annotations for leakage (57%), and adequate frequency of coughs to ensure right pressure 
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(n= 578) 
Traces for review 
N = 543 (94%) 
Concordant  
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Voiding cystometry              508 
Urethral Pressure Profile     315 
Stress Profile                           275 
Assessed for eligibility (n= 607) 
Figure 1. Study profile 
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sensor positions (25%). The mean number of coughs during the urodynamic investigation was 5 
(±2.3, range 1-17). The mean volume interval between coughs was 1x/100ml ±52. 
The mean of the fulfilled quality criteria (Table 3) was 10 (±1, range 1-12). For the five clinically most 
relevant items, the mean of fulfilled criteria was 4 (±1, range 0-5). 
In thirteen cases a final classification could not be made due to insufficient quality. In two cases 
this was based on an incorrect position of the catheters and in eleven traces a uroflowmetry was 
missing. 
Local specialists scored 268 of the 578 traces (46%) as discordant, the central researcher scored 277 
of the 530 classifiable traces as discordant (52%). For all discordant findings, the prevalence, kappa 
values and raw, positive and negative agreement are shown in Table 4.
The interrater reliability between local and central researcher for the diagnosis of USUI was found 
to be very good with kappa = 0.81 (95% CI 0.76-0.86, raw agreement 91%) and moderate for 
the observation of DO with kappa = 0.52 (95% CI 0.38-0.66, raw agreement 94%). The interrater 
agreement for the various items associated with voiding dysfunction (high preoperative PVR, low 
maximum flow velocity and obstructive micturition), was found to be poor with kappa values 
between 0.15-0.50, the raw agreement was good with 96-100%.
Table 2. Characteristics of the 543 patients
 
Medical history  
Age (years) 52 (±11) 
Body Mass Index (kg/m2) 27 (±5) 
Parity (number of children) 2 (±1) 
Nulliparous 23 (4%) 
Urogenital Distress Inventory   
SUI 196 (36%) 
MUI, predominant SUI 347 (64%) 
Subscale urinary incontinence score 55 (±22) 
Subscale overactive bladder score 24 (±23) 
Subscale obstructive symptoms score 15 (±21) 
Bladder diary   
Daily micturition frequency  8 (±2) 
Nightly micturition frequency 1 (±1) 
 
 
Data are presented as mean (±SD) or a number (%). 
Kg, kilogram; m, metre; SUI, stress urinary incontinence; MUI, mixed urinary incontinence. 
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Discussion
In this prospective multicentre study, the technical quality, the adherence to the GUP guidelines 
and the interrater reliability of the classification of urodynamics were assessed. Urodynamics 
should meet certain quality requirements to may provide additional information. Non-adherence 
Table 3. Quality control
 
Quality control criterion Yes %  No % Indeterminate % 
1. Appropriate filling speed 534 99  8 1   
2. Correct position of catheters 537 99  4 <1 1 <1 
3. Zeroed at atmospheric pressure 485 89  56 10 1 <1 
4. Filling up to functional capacity or 500ml 435 80  72 13 35* 6 
5. Good quality cough signals at appropriate intervals  138 25  404 75   
 Cough test performed 542 100  0 0   
6. Use of annotations; cough 445 82  97 18   
7. Use of marker; leakage 308 57  234 43   
8. Use of marker; sensation 527 97  15 3   
9. EMG connected 499 92  43 8   
10. Voiding command indicated 520 96  22 4   
11. Vesical pressure measurement during pressure flow 489 96  19 4   
12. Determination and registration of residual volume 456 87  68 13   
 
 
Percentages were calculated for the number of traces available for the concerning quality item (542 fillingscystometry, 508 voiding 
cystometry). 
 
* Functional capacity unknown; EMG, electromyogram. 
 
Table 4. Agreement on classification into discordant urodynamic findings
 
Discordant urodynamic finding N Local Central Kappa 95% CI RA PA NA 
Stress incontinence is not demonstrable 542 218 234 0.81 0.76-0.86 91% 80% 86% 
Detrusor overactivity 538 31 42 0.52 0.38-0.66 94% 38% 94% 
Small cystmetrical maximum capacity 542 4 11 0.12 -0.12-0.36 98% 7% 98% 
Low level of compliance  542 2 2 1.0  100% 100% 100% 
Weak flow 524 9 15 0.15 -0.05-0.35 96% 9% 96% 
Obstruction of micturition 524 2 2 0.50 -0.1-1.1 98% 33% 100% 
Postvoid residual 524 6 7 0.30 -0.03-0.63 100% 18% 98% 
 
 
 
Kappa is an index of agreement beyond chance. The measure of raw agreement indicates the number of instances in which raters agree 
exactly, relative to the total number of judgments. Positive agreement estimates the conditional probability, given that one of the raters, 
randomly selected, makes a positive rating, the other rater will also do so. Negative agreement estimates this for a negative rating. 
CI, confidence interval; RA, raw agreement; PA, positive agreement; NA, negative agreement. 
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to the guideline on GUP could interfere with a reliable interpretation of urodynamics and with the 
comparability of results between studies. In this study, it was demonstrated that the guideline on 
GUP was not strictly adhered to, but most traces were of well enough quality to adequately assess 
the presence of urodynamic SUI, DO and voiding pattern. 
The advised frequency of coughs and the use of annotations for leakage were frequently missing. 
This shortcoming of cough frequency and annotations has also been found in previous studies.16-19 
Regular coughs are an important step in ensuring that the urodynamic pressure sensors are 
functioning properly and remain in the right position during the investigation. In case quick 
pressure changes of coughs are registered, it is reasonable that slower changes (i.e. DO) will be 
recorded as well.20 In this study the mean frequency of coughs was once per 100ml. This interval 
is not considered as adequate according to the guideline on GUP. In most traces the coughs were 
however dispersed through the complete filling cystometry phase. Therefore we felt that, in spite 
of the lower interval, it was still possible to assess the position of the catheters. 
In our population of women with pure or predominant SUI complaints, the most frequently 
occurring discordant finding (40%) was the absence of urodynamic SUI. In other reports, 
urodynamic SUI could not be demonstrated in 16-29%.21-23 SUI may be masked by obstruction of 
the urethra by a transurethral catheter or due to the artificial setting. Catheter sizes were varying 
between 6-9 French, but in our study we could not detect a relation between the size of the 
catheter and lower prevalence of USUI. Patients may complain of SUI in another position or during 
other circumstances than the one used during conventional urodynamic investigation. 
The prevalence of DO was 6% according to the local specialist and 8% according to the central 
reviewer, this is comparable to other studies in women with complaints of SUI.24,25 The prevalence 
of a PVR above 100 ml in women with complaints of SUI has been reported between 5-11%.26 
In our study population, local specialist indicated a large PVR in 1.1 % versus 1.3% by the central 
reviewer, this low prevalence may be based on the exclusion of women with a PVR above 150 ml 
during clinical evaluation. 
The interrater reliability for the diagnosis of USUI was considered as ‘almost perfect’ and the kappa 
of the agreement on the diagnosis of DO was ‘moderate’. In a previous quality control evaluation 
of a multicentre study in women with overactive bladder complaints, agreement on the presence 
of DO was ‘good’ between central specialists (kappa = 0.83), but poor between local and central 
specialists (kappa = 0.24).19 In line with this report, the moderate kappa could be explained by 
differences in interpretation in case the performer of the urodynamic investigation immediately 
interprets the results during the test. 
Voiding dysfunction after surgery for SUI occurs in 7-36%, depending on the definition used.27-
31 A high preoperative PVR, low maximum flow velocity and obstructive micturition have been 
correlated to voiding dysfunction postoperatively in some studies.30,32 The interobserver reliability 
of voiding dysfunction in another study was kappa = 0.26. We found a poor interrater agreement 
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for the various items associated with voiding dysfunction as well. The poor agreement resulted 
from a difference in interpretation, cutoff values, classification based on the highest versus the 
lowest measurement or by the non-availability of the PVR measurement after free flow for the 
central reviewer. 
Our data show that urodynamic interpretation was consistent for diagnosing SUI. For the other 
discordant findings, positive and moreover negative agreement was considered as most relevant. 
Kappa value may be affected by the prevalence of the discordant findings.33 Reference values 
for various numerical cystometry parameters were available8, but strict cutoff levels for normal 
or abnormal have not been defined by the ICS and/or IUGA.6 In order to mimic routine clinical 
practice, we did not provide cutoff levels, but left the classification to the discretion of the observer. 
Still, the overall high agreement implies that the presence or absence of discordant findings could 
reliably be assessed. 
Strengths of this study were the large number of urodynamic traces which were retrieved from 30 
nationwide academic and non-academic hospitals and which were carefully reassessed. All traces 
were reassessed to avoid selection bias and to independently assess the prevalence of discordant 
findings. Furthermore the central review process was performed by one central reviewer, which 
eliminated central interrater variability. 
This study had also some limitations. In spite of the instruction in the study protocol, it was not 
determined before the trial whether guidelines on GUP were locally applied. Furthermore, inter-
institutional performance variability may be a confounding factor in this study. The experience of 
the performer of the investigation was not tested and a variety of equipment was used. The size 
and type of the transurethral catheter could e.g. influence recorded pressures and the prevalence 
of USUI and pressure recordings from water-filled, microtip and air-charged systems may not be 
interchangeable.34,35 In this study, urodynamic parameters were not an outcome measure, and 
therefore the influence of the variation in equipment will only be limited. Another limitation 
was that free flow measurement was only available for the blinded review process in 38% of 
traces. Furthermore in 13% of cases, the PVR was not recorded on the urodynamic traces. These 
measurements may have been performed with other equipment, not automatically combined 
with the urodynamic data and registered elsewhere, e.g. the file. These data may however have 
been available for the local attending specialist in the classification, but lacking in the central 
review process. 
The predictive value of urodynamics remains controversial. Preoperative DO, voiding dysfunction 
and absence of SUI have been correlated to impaired outcome, but these findings have been 
contradicted by others.31,36,37 Moreover, these discordant findings are only relevant if they have 
consequences for the choice of treatment or if one can predict the chances of a certain outcome, 
positive or negative. The clinical relevance of discordant findings and the related consequences 
will further be evaluated in the VUSIS 2 trial.13
63
Urodynamic quality and agreement on interpretationChapter 4
4
Conclusions 
The guideline on GUP was not strictly adhered to, but the technical quality of most traces was 
sufficient to assess the presence of USUI, DO and voiding pattern. Agreement on the absence 
for SUI was almost perfect. Other discordant findings with the patient’s history were often not 
identified but raw agreement was good. The clinical relevance of discordant findings and the 
related consequences need further evaluation. 
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Abstract
Introduction
The aim of this study was to assess the value of urodynamics prior to treatment in women with 
stress urinary incontinence.
Methods
We performed a multicentre non-inferiority randomised controlled trial. Women with stress 
urinary incontinence were randomly allocated to management based on a work-up with or 
without urodynamics. The primary outcome was clinical reduction of complaints as measured 
with the Urogenital Distress Inventory urinary incontinence subscale at 12 months after the onset 
of treatment. A mean difference in improvement of less than 8 was considered non-inferior. The 
study was analysed according to intention-to-treat.
Results
The trial was stopped prematurely because of slow recruitment. We randomly allocated 59 
women to a strategy with (N=31) or without (N=28) urodynamics. The mean improvement on 
the Urogenital Distress Inventory urinary incontinence subscale was 34 points in the group with 
urodynamics and 48 points in the group without urodynamics (difference 14 points in favour 
of the group without urodynamics, 95% CI -∞ to -0.26), confirming non-inferiority. Addition of 
urodynamics did not result in a lower occurrence of de novo overactive bladder complaints 
compared to a work-up without urodynamics (6/31 versus 1/28 RR 5.4 95% CI 0.70-42). In the group 
allocated to urodynamics, initial surgical management was more often abandoned compared to 
the group not allocated to urodynamics (5/31 versus 1/28; RR 4.5 95% CI 0.56-36).
Conclusions
In this relatively small study, the omission of urodynamics was not inferior to the use of urodynamics 
in the preoperative work-up of women with stress urinary incontinence. Women with stress urinary 
incontinence undergoing urodynamics had the risk of a choice for more prudent treatment which 
seemed to result in a delay until effective treatment. 
Trial registration 
Clinical Trials NCT00509730
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Introduction
Stress urinary incontinence (SUI) is a frequently occurring problem. The Health Council of the 
Netherlands estimated that yearly 64.000 new patients, of whom 96% women, consult their 
general practitioner because of urinary incontinence.1 Several national and international guidelines 
of professional organisations and authorities advise to perform urodynamics prior to invasive 
treatment for SUI.2,3 However, the National Institute for Clinical Excellence (NICE) recommends 
since 2006 that “the use of multi-channel cystometry is not routinely recommended before 
surgery in women with a clearly defined clinical diagnosis of pure SUI. The test is recommended 
for women with a clinical suspicion of detrusor overactivity (DO), symptoms suggestive of voiding 
dysfunction, or in those with previous surgery for SUI or anterior compartment prolapse”.4 This 
statement is, however, largely based on expert opinion rather than solid evidence.5
Urodynamics are an extension of signs and symptoms in an unphysiological setting. The 
information gained from urodynamic investigation may confirm or alter the clinical diagnosis or 
may influence the choice of intervention. When performing urodynamics, the assumption is that 
the urodynamic setting is capable of making a distinction between several pathophysiological 
mechanisms causing the same micturition symptoms. If this proves to be true, the outcome of 
the available treatment options derived from the urodynamic-based diagnosis would be better 
than treatment based on diagnosis made without urodynamics. Furthermore, urodynamics 
may prevent surgical intervention in women who may not benefit from surgery and who may 
undergo surgery unaware of potential risk factors for bad outcome.5 For example, the presence 
of voiding dysfunction on urodynamics is associated with a higher risk of postoperative retention 
of urine and the presence of DO is associated with lower outcomes after surgery.6,7 However, 
the urodynamic investigations that differentiate between several types of urinary incontinence 
and specify for the type of treatment, lack validation and predictive value in individual cases.8 
Furthermore, urodynamic investigation is costly, invasive, embarrassing to patients, and it inheres 
a risk of urinary tract infections of 6-22%.9-12 
Several studies have evaluated the value of urodynamics indirectly. A retrospective cohort 
study on tension free vaginal tape (TVT) has concluded that urodynamics did not have a 
predictive value on outcome after midurethral sling surgery.13 In a randomised controlled trial 
on Burch colposuspension compared with a pubovaginal sling procedure, the predictive value 
of urodynamics was evaluated; findings on urodynamic investigation did not predict stress 
continence outcome.14 The subjective and objective outcome of surgical intervention with 
or without preoperative urodynamic investigation has furthermore been compared in one 
retrospective study on colposuspension and one cohort study on TVT.15,16 In these two studies, 
no differences were found between the groups with and without urodynamics. The conclusion 
from the Cochrane Review on the value of urodynamics was that a randomised trial was needed.17
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Thus, the role of urodynamics in the evaluation of SUI in women is questionable and very 
much under debate. The objective of this randomised controlled trial was to determine clinical 
improvement after treatment according to an urodynamic-based diagnosis compared to 
treatment based on history, bladder diary and examination. Our hypothesis was that the omission 
of urodynamics is non-inferior to the inclusion of urodynamics in the preoperative work-up in 
women with (predominant) SUI. 
Material and Methods
We performed a multicentre, non-inferiority randomised controlled trial with the acronym ‘Value 
of Urodynamics prior to Stress Incontinence Surgery’ (VUSIS). This study was conducted in two 
academic and eight non-academic hospitals in the Netherlands. Ethical approval for this study has 
been obtained from the institutional review board of the Radboud University Nijmegen Medical 
Centre (2006/197). The board at all participating centres approved to local execution of the study. 
The registered number of this study is NCT 00509730.
Women were eligible for the study in case they had SUI or mixed urinary incontinence with 
predominant symptoms of SUI. To be included, conservative therapy must have failed and 
patients were opting and candidates for surgical treatment. Furthermore, incontinence suggestive 
for SUI must have been demonstrated on physical examination and/or bladder diary. Patients with 
previous incontinence surgery, a pelvic organ prolapse >1 centimetre beyond the level of the 
hymen (POP-Q stage 3 or more) and/or with a postvoid residual urine (PVR) of more than 150 ml 
on ultrasound or catheterisation were excluded. 
Women with (predominant) SUI were randomly allocated to standard work-up including 
urodynamics or to management based on history, physical examination and a bladder diary only. 
Randomisation occurred computer-generated by remote computer access and was stratified by 
centre with a 1:1 allocation using variable block sizes. This block randomisation was performed by a 
computer-generated random number list prepared by the database designer, the block sizes were 
blinded for researchers and health professionals. Both patients and health professionals were not 
blinded to the allocated work-up. All patients gave written informed consent before enrolment.
At study entry the following items were recorded: baseline characteristics (consisting of age, 
body mass index, parity, menopausal status, medication, intoxications, previous surgery and 
medical history), symptoms and physical examination, 48 hour bladder diary, 48 hour padtest, 
questionnaires (the validated Dutch Urogenital Distress Inventory (UDI)), urinalysis for the 
detection of urinary tract infection and residual urine measured by ultrasound, catheterisation or 
bladder scan. 
The UDI is a validated questionnaire on subjective bother from pelvic floor dysfunctions, where 
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the subscale scores are transformed in a continuous scale ranging from 0 to100.18-20 A high score 
on the UDI subscales indicate more bothersome symptoms on that particular subscale.21 
One group was allocated to the standard work-up for SUI which includes urodynamics. The 
decision for therapy in this group was based on history, bladder diary and physical examination 
in combination with the findings on urodynamics. In case the findings of urodynamics were in 
concordance with symptoms and signs, a surgical treatment was the eligible therapy. When the 
urodynamic findings were in discordance with symptoms and signs, a more individual treatment 
strategy could be tailored including medical treatment, prolonged physiotherapy, pessary 
treatment, but also surgical treatment. The urodynamics investigation was performed according 
to International Continence Society (ICS) standards and consisted of free flow and measurement 
of the PVR, filling cystometry with abdominal leak point pressure measurement and pressure 
flow study.22 Urethral pressure profilometry in rest and during stress was optional. Eight centres 
used urodynamic equipment of Medical Measurement Systems, one centre Andromeda and the 
remaining centre used equipment of Medtronic. The catheters (in two centres air-charged, in 
eight centres water-filled) had a size of 7 French. Standard filling speed was 50ml/min, filling and 
voiding cystometry were performed with the patient in sitting position. Every 100 ml a cough test 
was performed. 
Urodynamic findings were considered discordant with patient history in case of DO, weak flow, 
PVR, bladder hypocontractility, small cystometric maximum capacity, reduced bladder sensation 
or when SUI could not be demonstrated during urodynamics. Since no cutoff levels are available 
from guidelines and to mimic routine clinical practice, strict cutoff levels for normal and abnormal 
values were not provided by the researchers. 
Urinalysis for the detection of a urinary tract infection was routinely performed before urodynamics 
and when positive the patient was treated. No standard prophylactic antibiotic treatment during 
urodynamics was given. 
In the other group, the decision for urinary incontinence treatment was based on history, bladder 
diary and physical examination, but urodynamics were not performed. Surgical treatment was the 
most likely therapy, but the choice for the type of (surgical) treatment was left to the discretion of 
the attending doctor. 
For both groups, success of treatment was evaluated at 6 weeks, 6, 12 and 24 months after the 
onset of treatment. Follow-up consisted of a physical examination, completion of questionnaires 
(UDI, Patient Global Impression of Improvement (PGI–I) Scale), a bladder diary and a pad test. 
The PGI-I scale is rated on a 7-point Likert scale, with a range of responses from 1 (very much 
improved) through to 7 (very much worse).19
The questionnaires of the 6 weeks follow-up contained an extra question about patient’s 
experience of the urodynamic investigation. A 6-point scale was used between 1 (very unpleasant) 
to 6 (totally not unpleasant). A score of ≤3 was considered as unpleasant.
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During each follow-up moment, physical examination consisted of check for erosions of the 
midurethral sling, stress test for urinary leakage and measurement of the PVR. We also assessed 
an overall clinical outcome (cure rate) as measured with questionnaires and stress test. Subjective 
cure of SUI was defined as a negative answer on the UDI question concerning urine leakage 
related to physical activities. Objective cure was defined as a negative stress test on physical 
examination. Complete cure of SUI was defined as the combination of subjective and objective 
cure. Postoperative voiding dysfunction was defined as a score above zero on the UDI obstructive 
symptoms subscale. 
All definitions used were according to the recommendations of the ICS and the International 
Urogynaecological Association (IUGA).23
The primary outcome of this study was the mean improvement of the UDI subscale scores at 12 
months after treatment. The power calculation was performed prior to the study using the non-
inferiority assumption. The mean improvement of the UDI urinary incontinence subscale score in 
both groups was expected to be 35 points with standard deviation of 10. A difference in mean 
improvement of 8 points or less was considered non-inferior. Thus, 130 women in each group 
were needed to reach a power of 70% using less than 5% difference between patients with or 
without urodynamics. 
To avoid bias due to loss to follow up, patients who did not respond were contacted by telephone 
to increase the response rate. In case of missing values at 2 years, the observation at 1 year after 
start treatment was carried forward. 
The study was analysed according to the intention-to-treat principle and results were reported 
according to the number of valid observations. Analysis of covariance with group, centre and 
the baseline covariates as independent variables was used to estimate differences in cure and 
improvement of the UDI after one year with 95% confidence intervals (CI). When the upper limit of 
the 95% CI is less than 8, non-inferiority was supported. For dichotomous outcomes, the relative 
risk (RR) with 95% CI was determined. Data were analysed by using Statistical Package for the 
Social Sciences (SPSS) version 16.0. For all statistical tests, differences were considered significant 
at P <0.05. 
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Results
Study population
Figure 1 shows the study profile.24 Between August 2007 and September 2008 we included 59 
women of which 28 patients were randomly allocated to undergo treatment based on history, 
physical examination and bladder diary without prior urodynamic investigation, whereas 31 
women were allocated to a work-up with urodynamics. The trial was stopped prematurely 
because of slow inclusion.
Figure 1. Study profile 
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Assessed for eligibility (n= 70)
MUS, midurethral sling; DO, detrusor overactivity. 
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Table 1. Baseline characteristics
 
  With urodynamics  Without urodynamics 
  N=31   N=28 
Medical history 
Age (years) 44 (31-77)  43 (34-65) 
Body Mass Index (kg/m2) 26 (19-39)  24 (19-42) 
Postmenopausal status 10 (33%)  5 (19%) 
Parity (number of children) 2 (0-4)  2 (1-5) 
Previous prolapse surgery 6 (20%)  7 (25%) 
 Hysterectomy 3 (10%)  4 (14%) 
 Anterior repair 1 (3%)  1 (4%) 
 Posterior repair 1 (3%)  1 (4%) 
 Anterior and posterior repair 1 (3%)  1 (4%) 
Type of incontinence                                 SUI 26 (84%)  20 (71%) 
 MUI 5 (16%)  8 (29%) 
Urogenital Distress Inventory 
Subscale Urinary incontinence 50 (17-100)  50 (17-100) 
 Overactive bladder 11 (0-100)  0 (0-67) 
 Obstructive symptoms 0 (0-100)  0 (0-100) 
Bladder diary 
Daily micturition frequency  7 (4-14)  7 (4-14) 
Nightly micturition frequency 0 (0-2)  1 (0-2) 
Nocturia  14 (45%)  15 (54%) 
Incontinence episodes per day 3 (0-9)  3 (0-8) 
Number of incontinence pads per day 2 (0-9)  3 (0-7) 
 
 
Data are presented as median (range) or as number (%).  
N, number of patients; SUI, stress urinary incontinence; MUI, mixed urinary incontinence. 
 
The baseline characteristics of the groups are displayed in Table 1. Mean follow-up duration was 
22 months (±7). Physical examination was performed at least once during the follow-up period 
in 86% of the patients. Two patients (with urodynamics) were lost to follow up with regard to the 
subjective clinical outcome. 
Urodynamic parameters and discordant findings during urodynamic investigation are shown in 
Table 2. Of the patients who underwent urodynamics, 8 women (26%) scored the investigation 
as unpleasant. Urine analysis after urodynamic investigation was not routinely performed but 
nonetheless, a urinary tract infection was recorded in two women.
The initial treatment and the type of treatment during the follow-up period are shown in Figure 
1. In the group with urodynamics, abandoning or postponement of initial surgical management 
was more likely compared to the group who did not undergo urodynamics (5/31 versus 1/28; RR 
4.5 95% CI 0.56-36). 
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Outcomes
The mean improvement on the UDI urinary incontinence subscale between the groups with and 
without urodynamics after one year was 34 (±22) versus 48 (±22) respectively. The difference in 
mean improvement was 14 points in favour of the group without urodynamics with a 95% CI of 
-∞ to -0.26. Since the upper limit of the 95% CI is less than 8, non-inferiority of the omission of 
urodynamics is supported. 
Table 3 shows the subjective and objective outcomes. With measurement carried forward for six 
women, the subjective cure rate of urinary incontinence was lower, albeit not significant, in the 
group with urodynamics than in the group without urodynamics (rates 16/29 versus 21/28; RR 
0.69 95% CI 0.46-1.0). The complete case analysis showed subjective cure in 14/26 women with 
urodynamics versus 20/26 women without urodynamics (RR 0.60 95% CI 0.30-1.2).
In four patients DO was found, in one of them urodynamic SUI could not have been demonstrated. 
DO was the only urodynamic finding with consequences for the choice for therapy. In three of the 
four patients (75%), drug treatment was applied instead of initial surgery. Ultimately, 29 out of 31 
women (94%) in the group with urodynamics underwent an anti-incontinence operation during 
the study period. There was no clinical improvement measured with the UDI in the two women 
who were non-surgically treated. 
Absence of urodynamic SUI and/or discordant urodynamic findings (Table 2) were present in 
20 out of 31 women (65%) in the group with urodynamics. There was no difference in clinical 
Table 2. Urodynamic parameters of the women who underwent a work-up with urodynamics 
 
Urodynamic investigation                              N=31 
Maximum  free flow (ml/s) 19 (0-50) 
Residual (ml) 3 (0-200) 
CMC (ml) 387 (102-885) 
MUCP (mmHg) 77 (22-212) 
Discordant findings   
Urodynamic SUI is not demonstrable 15 (48%) 
Detrusor overactivity 4 (13%) 
Postvoid residual 0  
Small CMC 2 (6%) 
Weak flow 2 (6%) 
Any discordant finding 20 (65%) 
 
 
Data are presented as median (range) or as number (%). 
CMC, cystometric maximum capacity; MUCP, maximum urethral closure pressure; SUI, stress urinary 
incontinence. 
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Residual (ml) 3 (0-200) 
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Discordant findings   
Urodynamic SUI is not demonstrable 15 (48%) 
Detrusor overactivity 4 (13%) 
Postvoid residual 0  
Small CMC 2 (6%) 
Weak flow 2 (6%) 
Any discordant finding 20 (65%) 
 
 
Data are presented as median (range) or as number (%). 
CMC, cystometric maximum capacity; MUCP, maximum urethral closure pressure; SUI, stress urinary 
incontinence. 
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improvement measured with the UDI between women with (n=15) or without (n=16) urodynamic 
SUI in the urodynamics group (mean improvement UDI urinary incontinence subscale 31 (±28) 
versus 34(±18) P = 0.20). 
The occurrence of de novo overactive bladder complaints occurred more in the group with 
urodynamics but this was not statistically significant (6/29 versus 1/28 RR 5.4 95% CI 0.70-42). None 
of the patients with de novo overactive bladder complaints in the group with urodynamics had 
preoperative DO. 
Table 3. Subjective and objective outcome according to different definitions of cure
 
  With urodynamics Without urodynamics  
  
Primary outcome  N=31 N=28 [95% CI] 
 Mean improvement UDI-UI 34 (±22) 48 (±22) [-∞; -0.26] 
Subjective outcome       RR [95% CI] 
Global Improvement       
 Improvement 27 (93%) 27 (96%) 0.90 [0.78-1.1] 
 Equal 1 (3%) 0   
 Impairment 1 (3%) 1 (4%) 0.90 [0.06-14] 
 Missing 2  0   
Subjective cure       
 UDI, no SUI 20 (69%) 22 (79%) 0.82 [0.59-1.1] 
 Missing 2     
 UDI-UI 16 (55%) 21 (75%) 0.69 [0.46-1.0] 
 Missing 2  0   
Objective cure        
 Stress test negative 25 (93%) 23 (92%) 0.98 [0.77-1.3] 
 Missing 4  3   
 48 hour bladder diary 21 (81%) 24 (89%) 0.79 [0.59-1.1] 
 Missing 5  1   
Complete cure of SUI        
Subjectively and objectively cured 17 (63%) 20 (80%) 0.77 [0.52-1.1] 
Subjectively cured only  1 (4%) 0   
Objectively cured only  8 (30%) 3 (12%)  
No cure   1 (4%) 2 (8%) 0.45 [0.04-4.7] 
Missing  4  3   
 
 
Subjective cure of stress urinary incontinence was defined as a no leakage reported during physical activity (Urogential Distress 
Inventory). Objective cure of stress urinary incontinence  was defined as a negative stresstest by physical examination. Total cure of 
stress urinary incontinence was defined as the combination of total subjective and total objective cure. No cure was defined as 
objective and subjective leakage. 
N, number of patients; CI, confidence interval; RR, relative risk; UDI-UI, Urogential Distress Inventory urinary incontinence subscale; 
UDI, Urogential Distress Inventory; SUI, stress urinary incontinence. 
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Patients with preoperative DO showed improvement on the UDI urinary incontinence subscale 
after surgery, although this improvement was less compared to patients without DO (mean 
improvement 13 ±25 versus 36 ±22). 
Voiding dysfunction after treatment occurred less in the group with urodynamics: 3/29 versus 7/28 
in the group without urodynamics (RR 0.39 95% CI 0.11-1.4, P = 0.12). Tape exposures were reported 
in 2 out of 54 women (4%) who received a midurethral sling, without differences between the 
groups. 
Discussion
To our knowledge this is the first randomised controlled trial that compared clinical outcome 
of treatment after a work-up for SUI with and without urodynamics. Our findings show that the 
omission of urodynamics is non-inferior to the use of urodynamics in the preoperative work-up in 
women with (predominant) SUI. However, it is unknown whether this would have been the same 
in case of larger sample sizes. Although the sample size as calculated from the power analysis has 
not been reached, there are some interesting results. 
The omission of urodynamics to a combined diagnostic and therapeutic work-up did not impair 
the outcome in women with SUI. Performing urodynamics resulted in a trend to lower subjective 
cure rates, probably due to a lower willingness to choose for surgical therapy. Urodynamic findings 
seem to result in the choice for more prudent treatment options. In our study, there was no clinical 
improvement in those few women who were non-surgically treated. 
In case preoperative urodynamics would have been omitted out of the standard work-up, some 
discordant findings would be missed. The effect on the treatment selection, in case urodynamic 
findings were discordant with the patient’s history, was however only limited. DO was the only 
urodynamic finding with therapeutic consequences. Patients with preoperative DO showed 
improvement on the UDI after surgery, although this improvement was less compared to patients 
without DO. It is known that the subjective cure rate of SUI decreases in case of preoperative 
DO.25,26 However, DO can be cured in over 50% of women with colposuspension and midurethral 
sling.27,28 Therefore, the preoperative diagnosis of DO attributes to the counselling of patients on 
the perspectives, but it is the questionable whether DO should influence the management to a 
major extent. 
One of the inclusion criteria was observed incontinence on physical examination and/or bladder 
diary, but still urodynamic SUI was absent in almost half of cases. In other reports urodynamic SUI 
could not be demonstrated in 16-29%.29-31 A falls negative stress test during urodynamics could 
be caused by obstruction of the urethra by the transurethral catheter.31 The obstructive effect 
of a maximum diameter of 8 French catheter was considered as acceptable.32 In our studies the 
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maximum catheter size was 7 French, therefore, the low prevalence of urodynamic SUI compared 
with other studies could not be explained by catheter size. 
One study showed higher, albeit not significant, overall success after surgery in women with 
urodynamic demonstrable stress incontinence versus no urodynamic stress incontinence.14 
In another study cure rates were comparable in patients with and without urodynamic stress 
incontinence.25 In this study, we have also found no effect of urodynamic findings with regard to 
the presence of urodynamic stress incontinence on clinical outcome.
The advice to perform urodynamics prior to invasive treatment for SUI is advocated by several 
national and international professional organisations and authorities. Therefore the recommended 
management of women with SUI opting for surgical treatment is similar throughout countries, 
and our findings seem applicable to international practice.
The present study has some limitations. The inclusion was interrupted before the accomplishment 
of the necessary number of patients, which limits the strength of our findings. The principle 
investigators had to stop the trial, since the funding was at risk because of an imminent prolongation 
of the study period. Most centres offered multidisciplinary teams for patients with complaints 
of urinary incontinence and patients underwent urodynamics before they could be counselled 
about participation in the trial. On the other hand, some specialists had (already) stopped to 
perform urodynamics in this patient category, not awaiting the outcome of this study on the value 
of urodynamics. Furthermore, logistic problems (e.g. extra visits) in the including centres were part 
of the problem. Another limitation of the study is that the data completeness after one year was 
68%. However by obtaining information about subjective outcome of almost all patients, bias in 
the overall results was avoided. The findings on cure and improvement after surgery in our study 
are in line with previous studies on the value of urodynamics in SUI patients.15,16 
The strength of this study was the multicentre set up, and the adequate randomisation and 
allocation concealment. Therefore, the findings may be useful as well in a future meta-analysis 
on the value of urodynamics.17 Due to the study design, the outcomes of patients with discordant 
findings on preoperative urodynamics were “diluted” in the entire group of women with 
predominant SUI. To determine the effect of discordant urodynamic findings on management 
and outcome, a larger randomised controlled trial among women with discordant findings is 
momentarily conducted, with randomisation for immediate surgery or treatment as based on 
urodynamic findings.33
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Conclusions
The omission of urodynamics is not inferior to the inclusion of urodynamics in the preoperative 
work-up in women with (predominant) SUI. This study showed that the consequences of 
discordant findings between symptoms and urodynamics are only limited. 
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Abstract
Introduction
Stress urinary incontinence is a common problem. In the Netherlands, yearly 64.000 new patients, 
of whom 96% are women, consult their general practitioner because of complaints of urinary 
incontinence. Approximately 7.500 urodynamic evaluations and approximately 5.000 operations 
for stress urinary incontinence are performed every year. In major national and international 
guidelines from both gynaecological and urological scientific societies, it is advised to perform 
urodynamics prior to invasive treatment for stress urinary incontinence, but neither its effectiveness 
nor its cost-effectiveness has been assessed in a randomised setting. The Value of Urodynamics 
prior to Stress Incontinence Surgery (VUSIS) study evaluates the positive and negative effects with 
regard to outcome, as well as the costs of urodynamics, in women with symptoms of stress urinary 
incontinence in whom surgical treatment is considered.
Methods
A multicentre diagnostic cohort study will be performed with an embedded non-inferiority 
randomised controlled trial among women presenting with symptoms of (predominant) stress 
urinary incontinence. Urinary incontinence has to be demonstrated on clinical examination 
and/or bladder diary. Physiotherapy must have failed and surgical treatment needs to be under 
consideration. Patients will be excluded in case of previous incontinence surgery, in case of pelvic 
organ prolapse more than 1 centimetre beyond the hymen and/or in case of postvoid residual 
bladder volume of more than 150 ml on ultrasound or catheterisation.
Patients with discordant findings between the diagnosis based on urodynamic investigation and 
the diagnosis based on their history, clinical examination and/or bladder diary will be randomised 
to operative therapy or individually tailored therapy based on all available information. Patients 
will be followed for two years after treatment by their attending urologist or gynaecologist, in 
combination with the completion of questionnaires.
Six hundred female patients will be recruited for registration from approximately thirty hospitals in 
the Netherlands. We expect that 102 women with discordant findings will be randomised.
The primary outcome of this study is clinical improvement of incontinence as measured with the 
validated Dutch version of the Urinary Distress Inventory after 12 months. Secondary outcomes 
of this study include costs, cure of incontinence as measured by bladder diary parameters, 
complications related to the intervention, re-interventions, and generic quality of life changes.
Trial registration
Clinical Trials NCT00814749. 
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Introduction
Stress urinary incontinence (SUI) is a frequently occurring problem. The Health Council of the 
Netherlands estimated that yearly 64.000 new patients, of whom 96% are women, consult their 
general practitioner because of urinary incontinence.1
In major national and international guidelines of professional organisations and authorities, it is 
advised to perform urodynamics prior to invasive treatment for SUI, e.g. the guidelines of the 
Dutch Urological Association, the Dutch Society of Obstetrics and Gynaecology, International 
Continence Society and European Association of Urology.2,3 
Usual care in the Netherlands for urinary incontinence in the general practitioners setting is an 
investigation by history, clinical examination and bladder diary. When there is no clear indication 
for urgency urinary incontinence or neurological disease, the patient will be referred for 
physiotherapy. In case there is no improvement the patient will subsequently be referred to the 
gynaecologist or urologist.4 Patient history and clinical examination are important aspects of the 
assessment of patients that suffer from stress urinary incontinence. Patient history is quantified 
by using parameters based on validated questionnaires and a bladder diary for 1 to 2 days. The 
most common surgical therapy for SUI is the midurethral sling procedure of which the retropubic 
tension free vaginal tape (TVT) was first introduced. These slings have an average success rate of 
90%.5 
Urodynamics do not generate major morbidity but are generally considered as unpleasant by the 
patients, and inhere a risk of urinary tract infections as high as 20%.6 Urodynamics try to enhance 
the understanding of lower urinary tract functioning and reveal the underlying pathology that 
cause patients complaints. It is an extension of patient history and physical examination in an 
unphysiological setting. 
The assumption is that the urodynamic setting is capable of making a distinction between several 
pathophysiological mechanisms causing the same micturition symptoms. If this holds true, 
the outcome of the available treatment options derived from the urodynamic-based diagnosis 
would be better than treatment based on diagnosis made without urodynamics. However, the 
urodynamic investigations that differentiate between several types of SUI and specify for the 
type of operation, lack validation and predictive value in individual cases.7 Moreover, since the 
introduction of easy to administer midurethral polypropylene slings, a simplified reasoning has 
found ground that states that every type of SUI is treated in the same way and therefore no 
urodynamic investigation would be needed.
The value of urodynamics has never been the specific subject of a randomised controlled trial.8 
Several studies have evaluated the value of urodynamics indirectly. A retrospective cohort 
study on TVT has concluded that urodynamics do not have a predictive value on outcome after 
midurethral sling surgery.9 In a randomised controlled trial on Burch compared with pubovaginal 
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sling procedure, the predictive value of urodynamics was evaluated. Findings on urodynamic 
investigation did not seem to predict stress continence outcome.10 
The subjective and objective outcome of surgical intervention with or without preoperative 
urodynamic investigation has not been compared, with the exception of one retrospective study 
on colposuspension and one cohort study on TVT.11,12 In these two studies no differences were 
found between the groups with and without urodynamics. The strong conclusion from the 
Cochrane Review on the value of urodynamics was that a randomised trial is needed.13
Thus, the role of urodynamics in the confirmation of SUI in women is nowadays questionable 
and very much under debate. In 25-30% of the women the symptom of SUI is not demonstrable 
probably due to the artificial situation during the investigation.5 
If urodynamics are not needed to diagnose types of SUI, this could be to prevent complications 
of surgery such as an overactive bladder. However in almost half of the patients with overactive 
bladder symptoms, there are no abnormal detrusor contractions visible on urodynamics.14 On the 
other hand detrusor contractions during the filling phase of urodynamics that are regarded as 
the proof for overactive bladder complaints, can be seen in 20% of women without symptoms of 
an overactive bladder.15 It is therefore questionable, whether it can predict the therapeutic effect 
as well as the risk of complications, like de novo urgency or aggravation of urgency and urinary 
retention.7,8 
The introduction of minimally invasive techniques for SUI therapy, such as the midurethral 
tension free tape procedure, has led to an enormous increase in the number of operations in the 
Netherlands. In 1999, 1.600 operations were performed. This number has increased to over 4.000 
in 2003 and is expected to be 5.000 by today.16 
Economic relevance
We estimate that two thirds of all women with symptoms of SUI who had urodynamics will 
proceed to surgery and one third will be given another non-surgical intervention which is usually 
medication. From this calculation it appears that for this indication urodynamics are performed 
approximately 7.500 times per year in the Netherlands. At expected costs of about 300 euro per 
test, urodynamics stand for 2.25 million euro health insurance charges. 
In case urodynamics would be omitted, costs of possible extra complications are foreseen. We 
estimate a maximum of 10% additional urgency complaints.17,18 Antimuscarinic treatment is 
available but has a record of only short time usage in almost all patients, and thus the costs are 
limited.19 The other possible complication is urinary retention or voiding dysfunction. This occurs 
in less than 5% of patients after colposuspension, but is less in tension free midurethral slings and 
is supposed not to change with or without urodynamics.20 Therefore, this will not have major 
financial impact on the outcome. Possible further additional costs are costs related to reoperation 
(repositioning of the sling estimated at 0.5 -1%), and outpatients’ costs. 
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In conclusion, it is likely that urodynamics do not have a role in the quality of care for women 
with SUI and that urodynamic testing in women with SUI is not cost-effective. For this study our 
hypothesis was that there is no difference between outcome of surgery and individually tailored 
therapy in women with a discrepancy between urodynamic findings and findings from other 
investigations, such as history and clinical examination. In case of confirmation of this hypothesis, 
urodynamic investigation in women with predominant SUI could be safely omitted.
Materials and Methods
The ‘Value of Urodynamics prior to Stress Incontinence Surgery (VUSIS) 2’ study is a multidisciplinary, 
multicentre, diagnostic cohort study with a non-inferiority randomised controlled trial embedded. 
The primary aim of the study is to evaluate whether urodynamic testing is effective in patients 
with symptoms of SUI in whom surgical treatment is considered. All women with symptoms of 
(predominant) SUI in whom surgical treatment is considered will undergo urodynamic investigation. 
Only women with a discordant finding compared to history and physical examination will be 
randomised. Patients with concordant urodynamics will be registered (see Figure 1).
The study has been approved by the institutional review board of the Radboud University 
Nijmegen Medical Centre, in Nijmegen. Ethical approval for this study has been obtained on 02-
10-2008, number 2006/197.
Eligible patients will be identified by gynaecologists and urologists from participating hospitals in 
the Netherlands (see Addendum 1). All women presenting with SUI where conservative therapy 
(i.e. physiotherapy) has failed and surgical therapy is considered, will be asked for permission 
Figure 1. Summary of study design
Registration of all women with (predominant) stress urinary incontinence and indication for operation 
Concordant findings Individual treatment
Urodynamics
Discordant findings
No consent or 
contra-indication RCT
Individual treatment
Individual treatment
Immediate surgery
Questionnaires 
 
Follow-up 
during 2 years 
RCT
Questionnaires 
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of registration in the study. SUI must have been demonstrated on physical examination and/or 
bladder diary. Patients will be excluded in case of previous incontinence surgery, in case of pelvic 
organ prolapse 1 centimetre beyond the level of the hymen and/or in case of residual bladder 
volume of more than 150 ml on ultrasound or catheterisation (Table 1).
In all patients the following items will be recorded at inclusion: 
1. History and clinical examination 
2. 48 hour bladder diary
3. Validated quality of life questionnaires (Short Form 36, Euroqol 5D, Urinary Distress Inventory, 
Incontinence Impact Questionnaire, Defecatory Distress Inventory) 
4. Urinalysis for the detection of urinary tract infection 
5. Postvoid residual volume measured by ultrasound or catheterisation
All women will undergo urodynamic investigation. Urodynamics will be performed according to 
International Continence Society standards and consists of free flow and measurement of residual, 
provocative filling cystometry, pressure flow study and optional of a urethral pressure profilometry 
in rest and during stress.21 The outcomes will be matched with urodynamic findings to assess the 
potentially useful parts of the urodynamic findings. Postoperative urodynamics is not part of the 
study. 
Table 1. Study inclusion and exclusion criteria
  
 
Inclusion  
Symptoms of SUI and/or MUI, stress component is predominant 
Signs of SUI on physical examination or bladder diary   
Patient is a candidate for surgical treatment (as based on history and physical examination) 
Patient has attended at least 3 months of pelvic floor exercises 
Patient is capable to fill out questionnaires and understands the Dutch written and spoken language 
 
Exclusion  
Previous incontinence surgery   
MUI, urgency component is predominant   
Pelvic organ prolapse > 1cm beyond the hymen on Valsalva in supine position 
Postvoid residual > 150 ml on ultrasound or catheterisation 
Additional pelvic surgery (prolapse and/or hysterectomy) 
Patient is or wants to become pregnant 
Prior pelvic radiotherapy   
 
 
SUI, stress urinary incontinence; MUI, mixed urinary incontinence. 
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When the result of the urodynamics does not confirm the history of SUI, or shows relative contra-
indications for operation, the investigation is called discordant. Whether a test result is discordant 
is decided by the attending urologist or gynaecologist. Table 2 demonstrates the various reasons 
for discordance. 
Women with discordant findings on urodynamics will be approached to participate in the 
randomised controlled part of the study.
After they have given informed consent, the patients with discordant test results at urodynamics 
are randomly assigned to operative treatment or to individual tailored treatment. In the operative 
treatment group, the decision for intervention will be based on history and clinical examination 
only, which will be surgical treatment (a midurethral sling). The choice for the kind of procedure 
(retropubic or transobturator) is left to the discretion of the attending doctor. In the individually 
tailored treatment group, the decision for therapy will be based on history and clinical examination 
in combination with the result of the discordant findings on urodynamics. This includes medical 
treatment, prolonged physiotherapy, pessary treatment, but also surgical treatment can be one 
of the chosen therapies. 
All women with SUI, who present at one of the participating hospitals, will be referred to a 
gynaecologist, urologist or a specifically appointed research nurse for counselling. Eligible 
women will receive an information sheet. Once women with discordant test results have given 
consent for the trial, they are randomised through a website, according to a computer-generated 
randomisation sequence. Stratification will be applied for centre. Randomisation will be 1:1 for 
operative treatment and individual treatment.
Patients in the randomised controlled trial will be followed up from trial entry until the end of the 
study (anticipated average: two years). Follow-up is composed of the same items as recorded at 
inclusion. 
Table 2. Discordant findings on urodynamic investigation 
 
Stress incontinence is not demonstrable 
Detrusor overactivity 
Hypocontractility of the bladder 
Poor flow 
Residual urine 
Outflow obstruction 
Small cystometric capacity 
Increased bladder sensation 
Reduced bladder sensation  
Low level of compliance  
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After 6 weeks, 6, 12 and 24 months patients will visit their attending gynaecologist or urologist. 
Physical examination will be performed and consists of detection of erosions, stress test for urinary 
leakage, and measurement of the residual volume. The patients will complete the questionnaires 
at all moments of follow-up. 
After the intervention, additional therapy is possible in both arms and will be recorded in the 
case record form. The cohort group will receive the same questionnaires once, at one year after 
baseline. 
Patient outcome measures
The primary outcome of this study is clinical improvement of incontinence as measured with the 
validated Dutch version of the Urogenital Distress Inventory (UDI). Secondary outcomes of this 
study include costs, cure of incontinence as measured with bladder diary, complications such as 
re-operation or overactive bladder symptoms, and quality of life.
The trial results will be incorporated in a diagnostic model to compare the current strategy 
(urodynamic evaluation in all patients) with the alternative strategy (immediate TVT surgery 
without urodynamic evaluation). 
The study design will enable us to compare the costs and effects of the following strategies:
1. Immediate midurethral sling without preceding urodynamic evaluation. 
2. Urodynamic evaluation in all patients and midurethral sling depending on urodynamic 
evaluation results.
3. Sequential or probabilistic combinations, based on the prior probability of the fact that the 
urodynamic evaluation will change management.
Sample size considerations
The primary outcome of this study is the improvement of UDI at 12 months after baseline. The 
power calculation is performed using the non-inferiority assumption. The mean improvement of 
the UDI urinary incontinence subscale score in both groups was expected to be 35 points with 
a standard deviation of 10 points.25 A difference in mean improvement of 5 or less is considered 
as non-inferior. In each arm 51 women were needed to reach a power of 80% using one-sided 
testing and risk of type 1 error at 0.05. Informed consent was expected in 50% of eligible women 
and one out of three eligible women was expected to have discordant urodynamic findings. The 
calculation of the sample size of the cohort showed that 600 women were needed to assess 102 
women in the randomised controlled part of the study. 
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Economic evaluation
For each patient, utilization of health care services will be recorded prospectively, using case 
record forms, including urodynamic testing, surgery for SUI, re-operations, medical treatment for 
detrusor overactivity, care for urinary incontinence, and care for urinary retention. By multiplying 
these volumes of care with unit cost prices, direct medical costs incurred by SUI during the follow 
up period will be calculated for each patient. For unit cost prices, national guidelines will be 
used (CVZ, 2004). For costs of care for urinary incontinence and urinary retention, data from the 
literature will be used, converted to actual prices. We incorporated the health related quality of life 
questionnaire Euroqol 5D in our study to be able to calculate QALYs (quality-adjusted life-years), 
which is a measure of health outcome. A QALY is the change in quality of life induced by the 
treatment multiplied by the duration of the treatment effect and it provides the number of QALYs 
gained. QALYs can then be related to medical costs to arrive at a final common denominator of 
cost/QALY. This parameter can be used to compare the cost-effectiveness of the treatment. 
Statistical analysis
Multivariable analysis of covariance with group, centre and the baseline covariate as independent 
variables will be used to estimate differences in improvement of the UDI after 12 months between 
the groups with 95% confidence intervals. Other variables will be analysed similarly. 
Time plan for the VUSIS study
Patient recruitment starts in January 2009 and is planned to continue until January 2010. The 
follow-up has a duration of 24 months, so will continue until January 2012. The study is conducted 
in cooperation with several centres ensembled in the Dutch Urogynaecology Consortium. Most of 
the clinics have disposition over a research nurse, who attributes in administration and completion 
of the case record forms. All data are collected web based.
Knowledge transfer
The outcome of the study will be important for the debate on the value of urodynamics. In the 
current international operative practice for SUI there is a huge increase in the number of operations. 
Hence the value of time consuming and costly urodynamic investigations should be very clear. 
The results of our study will be submitted to different national and international scientific societies 
such as the International Continence Society and the International Urogynecologic Association, 
and is planned to be published in international scientific journals. 
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1.  Alant Vrouw, Amsterdam (Academic Medical Centre) 
2.  Alant Vrouw, Bilthoven (University Medical Centre Utrecht)
3.  Canisius Wilhelmina Hospital, Nijmegen
4.  Catharina Hospital, Eindhoven
5.  Diakonessenhuis, Utrecht
6.  Gelre Hospital, Apeldoorn
7.  Ikazia Hospital, Rotterdam
8.  Isala Klinieken, Zwolle
9.  Jeroen Bosch Hospital, ‘s Hertogenbosch
10.  Laurentius Hospital, Roermond
11.  Lievensberg Hospital, Bergen op Zoom
12.  Martini Hospital, Groningen 
13.  Maxima Medical Centre, Veldhoven
14.  Medisch Spectrum Twente, Enschede
15.  Nijsmellinghe Hospital, Drachten
16.  Onze Lieve Vrouwe Gasthuis, Amsterdam
17.  Radboud University Nijmegen Medical Centre, Nijmegen
18.  Reinier de Graaf Gasthuis, Delft
19.  Rijnstate Hospital, Arnhem
20.  Slingeland Hospital, Doetinchem
21.  Slotervaart Hospital, Amsterdam
22.  Sint Antonius Hospital, Nieuwegein
23.  Sint Elisabeth Hospital, Tilburg
24.  Sint Franciscus Hospital, Roosendaal
25.  Sint Franciscus Hospital, Rotterdam
26.  University Medical Centre Groningen 
27.  University Medical Centre Maastricht
28.  VieCuri, Venlo
29.  Vrije Universiteit, Amsterdam
30.  Zaans Medical Centre, Zaandam
Addendum 1. Participating hospitals in the Netherlands
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Abstract 
Introduction
It has been hypothesised that in women with stress urinary incontinence, urodynamics indicate 
who will benefit from surgery and who will not, thus improving clinical outcome. However, robust 
evidence to support this hypothesis is scarce.
Methods
We performed a multicentre diagnostic cohort study with an embedded non-inferiority 
randomised controlled trial in 6 academic and 24 non-academic hospitals in the Netherlands 
between January 2009 and November 2010. We enrolled women with (predominant) stress 
urinary incontinence, eligible for surgical treatment based on the clinical assessment with signs 
and symptoms. All patients underwent a urodynamic investigation. In case urodynamic findings 
were discordant with clinical assessment, participants were randomly allocated in a 1:1 ratio by 
block randomisation with a web-based application system to receive either immediate surgery or 
individually tailored therapy based on urodynamic findings. Participants and health professionals 
were not blinded for the allocated arm and the urodynamic results. The primary outcome was 
clinical improvement assessed by the validated Urogenital Distress Inventory 12 months after 
baseline. Analysis was by intention-to-treat; a difference in mean improvement of five points or 
less was considered non-inferior. 
Results
We studied 578 women with stress urinary incontinence, of whom 268 (46%) had discordant 
findings. 126 patients gave informed consent for randomisation and were allocated to receive 
immediate surgery (n=64) or individually tailored therapy (n=62). The mean improvement 
measured with the Urogenital Distress Inventory after one year was 39 and 44 points for the 
strategies with and without urodynamics, respectively (difference -5 points, 95% CI -∞ to 5). There 
were no differences with respect to cure or complication rate.
Conclusions
In women with uncomplicated stress urinary incontinence, immediate midurethral sling operation 
is not inferior to an individually tailored treatment based on urodynamic findings, therefore 
preoperative urodynamics should no longer routinely be advised.
Trial Registration
clinicaltrials.gov NCT00814749
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7
Introduction
Stress urinary incontinence (SUI), defined as the complaint of involuntary loss of urine on effort, 
physical exertion, coughing or sneezing, is a common problem among adult women, with an 
estimated prevalence between 25 and 57%.1-2 Several national and international guidelines 
of professional organisations and authorities advise to perform urodynamics prior to surgical 
treatment of SUI.3-4 
Urodynamics try to enhance the understanding of lower urinary tract function and reveal the 
underlying pathophysiology responsible for the patient’s complaints. The information gained 
from urodynamics may confirm or alter the clinical diagnosis that is based on medical history and 
physical examination, and may influence the choice of the intervention. However, many women 
perceive urodynamics as painful or embarrassing5 and they inhere a risk of causing urinary tract 
infections between 6 and 22%.6-9 Moreover, urodynamics are time consuming and costly. 
In Europe, approximately 100.000 midurethral sling operation are performed yearly.10 At expected 
costs of about 335 euro per test11, urodynamics account for over 50 million euro health insurance 
charges, leaving non-surgical treated patients out of consideration. In view of this massive use 
of urodynamics, the evidence that urodynamics add either to clinical decision making or to 
prediction of the outcome of treatment for SUI is limited.12-13 This results in decreased adherence 
to guidelines and strong practice variation.14-15 
We previously published an underpowered randomised controlled trial comparing a strategy with 
urodynamics and a strategy of immediate surgery in women with SUI, that indicated no benefit of 
urodynamics in the work-up of women with SUI.16 In two previous observational studies, findings 
on urodynamic investigation did not predict stress continence outcome of surgery.17-18 Based on 
this evidence gap, authors of a Cochrane Review on the value of urodynamics recommended that 
randomised controlled trials on the subject are eagerly needed.19 
Recently, the results of the VALUE-trial have been published, which showed that preoperative office 
evaluation alone was not inferior to evaluation with urodynamic testing.20 That RCT randomly 
allocated women with SUI to a workup with or without urodynamics. We conducted a multicentre 
RCT entitled “the Value of Urodynamics prior to Stress Incontinence Surgery (VUSIS 2) study”, in 
which all women with SUI underwent urodynamics and only those women with a discordant 
result from urodynamics and the medical history were randomised. By choosing such a design, we 
kept the group of women with concordant findings out of the randomised comparison, thereby 
focusing on women who might benefit from urodynamics. We investigated whether a strategy 
of immediate surgery was non-inferior to a strategy based on urodynamic findings followed by 
individually tailored therapy.
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Materials and Methods
We performed a multicentre, diagnostic cohort study with a non-inferiority randomised controlled 
trial embedded. The study was conducted in 6 academic and 24 non-academic hospitals in the 
Netherlands that were cooperating in the Dutch Urogynaecology Consortium (www.studies-
obsgyn.nl). Ethical approval for this study was obtained from the institutional review board of 
the Radboud University Nijmegen Medical Centre (2006/197), and boards of participating centres 
approved the study. Written informed consent was obtained from all patients before enrolment. 
This study was registered under number NCT00814749. The study protocol has been published 
previously.21
Study population
Between January 2009 and November 2010, we recruited women with uncomplicated SUI, 
considered as symptoms of pure SUI or mixed urinary incontinence with predominant SUI 
symptoms, who had previously failed conservative therapy, in particular pelvic physiotherapy, and 
were candidates for surgical therapy. SUI must have been demonstrated on physical examination 
and/or micturition diary. Patients were excluded in case of prior incontinence surgery, in case of 
pelvic organ prolapse with the leading edge of prolapse at least 1 centimetre beyond the level 
of the hymen and/or in case of a postvoid residual bladder volume (PVR) of 150 ml or more was 
present on ultrasound or catheterisation.
At study entry the following items were recorded; baseline characteristics, symptoms and clinical 
examination, 48 hour bladder diary, validated quality of life questionnaires (Urogenital Distress 
Inventory) and measurement of a PVR. The Urogenital Distress Inventory (UDI) consists of 11 items 
and five subscales on subjective bother related to micturition and prolapse symptoms.22 The 
subscale scores were transformed in a continuous scale ranging from 0 to 100 points.23 A high 
score on the UDI subscales indicates more bothersome symptoms on that particular subscale.
All eligible women underwent urodynamic investigation, performed according to International 
Continence Society standards.24 Urodynamic findings were considered discordant if SUI was not 
confirmed or in case of detrusor overactivity (DO), weak flow, postvoid residual, small cystometrical 
maximum capacity or reduced bladder sensation. Since no cutoff levels for normal and abnormal 
values of the above have been defined, classification was left to the discretion of the observer. 
In a central review process, all traces were assessed for quality using a standardised checklist 
based on the guideline on ‘Good Urodynamic Practice’, and a reassessment of interpretation of all 
urodynamic traces was performed.
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Randomisation and masking
Women with discordant findings between the history and clinical examination and urodynamics 
were requested to participate in a randomised controlled trial embedded in the cohort study. 
These women were, after informed consent, randomly assigned to either immediate surgery with 
a midurethral sling or to an individual tailored treatment, including drug treatment, prolonged 
physiotherapy, pessary treatment, or also surgical treatment. The choice for the kind of treatment 
in the individual tailored treatment group was left to the discretion of the physician. 
A web-based application was used for block randomisation with a variable block size between 
2 and 8. This block randomisation was performed by a computer generated random number 
list prepared by a database designer. The block sizes were blinded for researchers and health 
professionals. Randomisation was stratified per centre with a 1:1 allocation. Participants and health 
professionals were not blinded for the allocated arm and the urodynamic results. Patients who 
had discordant findings and agreed to outcome registration but did not give informed consent 
for randomisation, and patients with concordant urodynamic findings, were enrolled in the 
observational cohort (see figure 1). Patient data were entered into a password-protected web-
based database. 
During follow-up, questionnaires were sent to the patients and collected centrally. Data input 
of subjective outcome measurements was performed by researchers who were blinded for the 
treatment allocation.
Outcome measures 
The primary outcome of this study was effect in terms of improvement as measured with the 
Dutch validated version of the UDI at one year after baseline. 
In the randomised group effects of treatment were evaluated at 6 weeks, 6 and 12 months after 
randomisation. Follow-up was composed of a doctor’s visit, completion of questionnaires (UDI, 
Patient Global Impression of Improvement (PGI–I) Scale) and a bladder diary. The PGI-I scale is 
rated on a 7-point Likert scale, with a range of responses from 1 (very much improved) through to 
7 (very much worse).25 A response better than ‘Equal’ was counted as ‘Improved’ and worse than 
‘Equal’ was counted as ‘Impaired’.
The women in the observational cohort completed the questionnaires 12 months after the first 
intervention.
Statistical analysis
We hypothesised that a strategy without urodynamics would be non-inferior to a strategy with a 
urodynamic investigation. The mean improvement of the UDI urinary incontinence subscale score 
in both groups was expected to be 35 points with a standard deviation of 10 points.26 A difference 
in mean improvement of 5 points or less was considered as non-inferior. In each arm, 51 women 
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were needed to reach a power of 80% using one-sided testing and risk of type 1 error at 0.05. 
Informed consent was expected in 50% of eligible women and one out of three eligible women 
was expected to have discordant urodynamic findings.21 The calculation of the sample size of the 
cohort showed that 600 women were needed to assess 102 women in the randomised controlled 
part of the study.
The primary analysis of the RCT group was according to intention to treat and was reported 
according to the number of valid observations. In a secondary per protocol analysis we analysed 
those women in whom the protocol had been strictly followed.
Data analysis in the observational cohort study was based on the treatment received. 
Analysis of covariance with group, centre and the baseline covariates as independent variables 
was used to estimate differences in cure and improvement of the UDI after one year with 95% 
confidence intervals (CI). For dichotomous outcomes, the relative risks (RR) with 95% CI were 
assessed. Calculation of the percentages was based on the number of valid observations. 
A secondary objective of this study was to determine whether postoperative outcome could 
be predicted by urodynamic parameters. Associations between urodynamic parameters 
and improvement of complaints and the persistence of urinary incontinence were analysed 
using logistic regression analysis and are presented as odds ratio (OR) with 95% CI. All patients 
(randomised and non-randomised) were included in this analysis.
Data were analysed by using Statistical Package for the Social Sciences (SPSS) version 18.0. For all 
statistical tests, differences were considered significant at P < 0.05. 
The consolidated standards of reporting trials (CONSORT) statement on the reporting of non-
inferiority trials was followed.27
Results
Study population
Between January 2009 and November 2010, 607 women with complaints of (predominant) SUI 
were approached to participate in the trial, of whom 578 were eligible and gave their informed 
consent for outcome registration. The study profile is depicted in Figure 1. 
The baseline characteristics are shown in Table 1a. 368 out of 578 women (64%) indicated to have 
urinary loss during physical activity, coughing or sneezing and leakage when experiencing a 
feeling of urgency and were considered to have mixed urinary incontinence.
The quality control performed on all urodynamic traces showed that the technical quality of 
most traces was sufficient to assess the presence of SUI, DO and voiding pattern and the overall 
agreement between local and central researcher was good. 
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Treatment selection
Of the 578 included women, 268 women (46%) had urodynamic findings that were discordant 
with clinical history and physical examination (Table 1b). Informed consent for randomisation 
was obtained from 126 of these 268 women, of which 64 were allocated to undergo immediate 
midurethral sling surgery and 62 to an individual tailored treatment based on signs and symptoms 
in combination with urodynamic results. Forty-one (7%) women had a discordant urodynamic 
investigation based on the absence of urodynamic SUI, but were not approached for randomisation 
and received a midurethral sling.
Table 2 shows the received initial treatment and further treatments during the follow-up 
period. In two patients, there was a contra-indication for immediate surgery according to the 
attending physician and consequently for randomisation, based on dysfunctional voiding during 
urodynamics. In the group randomised to immediate surgical treatment, one violation of protocol 
has occurred; an operation was postponed and the patient received drug treatment based on DO 
in absence of urodynamic SUI. 
During the one year follow-up period, 530 of all 578 included women (92%) underwent a 
midurethral sling procedure (Table 2). In 3 women (0.5%) surgical management was abandoned 
Figure 1. Study profile 
 
Discordant (n=268)
Individual treatment Immediate surgery (n=64) Individual treatment (n=62) Individual treatment 
Lost to follow-up: 41 
Deceased:1 
12 months: 268 (86%)
Lost to follow-up: 6 
 
12 months: 58 (91%) 
Lost to follow-up: 4 
Deceased:1 
12 months: 57 (86%)
Lost to follow-up: 17 
 
12 months 125 (88%)  
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Randomised (n=126) 
Assessed for eligibility (n= 607)
Urodynamics (n= 602)
Concordant (n=334)
Excluded: 24 No consent for randomisation:  99 
● Not meeting inclusion criteria: 12 Contra-indication immediate surgery: 2 
● Duplicate input: 12 Not approached for randomization:  41 
Registered (n=310) Registered (n=142) 
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because of the presence of DO (n=2) or dysfunctional voiding (n=1). By 45 patients an operation 
was cancelled at the patient’s initiative (n=41) or due to comorbidity (n=4).
Primary outcome data were complete in 115 randomised patients (91%). Follow-up information 
on the subjective clinical outcome was available of 508 patients (88%). Mean follow-up duration 
was 13 months (±4).
Table 1a. Baseline characteristics of randomised and non-randomised patients
 
 Randomised patients  Non-randomised patients 
 
 
Surgery Individual treatment  
Urodynamics 
concordant 
Urodynamics 
discordant 
 n=64 n=62  n=310 n=142 
Medical history      
Age (years) 55 (±12) 54 (±14)  52 (±11) 51 (±11) 
Body Mass Index (kg/m2) 27 (±5) 27 (±5)  27 (±5) 27 (±5) 
Parity (number of children) 2(±1) 2 (±1)  2(±1) 2 (±1) 
Nulliparous 2(3%) 2 (3%)  13 (4%) 8(6%) 
Previous prolapse surgery 22 (34%) 17 (27%)    
Questionnaire      
Presence of SUI 21 (33%) 23 (37%)  110 (35%) 56 (39%) 
Presence of MUI 43 (67%) 39 (63%)  200 (65%) 86 (61%) 
UDI Urinary incontinence score 55 (±24) 51 (±21)  56 (±23) 55 (±22) 
UDI Overactive bladder score 28 (±26) 31 (±25)  23 (±22) 21 (±24) 
UDI Obstructive symptoms score 20 (±25) 17 (±26)  15 (±20) 13 (±20) 
Bladder diary      
Daily micturition frequency  8 (±2) 8 (±3)  8 (±2) 8 (±2) 
Nightly micturition frequency 1 (±1) 1 (±1)  1 (±1) 1 (±1) 
Presence of nocturia*  38 (59%) 36 (58%)  142 (46%) 65 (46%) 
Incontinence episodes per day 4 (±4) 4 (±3)  4 (±4) 4 (±4) 
Number of pads per day 3 (±2) 3 (±2)  3 (±2) 2 (±2) 
 
 
 
Data are presented as mean (± SD) or a number (%). 
SUI, Stress urinary incontinence; MUI, mixed urinary incontinence; UDI, Urogenital Distress Inventory; *Nocturia: ≥1 time interruption 
of sleep because of the need to micturate. 
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Outcomes
Table 3 shows outcomes one year after baseline. In the women participating in the randomised 
controlled trial, the mean improvement on the UDI urinary incontinence subscale was 39 points 
(±25) in the group who received individually tailored treatment, versus 44 points (±24) in the 
group receiving immediate surgery (difference in mean improvement was 5 points, in favour of 
the group who received immediate surgery, 95% -∞ to 5). This confirms non-inferiority for either 
one of both strategies. 
Subjective cure as measured with the UDI and objective cure as measured with the stress test and 
bladder diary were not different between the two arms of the randomised trial.
The difference in mean improvement measured with the UDI and the upper limit of the 95% 
CI were identical for data analysis based on the intention-to-treat analysis and the per protocol 
analysis.  
In women with complaints of mixed urinary incontinence who underwent a midurethral sling 
operation (n=341, FU available n=292), the urgency component was cured in 203/292 (70%) and 
the SUI component in 227/292 women (78%) after surgery. Improvement was indicated by 265/292 
women (91%).
Table 1b. Urodynamic findings of randomised and non-randomised patients
  
 Randomised patients  Non-randomised patients 
 
Surgery 
Individual 
treatment 
 
Urodynamics 
concordant 
Urodynamics 
discordant 
 n=64 n=62  n=310 n=142 
Urodynamic investigation      
Maximum free flow (ml/s) 21 (±12) 18 (±11)  27 (±13) 24 (±12) 
Residual (ml) 15 (±35) 36 (±91)  19 (±42) 23 (±41) 
CMC (ml) 376 (±148) 411 (±138)  417 (±126) 442 (±140) 
MUCP (mmHg) 68 (±40) 65 (±26)  64 (±40) 75 (±34) 
Discordant findings      
Absence of urodynamic SUI 50 (78%) 45 (73%)  N.A. 124(87%) 
Detrusor overactivity 12 (19%) 6 (10%)  N.A. 16 (11%) 
Residual volume 1 (2%) 4 (7%)  N.A. 1 (1%) 
Small CMC 1 (2%) 2 (3%)  N.A. 2 (1%) 
Poor flow 4 (6%) 2 (3%)  N.A. 4 (3%) 
Low compliance 1 (2%) 1 (2%)  N.A. 0 
Dysfunctional voiding 5 (8%) 5 (8%)  N.A. 3 (2%) 
 
 
 
Data are presented as mean (± SD) or a number (%).  
CMC, cystometric maximum capacity; MUCP, maximum urethral closure pressure; SUI, stress urinary incontinence;  
N.A., not applicable. 
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Predictive factors
DO was the only urodynamic parameter which was independently associated with the risk for 
postoperative persistence of incontinence. DO was present on urodynamics in 34/578 women 
(6%). In women with DO, 27/34 women (79%) had symptoms of mixed urinary incontinence. 
Of all women with DO (randomised and non-randomised) who were treated surgically, 23/28 
women (82%) indicated that the complaints of urinary incontinence had improved, compared to 
367/396 (93%) of women without DO (OR 0.36, 95% CI 0.13-1.03). Bothersome postoperative SUI 
was present in 9/28 (32%) women with DO, versus 69/409 (17%) women without DO (OR 2.3, 95% 
CI 1.01-5.4). 
 
Adverse events
In five women, within the first days postoperatively, a reinvention was performed to surgically 
release the sling. Clean intermittent catheterisation for a period longer than 6 weeks after surgery 
was indicated in 8/453 women (2%); in whom in two cases a reoperation was indicated because of 
large PVR’s. Of the women who underwent a reoperation, 3/8 had received a retropubic tape and 
4/8 patients had received a transobturator tape. 
 
 
 Randomised patients  Non-randomised patients 
 Surgery 
Individual 
treatment  
Urodynamics 
concordant 
Urodynamics 
discordant 
 n=64 n=62  n=310 n=142 
Initial treatment         
Surgery 61 (95%) 57 (92%)  280 (90%) 122 (86%) 
Conservative treatment based on 
urodynamics findings 
1* (2%) 4** (6%)  N.A.  6*** (4%) 
Other 2‡ (3%) 1‡‡ (2%)  29‡‡‡ (9%) 14× (10%) 
Treatment after one year          
Surgery 62 (97%) 61 (98%)  282 (91%) 125 (88%) 
Conservative treatment based on 
urodynamics findings 
0  0   N.A.  3 (2%) 
Other         2‡ (3%) 1‡‡ (2%)  28×× (8%) 14× (10%) 
 
 
* Detrusor overactivity; ** Detrusor overactivity (n=2), dysfunctional voiding (n=1), mild symptoms in combination with the absence of 
urodynamic stress urinary incontinence (n=1); *** Detrusor overactivity (n=4), dysfunctional voiding (n=2); ‡ patient’s request;  
‡‡ Postvoid residual , not confirmed during urodynamics; ‡‡‡ comorbidity (n=3), patient’s request (n=26);  
× patient’s request (n=13), comorbidity (n=1); ×× comorbidity (n=3), patient’s request (n=25);  N.A., not applicable. 
Table 2. Treatment received in randomised and non-randomised patients
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Discussion
This study evaluated the value of urodynamics in the preoperative workup in women with 
complaints of SUI. We found that in women with complaints of SUI and urodynamics discordant 
with clinical assessment, outcome of immediate midurethral sling operation was not inferior to 
outcome of individually tailored treatment based on urodynamic findings. 
All patients in whom surgery was considered after history taking were included. This allowed us to 
determine the effect of urodynamic findings on deviation of the intended surgery and to determine 
whether alternative treatment enhanced positive outcomes or avoided complications. Alternative 
treatments, e.g. drugs and prolongation of pelvic floor muscle training, are aimed at controlling 
Reoperation occurred in 1/64 woman in the immediate surgery group, in none/62 women of 
the individually tailored group, and in 13/452 women in the observational cohort. Indications for 
reoperation were tape exposure (n=3), a large PVR (n=7) or persistence or recurrence of SUI (n=4).
 
 
  Randomised patients* 
  Non-randomised patients* 
  Immediate 
surgery 
Individual 
treatment 
  
 Urodynamics 
concordant 
Urodynamics 
discordant    
Questionnaires (n=64) (n=62)  (n=282) (n=125) 
Mean improvement UDI-UI 44 (±24) 39 (±25) 95% CI [-∞; 5] 
 
48 (±26) 41 (±27) 
UDI Urinary Incontinence 10 ±18 11 ±18 P = 0.99 
 
11 ±19 13 ±21 
UDI Overactive bladder 11 ±17 9 ±13 P =0.57 
 
9 ±14 10 ±17 
UDI Obstructive symptoms 11 ±22 14 ±22 P =0.45 
 
9 ±15 10 ±16 
    RR [95% CI] 
 
  
Global Improvement# Improvement 50/55 (91%) 52/57 (91%) 1.00 [0.89-1.12] 
 
207/222 (93%) 92/103 (89%) 
 Equal 2/55 (4%) 2/57 (4%)  
 
12/222 (5%) 8/103 (8%) 
 Impairment 3/55 (6%) 3/57 (5%)  
 
3/222 (1%) 3/103 (3%) 
No presence of SUI  43/58 (74%) 42/56 (75%) 0.99 [0.80-1.23] 
 
171/230 (74%) 71/105 (68%) 
No presence of UI   41/58 (71%) 37/55 (68%) 1.05 [0.82-1.35] 
 
161/230 (70%) 64/105 (61%) 
Micturition diary (48 hour)    
 
  
No leakage 45/53 (85%) 41/50 (82%) 1.04 [0.87-1.23]    
Stress test     
 
  
Negative 37/38 (97%) 33/34 (97%) 1.00 [0.93-1.09]    
 
 
*Results are reported according to the number of valid observations. # Patient Global Impression of Improvement Scale. CI, confidence 
interval. UDI, Urogenital Distress Inventory. RR, relative risk. SUI, stress urinary incontinence. UI, urinary incontinence. 
Table 3. Outcome after one year of follow-up
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a certain discordant condition. Alternative treatment may therefore reduce the occurrence of 
postoperative adverse events like overactive bladder complaints or voiding dysfunction. However, 
alternative treatment also has an obvious risk of delaying an effective treatment for the complaints 
of SUI. In our study, the effect on treatment selection of discordant urodynamic findings was very 
limited. DO (n=7) and dysfunctional voiding (n=2) were the findings in this group of women which 
lead to initially abandon surgical treatment, however, after one year only 3 women (0.5%) did not 
undergo surgery based on discordant urodynamic findings.
Strengths of this study were the adequate randomisation and allocation concealment and the 
prospective evaluation of a large number of women with (predominant) SUI who underwent 
quality controlled urodynamics in a nationwide study at academic and non-academic centres. 
This makes our results applicable to patients in secondary or tertiary care. 
We decided to randomise only women with a discordant result from urodynamics and the medical 
history. By choosing such a design, we kept the group of women with concordant findings out 
of the randomised comparison, thus reducing random error.28 By applying this design, we were 
able to demonstrate, complementary to the results of the VALUE-trial, that also in women where 
the urodynamics had showed discordant findings, an individualised treatment did not improve 
outcome as compared to immediate surgery in spite of the urodynamic finding(s).
This study has also some limitations. The attending specialist was not blinded for the allocated 
arm and for the urodynamic results. Due to this, treatment selection could be influenced by 
urodynamic findings, which has led to one violation of protocol and bias in objective outcome 
measurement could not be excluded. However, for the primary (subjective) outcomes, the data 
collectors were blinded to the allocated arm which avoided detection bias. 
Treatment was not standardised for those women who were allocated to individual tailored 
treatment based on urodynamics findings. In this study, choices as made in clinical daily practice 
were followed and most women underwent an operation within one year regardless of discordant 
urodynamic finding(s). Thus, this study does not answer further questions regarding the long-
lasting effects of alternative treatment in this group. 
The advice to perform urodynamics prior to invasive treatment for SUI is advocated by several 
national and international professional organisations and authorities. Therefore the recommended 
management of women with SUI opting for surgical treatment will be similar throughout countries, 
and our findings seem therefore applicable to international practice. 
In case urodynamics do not attribute to treatment selection, they can be used for counselling 
about the perspectives on postoperative outcome. One study showed higher, albeit not significant, 
overall success after surgery in women with urodynamic demonstrable stress incontinence versus 
no urodynamic stress incontinence.17 In one underpowered randomised controlled trial and in 
one retrospective study, cure rates were comparable in patients with and without urodynamic 
SUI.16,29 In this study, we also have not found any effect of urodynamic findings with regard to SUI 
on clinical outcomes.
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The need for preoperative urodynamics is often justified by the consideration that pre-existing DO 
may be either a contra-indication for surgery or at least carries the risk for a worse prognosis.29-31 
It is known that the subjective cure rate is lower in case of preoperative DO.29,32 In the present 
study, DO was the only urodynamic parameter which was associated with a compromised cure 
of symptoms of SUI. In another study, DO has also been identified as the only independent risk 
factor for lower cure rates of SUI following surgery (OR 2.9 95% CI 1.3-6.7).18 Since complaints 
of urinary incontinence in women with DO improved in 81% of the women, it seems justified 
that the detection of DO preoperatively does not naturally lead to deviation of the intended 
surgery. Moreover, it is questionable also whether counselling on the postoperative perspectives 
in patients with DO does counterbalance the disadvantages of urodynamics. The difference in 
improvement between women with and without DO was approximately 11%. DO was found in 
6% of women, which implies that in 152 women urodynamics need to be performed to predict no 
improvement of complaints in one extra woman correctly.
Surgery for SUI can lead to postoperative voiding dysfunction including urinary retention, this 
occurs in 7-36%, depending on the definition used.33-37 A high preoperative PVR and a low 
maximum flow velocity have been correlated to voiding dysfunction postoperatively in some 
studies 36,38-39 although other studies contradict that voiding dysfunction could be predicted 
by urodynamic parameters.37,40 We excluded women with a large PVR, as well as women with 
previous incontinence surgery or an advanced pelvic organ prolapse. The results of this study are 
therefore not applicable to those women with “complicated” SUI, the relevance of preoperative 
urodynamics in these patients needs further evaluation.
Conclusions
In women with complaints and clinically objectified SUI, an immediate midurethral sling operation 
is not inferior to an individually tailored treatment based on urodynamic findings and urodynamics 
do not represent a substantial predictor of poor outcome. Since urodynamics are costly, invasive 
and may induce urinary tract infections, urodynamics should no longer be advised routinely prior 
to primary surgery in women with (predominant) SUI.
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General discussion
In this thesis, the various aspects of the value of urodynamics prior to stress incontinence surgery 
were evaluated. This thesis thereby provides insights in the additional retrieved information of 
urodynamics, the current use and opinion of specialists and the predictive value on outcome. In 
this general discussion, we have summarised our main results and discussed the findings and its 
implications to daily practice. 
Introduction
Urodynamics
A urodynamic investigation is performed prior to stress incontinence surgery to confirm the 
clinical diagnosis based on symptoms and signs and to detect factors which may influence the 
effectiveness of surgery and the probability of complications.1-3 
The investigation tries to enhance the understanding of lower urinary tract function and reveal 
the underlying pathophysiology responsible for the patient’s complaints. However, urodynamics 
remain an artificial setting and results can be distorted by the circumstances of the urodynamics 
like an uncomfortable situation and the necessity to urinate with catheters in place. Nonetheless, 
urodynamic observations are widely regarded as gold standard for the determination of the type 
of incontinence and are seen as the final verdict for the therapeutic strategy. 
The diagnostic accuracy of a test is normally determined by verifying test results against the gold 
standard which defines true disease status. However, the diagnostic accuracy of urodynamics 
cannot be assessed in this way, because there is no accepted gold standard.4 It may thus be 
difficult to determine the accurate diagnosis in case the history and the urodynamic diagnosis 
disagree. To determine ‘the gold standard’ for diagnosing the type of incontinence, it may be 
determined which diagnosis enhances the best outcome of treatment; a diagnosis based on 
urodynamic findings included, or based on clinical evaluation only.
The present situation
For years, several national and international guidelines, advised to perform urodynamics prior 
to surgical treatment of women with stress urinary incontinence (SUI). The National Institute for 
Health and Clinical Excellence (NICE) guideline was in 2006 the first to state that preoperative 
urodynamics were not necessary in women with pure SUI and defined criteria when urodynamics 
should be performed. Recently, also other associations made adaptations to their guideline 
and advocates the use of urodynamics in complicated cases of urinary incontinence, uncertain 
pathophysiology, or the presence of neurogenic voiding dysfunction.5-6 However, so far the 
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recommendations were not validated prospectively and the adaptations encountered opposition 
by various clinical experts.7-8
In the Netherlands, the preoperative work-up in women with (predominant) SUI varies strongly 
between centres. It ranges between evaluation and treatment in primary care setting without an 
extensive diagnostic evaluation, and direct referral to undergo urodynamics even before seeing 
a specialist.9 
The assumption is that the urodynamic setting is capable of making a distinction between several 
pathophysiological mechanisms causing the same micturition symptoms, but needing different 
treatments. Since the introduction of easy to administer midurethral polypropylene slings, a 
simplified reasoning has become popular indicating that every type of SUI is treated identically. 
The adherence to the guideline is decreasing, and the work-up for women is nowadays more 
dependent of the presumed value as experienced by the attending specialist than on scientific 
evidence (Chapter 3). There is therefore a necessity of conclusive scientific evidence to determine 
whether preoperative urodynamic investigation is valuable in the preoperative work-up of surgery 
for SUI. 
Guidelines should then be modified based on evidence to create a more uniform work-up. The 
guideline should be based on the best available evidence and should be easy applicable to daily 
practice to reach optimal implementation.
The current evidence
In Chapter 2, we have reviewed the potential role of urodynamics in the clinical decision making 
in women with urinary incontinence as based on the available literature. We found that the level 
of agreement between classification of incontinence based on clinical evaluation and based on 
urodynamic investigation was poor. Reclassification of the type of incontinence was especially high 
among women with symptoms of mixed urinary incontinence, where the diagnosis was altered 
after urodynamics in two thirds of these patients. In women with mixed urinary incontinence, 46% 
had pure SUI on urodynamics. In case the complaints of SUI were predominant, 65% of the women 
were diagnosed as having urodynamic SUI.10 
Randomised controlled trials that compared clinical outcome of treatment based on a work-up 
with and without urodynamics have not been published until now. In two previous observational 
studies where all women underwent urodynamics, findings on urodynamic investigation did 
not predict stress continence outcome.11-12 The subjective and objective outcome of surgical 
intervention with or without preoperative urodynamic investigation has furthermore been 
compared in one retrospective study on colposuspension and one cohort study on the retropubic 
tension free vaginal tape (TVT).13-14 In these two studies no differences were found between 
the groups with and without urodynamics. Moreover, the conclusion from a recently updated 
Cochrane review on the value of urodynamics was that randomised trials are needed.4
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Comments on the study design
Randomised comparison of a diagnostic test: VUSIS 1 and VUSIS 2
The authors of the Cochrane review suggested a randomised controlled trial with random 
allocation to a work-up with and without urodynamics.4, 15 This design was adopted in ‘the Value 
of Urodynamics prior to Stress Incontinence Surgery (VUSIS) 1’ study (Chapter 5). The VUSIS 1 
study had to be stopped prematurely due to a disappointing inclusion rate. At that time, the 
Dutch Urogynaecology Consortium was only just starting. Most centres had furthermore just 
started projects with multidisciplinary teams for patients with urinary incontinence and patients 
underwent urodynamics before they could be counselled about participation in the trial. On 
the other hand, some specialists had (already) stopped to perform urodynamics in this patient 
category not awaiting the outcome of the study. An alternative study design was developed: 
VUSIS 2 (Chapter 6). In Figure 1 both study designs are shown schematically. 
The subgroup of women with discordant urodynamic findings were expected to contribute 
most to the potential difference between two trial arms. In the VUSIS 1 study, these women 
with discordant findings were expected to be equally divided over the group with and without 
urodynamics. In the VUSIS 2 study, the women with discordant findings were specifically included 
in the randomised trial. In this manner, the decision point whether or not to perform urodynamics 
Figure 1. Study designs 
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was delayed until the clinical decision on what to do with urodynamic discordant findings. This 
design improved trial efficiency.16 
The advantage of the VUSIS 2 design in comparison to the VUSIS 1 design was that in case of 
a difference in treatment outcome, it would have been possible to make conclusions on the 
effectiveness of the test itself. Whereas in the VUSIS 1 it would have remained unclear to what 
degree results depended on treatment, accurate selection or both. On the other hand, an 
advantage of the VUSIS 1 trial was that urodynamics could never have influenced treatment in the 
‘no urodynamics’ arm, whereas in the VUSIS 2 trial, it cannot be fully excluded that urodynamic 
findings may have influenced treatment selection in the ‘immediate surgery’ arm in any way. 
Non-inferiority 
Preoperative urodynamics are an accepted standard procedure in the work-up of women with 
SUI. Urodynamics has disadvantages such as costs, risk for urinary tract infection, patient’s 
discomfort and they are time-consuming. When comparing two diagnostic-treatment strategies 
with unknown benefits but known disadvantages, a non-inferiority trial is more appropriate than 
the typical superiority design. In Figure 2 we show the possible scenarios of observed outcome 
differences. 
The difference in mean improvement measured with the Urogenital Distress Inventory between 
treatment based on a diagnosis with and without urodynamics, was -14 points in favour of the 
group without urodynamics (95% CI -∞ to -0.26) in the VUSIS 1 study, and -5 points in favour of the 
Possible scenarios of the difference in mean effect measured with the Urogenital Distress Inventory urinary incontinence 
subscale between a work-up including urodynamic findings and a work-up without or not based on urodynamic findings.
The upper limit of the 95% CI of the difference in mean improvement is indicated with delta (Δ). 
Figure 2. Possible scenarios of observed outcome differences in non-inferiority trial, from one-sided 
95% confidence interval
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group who received immediate surgery (95% CI -∞ to 5) in the VUSIS 2 study. Both in the VUSIS 1 
and VUSIS 2 study, the upper limit of the 95% CI of the difference in mean improvement between 
the two strategies did not exceed the non-inferiority margin. In the VUSIS 1 study, the upper 
limit of the confidence interval was even below zero, therefore, treatment based on a work-up 
without urodynamics may also be classified as superior (see Figure 2). Because urodynamics are 
attended with higher costs and it is more invasive, a work-up without urodynamics would already 
have been preferable in case of non-inferior outcomes. We did not define superiority prior to 
the trial, and moreover the calculated number for adequate power in the VUSIS 1 study was not 
accomplished. This implies that more supportive evidence from the VUSIS 2 study was needed for 
strong conclusions. 
Good Urodynamic Practice
The reliability and reproducibility of urodynamic data depends on standardised testing techniques, 
adequate reports and interpretation.17 These factors may differ among centres and practitioners, 
and may both influence clinical decision making and scientific results. In 2002 the International 
Continence Society developed a guideline on ‘Good Urodynamic Practice’ (GUP) to improve 
standardisation of the performance of urodynamics across centres.18
In both VUSIS studies, the research protocols indicated that urodynamics should be performed 
according to the GUP standards. However, it was not determined before the trials whether 
guidelines on GUP were locally applied and the type of equipment was not standardised. The size 
and type of the transurethral catheter could e.g. influence recorded pressures and the prevalence 
of urodynamic SUI and pressure recordings from water-filled, microtip and air-charged systems 
may not be interchangeable.19-20 Because urodynamic parameters were not an outcome measure, 
the influence of the variation in equipment will only be limited. In Chapter 4, the results from the 
urodynamic quality control study were presented. We found that the guideline on GUP was not 
strictly adhered to, but most traces could be analysed for the three most relevant components 
namely the presence of urodynamic SUI, detrusor overactivity (DO) and voiding pattern. 
Outcomes
Outcomes of the randomised controlled trials
The primary objective to perform the VUSIS studies was to answer the question whether outcome 
of treatment based on a diagnosis without urodynamic information is non-inferior to outcome of 
treatment based on urodynamic findings. 
In the VUSIS 1 study, the difference in mean improvement on the Urogenital Distress Inventory 
urinary incontinence subscale between the groups with and without urodynamics after one year 
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was -14 points (95% CI of -∞ to -0.26). In the VUSIS 2 trial the difference in mean improvement 
between the individual treated group based on urodynamic findings and the group who 
immediately received a midurethral sling operation, was -5 points (95% CI -∞ to 5). Therefore, 
both studies showed that an immediate midurethral sling operation based on a clinical diagnosis 
was not inferior to an individually tailored treatment based on urodynamic findings (Figure 2). 
Consequently, urodynamics seem not necessary in the preoperative work-up in women with a 
first episode of symptoms of (predominant) SUI.
Consequences of urodynamics findings in treatment selection 
In Chapter 3, 5 and 7 we found that urodynamic findings hardly influence treatment selection and 
only incidentally lead to a deviation of an intended operation. When SUI was observed during 
clinical examination and/or bladder diary, the absence of urodynamic SUI as the only discordant 
finding did not influence treatment selection. DO and dysfunctional voiding lead to abandonment 
of initial surgical treatment, but after one year most of these women had still undergone surgery. 
Alternative treatments, e.g. drugs and bladder training, aim at controlling a certain co-existing 
condition to reduce the occurrence of postoperative adverse events like overactive bladder 
complaints or voiding dysfunction. However, we found that alternative treatments were not 
effective enough to realise improvement and had a risk of a delay in effective treatment for the 
complaints of SUI (Chapter 5 and 7). 
For women with poor intrinsic urethral sphincteric function, as assessed by low maximum urethral 
closure pressures (less than 20 cm H2O), a retropubic approach results in better continence rates 
than the transobturator sling but are also potentially more obstructive.21-24 Therefore the use of 
the urethral pressure profile could attribute to the determination of the most effective type of 
sling in individuals. We found that only 9% of the specialists differentiate in the choice of sling 
on measurement of the closure mechanism (Chapter 3). The majority of specialists apply only 
one type of sling procedure, which is possibly due to surgeon’s experience and familiarity with 
that specific type (various brands of transobturator or retropubic tapes). Further discussion on 
maximum urethral closure pressure in VUSIS patients follows below. 
Predictive value of urodynamics and counselling 
In case urodynamics predict a lack of postoperative improvement or the occurrence of adverse 
events, such as a large postvoid residual (PVR), urodynamics would prevent women from non-
effective surgery and could attribute to the counselling on the perspectives on postoperative 
outcome.
In both VUSIS studies we found that the presence or absence of urodynamic SUI was not related to 
cure rate after surgery. In the literature, there is one study that showed higher, albeit not significant, 
overall success after surgery in women with urodynamic demonstrable stress incontinence 
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versus no urodynamic stress incontinence.12 Our findings confirm the results of a retrospective 
study among 437 women, in which cure rates were comparable in patients with and without 
urodynamic SUI (Chapter 7).25 Therefore, in case SUI is demonstrated during clinical examination, 
urodynamics are not necessary to perform for the confirmation of the clinical diagnosis.
DO was found to be the only urodynamic parameter which was associated with impaired cure of 
symptoms of SUI in the VUSIS 2 cohort study. Since women with DO improved in 82% as compared 
to 93% in women without DO, it seems justified that DO does not naturally lead to deviation 
of the intended surgery. It remains questionable whether a more accurate counselling on the 
postoperative perspectives in women with DO, counterbalances the disadvantages attended with 
urodynamics. In Chapter 7, we calculated that urodynamics need to be performed in 151 women 
to correctly predict one extra woman who will not improve after surgery (number needed to test). 
DO was not found to be a predictor for urgency urinary incontinence postoperatively in the 
multivariable logistic regression analysis. This is in line with one other retrospective study, in which 
DO was also identified as independent predictor for the persistence of complaints of SUI and 
was not related to urgency urinary incontinence postoperatively.11 It is remarkable that now two 
studies, in 890 women total, found that DO was only an independent predictor of postoperative 
symptoms of SUI and not for symptoms of urgency urinary incontinence. A solid explanation for 
these findings could not be given.
Postoperative voiding dysfunction including urinary retention occurs in 7-36%, depending on 
the definition used.26-30 In VUSIS 2, clean intermittent catheterisation for a period longer than 
6 weeks after surgery was indicated in 8/453 women (2%). In five women within the first days 
postoperatively an immediate re-intervention was performed to release the sling, and in two 
other women a reoperation was indicated because of the persistence of large PVR’s. A correlation 
between preoperative voiding parameters and postoperative voiding dysfunction was not 
identified but this may be due to the low prevalence of voiding dysfunction and the exclusion of 
patients with a potential risk factor.
In other studies, lower leak point and closure pressures, as well as less mobile urethras, were 
correlated with impaired success of treatment.31-36 However, not all studies have found these 
correlations.14, 37-38 In our study, data on the Valsalva leak point pressure (VLPP) were frequently 
lacking. A urethral pressure profile was performed in 16/31 women (52%) in the VUSIS 1 study 
and in 262/578 women (45%) in the VUSIS 2 study. Maximum urethral closure pressures were 
not identified as independent risk factor for failure of an anti-incontinence procedure in the 
multivariable logistic regression analysis. In most studies reporting on outcome of transobturator 
and/or retropubic tapes, the number of women with a poor intrinsic urethral sphincteric function 
was small, and thus a clear prevalence of intrinsic sphincteric deficiency among women with 
symptoms of SUI could not be obtained from the literature. In the VUSIS 2 study, a maximum 
urethral closure pressure of less than 20cm H2O was present in only 16/262 women (6%). The low 
prevalence limited us to perform a subgroup analysis.
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Applicability of the results for the daily clinical practice 
Forty-one percent of Dutch urogynaecologists indicated to consider themselves not capable 
to interpret a urodynamic trace, in contrast to only 18% of the urologist (Chapter 3). The local 
classification however, done by a urogynaecologist or urologist, determined the eligibility for 
randomisation and the treatment strategy. Therefore, the reliability of this classification was 
important for the reproducibility of our results. Reference values for various numerical cystometry 
parameters are available39, but strict cutoff levels for normal or abnormal have not been defined by 
the International Continence Society and/or the International Urogynaecological Association.40 In 
order to mimic routine clinical practice, we did not provide cutoff levels, but left the classification 
to the discretion of the doctor. We showed that the interrater reliability between local and central 
researcher for the diagnosis of urodynamic SUI was found to be very good with kappa = 0.81 (raw 
agreement 91%) and moderate for the observation of DO kappa = 0.52 (raw agreement 94%). 
Other discordant findings with the patient’s history were often not identified but raw agreement 
was good with more than 96% for all findings (Chapter 4). Therefore, in our opinion the urodynamic 
traces of the studied women were of sufficient technical quality and the overall high agreement 
implies that the presence or absence of discordant findings could reliably be assessed. 
A limitation of the VUSIS studies was that treatment was not standardised for the women who 
were allocated to individual tailored treatment based on urodynamics findings. The majority 
underwent an operation regardless the discordant finding(s). This knowledge was regarded as a 
strong result on the current place of urodynamics in daily clinical practice. Standardisation would 
however have attributed to better reproducibility of the study results and to determine treatment 
effectiveness based on various discordant urodynamic findings. However, the aim of the trial was 
to deliver evidence of effectiveness or ineffectiveness in an everyday clinical context.
Topics for future research 
Cost-reduction and Implementation
With the results of our studies we found that in women with primary (predominant) SUI, 
urodynamics can be omitted. With increasing pressure on health care budgets, it is important 
that our findings are implemented quickly. Guidelines should be updated and an implementation 
study should be performed to realise a change in patients’ care to convert best evidence to best 
practice.
Complicated SUI
We have focused on women with pure or predominant SUI. Women without previous continence 
surgery, a large PVR, as well as women with an advanced prolapse and women with mixed, 
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predominant urgency urinary incontinence were excluded. The results of this thesis are therefore 
not applicable to women from these groups with “complicated” SUI. 
Persistent or recurrent symptoms of urinary incontinence after tape placement are a clinical 
challenge regarding assessment and management. In literature there is only limited information 
available, and reported studies concern only small populations. Prevalence of the problem may 
be underestimated, because individual centres see relatively small numbers of women with 
postoperative problems. Moreover, the number of yearly performed operations has increased in 
recent years and the problems may be yet to come.41 Additional (multicentre) studies are required 
to determine which variables influence outcome and attribute to optimal effective treatment 
selection in these challenging cases. 
Conclusions 
Symptoms and signs of urinary incontinence have a poor correlation with urodynamic diagnosis. 
(Chapter 2)
The guideline adherence is low, resulting in practice variation. (Chapter 3)
The quality of urodynamic traces and the interobserver agreement in interpretation and 
classification of urodynamic traces in women with complaints of stress urinary incontinence is 
good. (Chapter 4)
In case there is an indication for an operation based on symptoms, signs, and counselling on the 
perspectives; discordant urodynamic findings seldom result in deviation of the intended surgery. 
(Chapter 3, 5, 7) 
The omission of urodynamics does not enhance impaired outcome. In aspect to costs and risks of 
urodynamics, the omission of preoperative urodynamics is preferable. (Chapter 5, 7)
Women with detrusor overactivity on urodynamics had a lower continence rate after surgery, 
however the presence of detrusor overactivity does not predict poor postoperative outcome or 
urgency urinary incontinence. (Chapter 7)
123
General discussionChapter 8
8
Topics for future research
An update of the guidelines, amongst others based on the results of this thesis, and its 
implementation could attribute to a more uniform and evidence-based clinical practice. 
The relevance of preoperative urodynamics in patients with complicated stress urinary 
incontinence needs further evaluation.
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In Chapter 1 the general outline and the aims of the thesis were described. The main objective 
of this thesis was to assess whether the additional information gained by urodynamics influences 
clinical decision making, and particularly whether this leads to an improvement in clinical 
outcomes. 
The objective of the study in Chapter 2 was to determine the reclassification rate of clinically 
diagnosed stress, mixed and urgency urinary incontinence after urodynamic investigation. 
Determination of the type of incontinence is important since it determines the type of treatment 
and predicts its expected success and complications. We performed a systematic review of the 
published literature. Twenty-three (23) papers involving 6.282 women with urinary incontinence 
were included. The pooled reclassification rate was the highest among patients with symptoms 
of mixed urinary incontinence, where 46% of the patients had stress urinary incontinence and 
21% had detrusor overactivity on urodynamic investigation. A clinical diagnosis of stress urinary 
incontinence was reclassified into mixed urinary incontinence in 9% of women and into detrusor 
overactivity in 7% of cases, whereas 8% had no abnormalities during urodynamics. None of 
the publications studied the effect of reclassification on treatment or clinical outcomes after 
treatment. With this study, we showed that the level of agreement between classification based 
on clinical evaluation and based on urodynamic investigation is poor. Urodynamic observations 
are regarded as gold standard, but based on the poor correlation, this assumption should be 
questioned. 
In Chapter 3, the current use and the opinion of Dutch gynaecologists and urologist on 
preoperative urodynamics in women with complaints of stress urinary incontinence was 
presented. We performed an E-survey among all Dutch gynaecologists and urologists who have 
stress urinary incontinence as focus in daily practice. Of the 260 targeted specialists, 163 (63%) 
responded. There was a wide variety in the diagnostic work-up of women with stress urinary 
incontinence, ranging between evaluation/treatment in a primary care setting and direct referral 
to undergo urodynamics even before seeing a specialist. We found that 37% of the respondents 
performed standard preoperative urodynamics in women with predominant stress urinary 
incontinence; in the preferred practice, this would reduce to only 18%. Eighty percent (80%) 
indicated that they would operate a patient without urodynamic stress urinary incontinence in 
case the stress test was positive, whereas 21% would do this in case the clinical stress test was 
negative as well. Only 9% of the respondents indicated that they adapted the choice of the type 
of sling based on urethral pressure profilometry parameters. 
Despite the advice of the guidelines, urodynamics are not routinely performed and outcomes 
hardly influence the choice of treatment. 
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The value of information obtained with urodynamics depends on the quality of testing techniques, 
reports and interpretation. These factors may differ among centres and practitioners in multicentre 
trials. In Chapter 4 we determined the technical quality of urodynamic investigations and the 
interobserver agreement on the classification, even as the related consequences between local 
and central researchers. 
This study was performed among 578 women included in the multicentre trial entitled ‘the Value 
of Urodynamics prior to Stress Incontinence Surgery (VUSIS) 2’ study (Chapter 7). All participants 
underwent multi-channel urodynamics. Copies of 543 urodynamic traces (94%) were obtained 
and were reviewed blindly by one central reviewer and assessed for quality using a standardised 
checklist based on the guideline on Good Urodynamic Practice. In most traces (>99%) pressure 
catheters were appropriately positioned and during all urodynamic investigations a cough test 
was performed. The traces scored poorly in terms of the use of annotations for leakage (57%) and 
adequate frequency of coughs to ensure right positions (25%). The interrater reliability between 
local and central researcher for the diagnosis of urodynamic stress incontinence was very good 
with kappa = 0.81 (raw agreement 91%) and for the observation of detrusor overactivity kappa 
= 0.52 (raw agreement 94%). Other discordant findings with the patient’s history were often not 
identified but the raw agreement was good. 
In 2006, the controversies in the literature led to the start of a multicentre non-inferiority 
randomised clinical trial on the preoperative value of urodynamics in women with stress urinary 
incontinence. The results of the VUSIS 1 study are presented in Chapter 5. The main objective of 
the VUSIS 1 study was to assess the value of urodynamics prior to treatment among women with 
stress urinary incontinence. The trial was stopped prematurely due to slow recruitment. Fifty-
nine women with complaints of stress urinary incontinence were randomly allocated to either 
a strategy with (N=31) or without (N=28) urodynamics. The difference in mean improvement on 
the Urogenital Distress Inventory urinary incontinence subscale was 14 points in favour of the 
group without urodynamics (34 points ±22 versus 48 points ±22, 95% CI -∞ to -0.26], confirming 
non-inferiority. In the group allocated to urodynamics, initial surgical management as indicated 
based on the patient’s symptoms and signs was more often abandoned compared to the group 
not allocated to urodynamics. The conclusion of this relatively small study was that the omission 
of urodynamics was not inferior to the use of urodynamics in the preoperative work-up of 
women with stress urinary incontinence. Women with complaints of stress urinary incontinence 
undergoing urodynamics were at risk of a choice for more prudent treatment which seemed to 
result in a delay until effective treatment. 
A more effective study design to answer the research question was approved by the funder and 
the Institutional Review Board: the VUSIS 2 study. Chapter 6 provides a detailed description of 
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the study protocol. The trial was set up within the Dutch Urogynaecology Consortium, which 
is a collaboration of gynaecologic clinics in the Netherlands (www.studies-obsgyn.nl/VUSIS). Six 
Dutch academic and twenty-four non-academic hospitals participated in the trial. Patients with 
discordant findings between the diagnosis based on their history, clinical examination and/or 
bladder diary and the diagnosis based on urodynamic investigation were randomised to operative 
therapy or individually tailored therapy based on all available information. 
The primary outcome of this study was treatment effect as measured with the Urogenital Distress 
Inventory at 12 months after baseline. The power calculation was performed prior to the study 
using the non-inferiority assumption. The calculation of the sample size of the cohort showed that 
600 women were needed to assess 102 women in the randomised controlled part of the study, 
with a power of 80% using one-sided testing and risk of type 1 error at 0.05.
A secondary objective of this study was to determine whether postoperative outcome could be 
predicted by urodynamic parameters. Associations between urodynamic parameters and the 
persistence or presence of complaints of stress and urgency urinary incontinence were analysed.
The results of this non-inferiority randomised controlled trial were described in Chapter 7. 
Between January 2009 and November 2010, 607 women with complaints of (predominant) stress 
urinary incontinence were approached to participate in the VUSIS 2 trial, of whom 578 were 
eligible and gave informed consent for outcome registration. Two hundred sixty five (265) out 
of 578 included women (46%) had discordant findings, 126 patients gave informed consent for 
randomisation and were allocated to immediate surgery (n=64) or to individually tailored therapy 
as based on urodynamic findings (n=62). The difference in mean improvement as measured with 
the Urogenital Distress Inventory after one year was 5 points in favour of immediate surgery (39 
points versus 44 points, 95% CI -∞; 5). The conclusion of this study was that in women with a first 
episode of (predominant) stress urinary incontinence, a strategy with an immediate operation is 
not inferior to an individually tailored treatment based on urodynamic findings. 
In Chapter 8 our main results are summarised and we discussed the findings of this thesis and its 
implications to daily practice. 
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Urine-incontinentie is een veelvoorkomende klacht. Jaarlijks presenteren ongeveer 64.000 
patiënten zich met deze klacht, waarvan 96% vrouw is. Van alle vrouwen die naar de huisarts gaan 
vanwege urineverlies, heeft naar schatting 50% last van stressincontinentie, 40% van gemengde 
incontinentie en 10% van aandrangincontinentie. Urine-incontinentie is geen levensbedreigende 
ziekte, maar de klachten kunnen een grote invloed hebben op de kwaliteit van leven.
Het type incontinentie is bepalend voor het beleid en de te verwachte resultaten van een 
behandeling. Bij vrouwen met stressincontinentie wordt gestart met bekkenbodem fysiotherapie. 
Wanneer dit onvoldoende verbetering geeft, komen patiënten in aanmerking voor de operatieve 
plaatsing van een kunststofbandje (midurethrale sling). 
Tot voor kort was men breed gedragen van mening dat een preoperatief urodynamisch onderzoek 
aanvullende informatie kan verschaffen over kansen op succes en op complicaties. Echter, de 
klachten die vrouwen beschrijven komen in veel gevallen niet overeen met de bevindingen 
tijdens het urodynamisch onderzoek. Het is nog onvoldoende duidelijk welke vrouwen nu precies 
baat hebben bij dit onderzoek en of urodynamisch onderzoek daadwerkelijk leidt tot een betere 
klinische uitkomst. 
Dit proefschrift gaat over de waarde van urodynamisch onderzoek in de diagnostiek en 
behandeling van vrouwen met stressincontinentie. In Hoofdstuk 1 worden de achtergrond en 
onderzoeksvragen van dit proefschrift beschreven. Het belangrijkste doel was om vast te stellen 
in welke mate urodynamisch onderzoek de keuze van behandeling en daarmee de klinisch 
uitkomst beïnvloed. 
In Hoofdstuk 2 bekeken we de overeenkomst tussen de diagnose gesteld op basis van 
anamnese en lichamelijk onderzoek en de diagnose op basis van het urodynamisch onderzoek. 
We bepaalden voor de verschillende typen incontinentie hoe vaak deze geclassificeerd werden 
in een ander type na het urodynamisch onderzoek. In een literatuurstudie werden 23 relevante 
artikelen met betrekking op 6.282 vrouwen met klachten van urine-incontinentie geselecteerd. 
Bij vrouwen met een klinische diagnose van stressincontinentie werd in 9% de urodynamische 
diagnose gemengde incontinentie vastgesteld, in 7% liet het urodynamisch onderzoek alleen 
detrusor overactiviteit zien en in 8% werden er geen afwijkingen gevonden. Bij vrouwen met 
klachten van gemengde incontinentie werd op basis van urodynamische bevindingen het 
type incontinentie in 46% geclassificeerd als zuivere stressincontinentie en in 21% werd alleen 
detrusor overactiviteit gevonden. De mate van overeenkomst tussen de klinische evaluatie en het 
urodynamisch onderzoek is dus beperkt.
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Ondanks dat richtlijnen adviseren om preoperatief een urodynamisch onderzoek te verrichten, 
zijn er grote verschillen in het standaard beleid. Zo zijn er vrouwen die behandeld worden door 
de huisarts op basis van een diagnose zonder urodynamisch onderzoek, maar worden er ook 
vrouwen direct verwezen en ondergaan een urodynamisch onderzoek zonder enige vorm 
van behandeling of zonder een consult bij een specialist te hebben gehad. In Hoofdstuk 3 
hebben we gekeken hoe op dit moment het urodynamisch onderzoek gebruikt wordt en wat 
de waarde is volgens gynaecologen en urologen die gespecialiseerd zijn in de behandeling van 
stressincontinentie. Een digitale vragenlijst werd verstuurd naar alle gynaecologen en urologen 
die stressincontinentie als aandachtsgebied hebben. Het aantal specialisten werd geschat op 
260, daarvan reageerden 163 specialisten (63%) op het verzoek. In de huidige situatie wordt in 
37% van de ziekenhuizen standaard een urodynamisch onderzoek uitgevoerd voorafgaand aan 
een operatie voor stressincontinentie, slechts 18% van de specialisten vindt dit noodzakelijk. Veel 
specialisten verrichten bij voorkeur alleen een urodynamisch onderzoek als vrouwen klachten 
hebben van onder andere een sterke aandrang, de plas niet op kunnen houden of het gevoel 
hebben dat ze niet volledig uitplassen. 
Er zijn studies gepubliceerd die concludeerden dat bij vrouwen met een lage afsluitdruk van de 
urethra een retropubische bandje tot betere uitkomsten leiden dan een transobturator bandje. De 
keuze voor het type kunststofbandje wordt echter maar door 9% van de specialisten bepaald op 
basis van de meting van de urethrale afsluitdruk.
De waarde van de informatie die verkregen kan worden met urodynamisch onderzoek is 
afhankelijk van de kwaliteit van het onderzoek, de verslaglegging en de interpretatie van de 
bevindingen. In studies die verricht worden in meerdere ziekenhuizen kan dit verschillen tussen 
personen en centra. In Hoofdstuk 4 bekeken we de technische kwaliteit en de overeenkomst in 
interpretatie van de resultaten van het urodynamisch onderzoek tussen de lokale specialisten en 
een centrale beoordelaar. We gebruikten hiervoor urodynamische gegevens van 578 vrouwen 
die geïncludeerd werden in ‘the Value of Urodynamics prior to Stress Incontinence Surgery 
(VUSIS) 2’ studie. Alle vrouwen ondergingen een urodynamisch onderzoek. Voor de centrale 
herbeoordeling beschikten we over 543 curven (94%) van urodynamische onderzoeken. De 
‘International Continence Society’ (ICS) heeft een richtlijn ontwikkeld hoe een urodynamisch 
onderzoek uitgevoerd zou moeten worden, genaamd de richtlijn ‘Good Urodynamic Practice’. Op 
basis van deze richtlijn werd een checklist opgesteld om de curven op een gestandaardiseerde 
manier te beoordelen.
De drukkatheters waren juist gepositioneerd in het merendeel van de onderzoeken (>99%) en in 
alle onderzoeken was tenminste één keer een hoesttest verricht. De onderzoeken scoorde slecht 
op het gebruik van notities over urineverlies (57%) en de aanbevolen frequentie (een hoesttest 
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per 50 ml) om te controleren of katheters correct gepositioneerd zijn, was lager in 75% van de 
onderzoeken. 
De overeenkomst tussen lokale en centrale onderzoeker in het vaststellen van de diagnose van 
urodynamisch stressincontinentie was goed met een kappa van 0.81 (95% betrouwbaarheidsinterval 
0.76-0.86, mate van overeenkomst 91%) en voor de diagnose van detrusor overactiviteit was kappa 
0.52 (95% betrouwbaarheidsinterval 0.38-0.66, mate van overeenkomst 94%). Andere discordante 
bevindingen ten opzichte van anamnese en klinisch onderzoek werden niet vaak geclassificeerd, 
de overeenkomst hierin was goed.
Door deze studie konden we concluderen dat de richtlijn ‘Good Urodynamic Practice’ niet strikt 
wordt nagevolgd, maar dat de technische kwaliteit van het merendeel van de onderzoeken 
voldoende was om deze te beoordelen op de aanwezigheid van stressincontinentie, detrusor 
overactiviteit en de functionaliteit van de blaaslediging. 
Naar aanleiding van de discussie in de literatuur werd in 2006 een multicentrische, gerandomiseerd 
gecontroleerde studie opgezet naar de waarde van preoperatief onderzoek bij vrouwen met 
stressincontinentie (VUSIS 1 studie). De resultaten van deze studie worden weergegeven in 
Hoofdstuk 5. Vrouwen werden gerandomiseerd voor een beleid gebaseerd op een diagnostisch 
traject met of zonder urodynamisch onderzoek. De primaire uitkomstmaat was klinische reductie 
van incontinentie klachten, gemeten met de Nederlandse versie van de Urogenital Distress 
Inventory (UDI) 12 maanden na het starten van de behandeling. Een gemiddeld verschil in 
verbetering van minder dan 8 punten werd beschouwd als non-inferieur.
De studie werd voortijdig gestopt vanwege tegenvallende patiënteninclusie. Er werden 59 
vrouwen gerandomiseerd voor een beleid met (n=31) en een beleid zonder urodynamica (n=28). 
Het gemiddelde verschil in verbetering gemeten met de UDI was 14 punten, ten gunste van de 
groep die geen urodynamisch onderzoek ondergingen (48 punten ±22 versus 34 ±22, 95% CI -∞; 
-0.26). In de groep vrouwen die een urodynamisch onderzoek ondergingen, werd vaker afgezien 
van een operatie in vergelijking met de vrouwen die geen urodynamisch onderzoek ondergingen 
(5/31 versus 1/28; relatief risico 4.5; 95% CI 0.56-36). 
Concluderend liet deze relatief kleine studie zien dat een beleid gebaseerd op een diagnose 
zonder urodynamisch onderzoek niet slechter is dan een beleid gebaseerd op een diagnose met 
urodynamisch onderzoek. 
De studie opzet werd aangepast en er werd een doorstart gemaakt als VUSIS 2 studie. In Hoofdstuk 
6 wordt het studieprotocol beschreven. Zes academische ziekenhuis en 24 niet-academische 
ziekenhuizen participeerden in de studie. Vrouwen met klachten van stressincontinentie waarbij 
conservatieve behandeling (zoals bekkenbodem fysiotherapie) onvoldoende verbetering 
gaven en dus in aanmerking kwamen voor een incontinentieoperatie, werden geïncludeerd. 
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Exclusiecriteria waren een eerdere incontinentie ingreep, een prolaps tot meer dan 1 cm voorbij 
het hymen en/of een residu na mictie van meer dan 150ml, gemeten met een echo of door 
middel van catheterisatie.
Vrouwen met een discordante bevinding tijdens het urodynamisch onderzoek in relatie tot 
anamnese en lichamelijk onderzoek (bijvoorbeeld detrusor overactiviteit, afwezigheid van 
urodynamische stressincontinentie) werden gerandomiseerd voor een operatieve behandeling of 
voor geïndividualiseerd beleid. Deze geïndividualiseerde behandeling kon bestaan uit medicatie, 
aanvullende bekkenbodem fysiotherapie, een pessarium, maar ook uit een operatie. 
De primaire uitkomstmaat van deze studie was klinische verbetering gemeten met de UDI na één 
jaar.
De powerberekening was gebaseerd op het principe van non-inferioriteit. Een verschil in 
gemiddelde verbetering van ≤5 punten werd beschouwd als non-inferieur. Er waren 51 vrouwen 
nodig per arm voor een power van 80%, met eenzijdige toetsing op 0.05. Wij verwachtten dat 
30% van de vrouwen met stressincontinentie een discordante bevinding zou hebben tijdens het 
urodynamisch onderzoek. Met een verwachte toestemming voor randomisatie van 50%, was de 
benodigde inclusie 600 vrouwen. 
De resultaten van de VUSIS 2 studie worden beschreven in Hoofdstuk 7. In de periode tussen 
januari 2009 en november 2010 werden 607 vrouwen benaderd, hiervan ondergingen 5 vrouwen 
geen urodynamisch onderzoek en 24 vrouwen voldeden niet aan de in- en exclusiecriteria. 
Van de 578 geïncludeerde vrouwen, hadden 268 vrouwen (46%) een discordante bevinding 
tijdens het urodynamisch onderzoek. Toestemming voor randomisatie werd gegeven door 126 
patiënten, waarvan 64 vrouwen een operatie (midurethrale sling) kregen en 62 vrouwen een 
geïndividualiseerd beleid. 
Het verschil in gemiddelde verbetering van de klachten van urineverlies, gemeten met de UDI, 
was 5 punten ten gunste van de groep die direct een operatie onderging (44 ±24 versus 39 ±25, 
95% CI -∞; 5). 
Concluderend kan gesteld worden dat bij vrouwen met een eerste episode van stressincontinentie 
een strategie met standaard midurethrale sling niet slechter is dan een geïndividualiseerde 
behandeling gebaseerd op urodynamisch bevindingen. Omdat urodynamisch onderzoek invasief 
is, gepaard gaat met kosten, en een aanzienlijke kans geeft op een urineweginfectie, dient het 
urodynamisch onderzoek niet meer standaard te worden uitgevoerd bij vrouwen met een eerste 
episode van stressincontinentie.
In hoofdstuk 8 worden de belangrijkste bevindingen van dit proefschrift samengevat en 
bediscussieerd.
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List of Abbreviations
CI   Confidence Interval
DO   Detrusor Overactivity
GUP  Good Urodynamic Practice
ICI  International Consultation on Incontinence
ICS   International Continence Society
IUGA  International Urogynaecological Association
LUTS   Lower Urinary Tract Symptoms
MUI   Mixed Urinary Incontinence
NICE  National Institute for Health and Clinical Excellence
OR  Odds Ratio
OAB  Overactive Bladder
PGI-I  Patient Global Impression of Improvement scale
POP-Q   the ICS Pelvic Organ Prolapse Quantification examination
PVR  Postvoid Residual
QALYs   Quality-Adjusted Life-Years
QUADAS   Quality Assessment of Diagnostic Accuracy Studies
RCT  Randomised Controlled Trial
RR  Relative Risk
ROC   Receiver Operating Characteristics 
SUI   Stress Urinary Incontinence
TOT   Transobturator Tape 
TVT   Tension Free Vaginal Tape
UDI   Urogenital Distress Inventory 
USUI  Urodynamic Stress Urinary Incontinence
VUSIS   Value of Urodynamics prior to Stress Incontinence Surgery
140
List of co-authorsChapter 10
141
List of co-authors
10
Chapter 10
List of co-authors and their affiliations
CIM Aalders  Department of Obstetrics & Gynecology
   Rijnstate Hospital, Arnhem
MY Bongers  Department of Obstetrics and Gynaecology
   Maxima Medical Centre, Veldhoven
J den Boon   Department of Obstetrics and Gynaecology
   Isala Klinieken, Zwolle
SR Broekhuis  Department of Obstetrics and Gynaecology
   Radboud University Nijmegen Medical Centre
HAM Brölmann  Department of Obstetrics and Gynaecology
   VU Medical Centre, Amsterdam
V Dietz   Department of Obstetrics and Gynaecology
   Catharina Hospital, Eindhoven
FE Hartog  Department of Obstetrics & Gynecology
   Rijnstate Hospital, Arnhem
JPFA Heesakkers  Department of Urology
   Radboud University Nijmegen Medical Centre
JS Hoogstad-van Evert Department of Obstetrics & Gynecology
   Radboud University Nijmegen Medical Centre
MC Hovius  Department of Urology
   Onze Lieve Vrouwe Gasthuis, Amsterdam
JH Kleinjan  Department of Urology
   Sint Franciscus Hospital, Roosendaal
KB Kluivers  Department of Obstetrics and Gynaecology 
   Radboud University Nijmegen Medical Centre
PH Langen  Department of Urology
   VieCuri Hospital, Venlo
JW de Leeuw  Department of Obstetrics and Gynaecology
   Ikazia Hospital, Rotterdam
GGA Malmberg  Department of Obstetrics & Gynecology
   Slingeland Hospital, Doetinchem
AL Milani   Department of Obstetrics and Gynaecology
   Reinier de Graaf Gasthuis, Delft
BWJ Mol   Department of Obstetrics and Gynaecology
   Academic Medical Centre, Amsterdam
142
Woorden van dank Chapter 10
EJ Roos   Department of Obstetrics and Gynaecology
   Sint Antonius Hospital, Nieuwegein
JPWR Roovers  Department of Obstetrics and Gynaecology
   Academic Medical Centre, Amsterdam
J Schaafstra  Department of Urology
   Canisius Wilhelmina Hospital Nijmegen
WA Spaans  Department of Obstetrics and Gynaecology
   Gelre Hospital, Apeldoorn
ESM Tiersma  Department of Obstetrics and Gynaecology
   VU Medical Centre, Amsterdam
CH van der Vaart  Department of Obstetrics and Gynaecology
   University Medical Centre, Utrecht
ME Vierhout  Department of Obstetrics and Gynaecology
   Radboud University Nijmegen Medical Centre
143
Woorden van dank Chapter 10
10
Woorden van dank
Honderden UDO’s en 637 bereidwillige patienten hebben de basis gevormd voor dit proefschrift. 
Echter, zonder de hulp en ondersteuning van velen zou me dit niet zijn gelukt. Iedereen die 
betrokken is geweest bij de totstandkoming van dit boekje wil ik daarom heel erg bedanken! 
Zonder iemand te kort te willen doen, wil ik hieronder de belangrijkste mensen persoonlijk 
vermelden. 
Allereerst gaat mijn dank uit naar mijn promotores en copromotores. 
Beste Mark, ik heb de afgelopen jaren met heel veel plezier onder jouw begeleiding gewerkt. 
Je gaf me veel vrijheid en vertrouwen, en creëerde daarmee de ideale werksfeer voor mij. Je 
enthousiasme werkt zeer aanstekelijk, net als je niet te vergeten rechtdoorzee-emails. Bedankt 
voor de leerzame en leuke tijd! 
Beste Ben Willem, via jou kwam ik in Nijmegen bij de VUSIS terecht. Ik heb veel respect voor hoe 
jij je inzet voor alle consortium studies en ook geinteresseerd en betrokken bent in de individuele 
projecten en in de individu. De doorstart van de VUSIS 2 had in het begin veel weg van ‘trekken 
aan een dood paard’, toch wist jij me te motiveren om moed te houden en door te gaan. Bedankt 
voor je interesse en motiverende begeleiding! 
Mijn steun en toeverlaat. Lieve Kirsten, het was zo ontzettend prettig om jou als directe begeleider 
te hebben. Altijd benaderbaar, positief en vol vertrouwen. Na onze overleg momentjes was ik 
weer voorzien van een nieuwe lading energie en vol ideeën. Het afgelopen jaar was alles behalve 
makkelijk voor je. Waar jij je verontschuldigde, had ik ontzettend veel bewondering voor je dat je 
er altijd voor me was. Bedankt voor alles en ik hoop dat we ook in de toekomst nog veel zullen 
samenwerken!
Beste John, van jou kreeg ik de mail met “het gaat van een leijsen dakje” toen de inclusie na 
een trage start op gang kwam. Je hebt me de ins en outs van het urodynamisch onderzoek 
bijgebracht toen we al die honderden UDO’s beoordeelden. Ook nam jij me mee naar Bristol, wat 
me een hoop inspiratie gaf! Je blik op de stukken door de kritische urologische bril maakte het 
compleet. Bedankt voor de fijne en gezellige begeleiding!
Lieve Suzan, ik nam van jou het stokje over als studie-coordinator van de VUSIS. Een rijdende trein 
was het niet echt te noemen, maar het was heel fijn dat ie al door jou gevormd was! Nu is het af, 
en volgens mij heb ik nog een bezoekje aan de kroeg van je tegoed…
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Ook ben ik zeer dankbaar voor de inzet van alle gynaecologen en urologen van de deelnemende 
centra, in het bijzonder Fred Milani, echt ontzettend bedankt allemaal voor jullie hulp bij het 
includeren van de benodigde patienten. 
Alle research nurses, Petra en Margot van het Trialbureau, julie hulp en bijdrage aan de VUSIS is 
onmiskenbaar. Jullie hebben zo ontzettend veel werk verzet voor de inclusie, invoer en follow-up. 
Jullie weten niet half hoe dankbaar ik jullie ben!!! Nelly, jij in het bijzonder! 
Lieve gynaecologen uit het St Antonius Ziekenhuis te Nieuwegein, ik was zo blij dat ik na mijn 
keuze coschap terug kon komen als ANIOS bij jullie. Ook al ben ik inmiddels al weer een paar jaar bij 
jullie weg, ik hoor nog steeds wel eens een stemmetje in mijn hoofd met wijsheden die ik van een 
van jullie heb meegekregen! Dank voor de steun om naast mijn ANIOS baan een promotietraject 
aan te gaan en dit ook mogelijk te maken door onderzoekstijd te creëren. Lieve collega’s van de 
goede oude tijd, wat was het super! Het is fijn dat er cluster-overstijgende dagen bestaan, want ik 
hoop jullie nog vaak te zien!
Lieve gynaecolgen uit het Rijnstate Ziekenhuis, een kliniek verlaten waar je het erg naar je zin had 
is lastig, maar ik had echt het gevoel in een warm bad te stappen in Arnhem! Heel erg bedankt 
voor alles wat ik geleerd heb en de talloze mogelijkheden die jullie me boden om me in de kliniek 
te blijven ontwikkelen. Het was een feest om met jullie te mogen werken! 
Lieve Laszlo en Annemiek, jullie boden me de kans een jaartje onder jullie hoede de ins en outs 
van de VPG te leren. Ontzettend bedankt voor jullie geduld, de zeer prettige samenwerking en de 
wijze woorden die mij als arts hebben veranderd!
Lieve Brigitte, Ciska, Carolien, Ellen, Helma, Petra, Sharon, Sylvia en Ans; wat was het leuk dat jaartje 
met jullie! Ik heb het heel erg (oh wat errug) naar me zin gehad, jullie zijn echt toppertjes met z’n 
allen! 
Lieve Rijnstate-matties, inmens(ch) leuke dingen hebben we meegemaakt zoals Nescio-borrels 
met kabouterbiertje, weekendjes zeilen en wintersport of knolhoppen. Succes allemaal met jullie 
carrière en alles daar om heen. 
Alle verloskundigen, verpleegkundigen, kraamverzorgsters en poli Gyn medewerkers van 
het Rijnstate, bedankt voor de fijne samenwerking en de gezellige diensten met omgekeerd 
verstoppertje en ‘wie ben ik’! Lieve Han, bedankt voor je hulp met de nachtelijke invoer van de 
vele vragenlijsten!
Ze zeggen wel eens dat het niet gaat om het doel maar om de weg erheen. Lieve (ex) garden 
mates, dankzij jullie was het een ontzettend leuke reis door onderzoeksland. Zoveel leuke 
vrimibo’s bij Anneke of ‘de week is weer doormidden-borrel’ bij de Esculaaf, bokbiertochten en 
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toffe weekendjes. Publicatietaart, de lunch (in de zon) en alle flauwe mailwisselingen maakten 
onderzoek doen alles behalve een individuele aangelegenheid! Onco-onderzoekers bedankt 
dat ik als algemene gyn-er getollereerd werd aan jullie kant! Karin, zorg goed voor Elvis, Tony en 
BAM! Bertho, thanx voor de heerlijke nespresso’s, je positiviteit en attentheid; een rode piste is 
een mooi doel, maar de weg er heen was misschien nog wel mooier. Annemijn, gezellig dat ons 
pad zo synchroon loopt! Fietsmattie Remko, aan stelling 12 mist natuurlijk nog een ding: ‘pain 
in the ass’. Duizenden kilometers hebben we samen afgelegd met toch wel als hoogtepunt de 
elfstedenfietstocht en als dieptepunt de rit naar Xanten door de mist (al was dat ook wel weer een 
overwinning). De grote vraag is natuurlijk, alias stelling 13 hebben we alle doelen al bereikt of gaan 
we ooit nog een echte berg opfietsen?
Mijn toffe paranimfen, Charlotte en Refika. Latente liefdes zijn door jullie bloot gelegd, zoals port 
drinken en sushi eten. Ik kwam als een nep-nijmo-parttime-onderzoeker een dag in de week in de 
tuin, super bedankt dat jullie me hebben geadopteerd. Charlie, dankzij jou hoorde ik toch bij een 
clubje; het oncontinentieclubje! Ik heb nooit een (hele) dag spijt gehad van mijn verhuizing naar 
Nijmegen en dat kwam door jullie! Het was fijn om in de eindfase samen te sparren, klagen, blij 
worden van de kleinste dingen en trots te zijn op ons zelf!
Dan nog een woord aan mijn opvolgster! Lieve Bianca, wat een mazzel dat we toch nog een paar 
dagen samen hebben mogen werken en jij nu mijn ‘kindje’ adopteert! Voor mij zit het er op en 
voor jou gaat het beginnen. Onze eerste buiten-universitaire besprekingen leken soms meer op 
bier- of wijnproeverijen, maar het is super om te zien met hoeveel enthousiasme je je op de data 
stort. Je kunt altijd rekenen op mijn steun!
Een goed begin vormt een uitstekende grondslag voor later succes. Lieve Babs, Gijs en Sjorrel, 
m´n studiematties vanaf het eerste jaar. Dankzij jullie heb ik nog altijd enkele hiaten in mijn 
geneeskunde kennis, maar daardoor heb ik ruimte gehouden voor dingen die echt belangrijk zijn! 
Als promoveren ‘’trouwen met jezelf is’’, dan zijn we over een paar maanden allemaal getrouwd. 
Wie had gedacht dat het zo goed met ons zou komen?! 
Lieve Ilona, Marieke, Stevie, Marije, Beluga-chicks en alle andere leuke en lieve Utrecht-
vriendinnetjes: bedankt voor jullie belangstelling de afgelopen jaren en de ontspanning op z’n 
tijd!
Lieve pap en mam, wat heb ik het getroffen met twee fantastische ouders! Het zal vast wel eens 
abracadabra zijn geweest waar ik nu precies mee bezig was de afgelopen jaren, maar met dit 
boekje valt alles hopelijk een beetje op zijn plaats. Het is fijn dat ik altijd bij jullie terecht kan, als 
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er iets te vieren valt zijn jullie van de partij, maar ook op moeilijke momenten stonden jullie altijd 
voor me klaar. Jullie geven mij het gevoel dat jullie trots zijn op wat ik deed en doe, en gaven me 
de vrijheid om mijn eigen keuzes, en soms ook fouten, te maken. Ik ben zo ontzettend blij met 
jullie!
Lieve Anoek en Jochem, mijn top zus en mijn super broertje! en Pieter, want jij bent inmiddels 
echt onderdeel van de familie! Met jullie is het nooit saai en nooit stil! Ik heb het zo ontzettend 
getroffen met zo´n fantastische familie, jullie staan altijd voor me klaar en aan humor ontbreekt het 
nooit. Heel erg fijn dat jullie altijd zo geinteresseerd waren. En Jochem, misschien is je vocabulair 
na het lezen van dit boekje nog verder uitgebreid met medische woorden die heerlijk in de mond 
liggen? Lieve Mijntje, ik ken je pas net maar je bent nu al niet meer bij ons gezin weg te denken, ik 
kijk er naar uit dat je met ons mee kan lachen. 
Allerliefste Vincent, zonder jou was me dit nooit gelukt! Het was fijn dat als ik gek werd van de 
door-mijzelf-veroorzaakte stress, jij mijn extern relativerend vermogen was! Jij geeft me rust, laat 
me stralen en laat me genieten van het leven. De wereld is zoveel mooier met jou!
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Op dinsdag 21 juni 1983, een zeer warme en zonnige zomerdag, wordt Sanne van Leijsen geboren 
in Oosterhout (NB). In dit dorp met stadsrechten groeit zij op met haar zus Anoek en broertje 
Jochem. In 2001 haalde zij haar VWO-diploma aan het Mgr Frencken College te Oosterhout. Het 
lot was haar gunstig gestemd; ze werd direct ingeloot voor geneeskunde in de stad van haar 
eerste keus: Utrecht. Tijdens de co-schappen en een keuzestage in het Igogwe Hospital in Tanzania 
begon de liefde voor de gynaecologie op te bloeien. In haar laatste jaar studie koos ze daarom 
voor een combistage Gynaecologie. In het UMC Utrecht deed zij een wetenschappelijk stage naar 
het optreden van foetomaternale transfusie bij sectio caesarea. De semiarts-stage vond plaats 
in het St Antonius Ziekenhuis te Nieuwegein. Na het behalen van de geneeskunde bul in 2007 
ging ze met heel veel plezier in dit ziekenhuis aan de slag als ANIOS Obstetrie &Gynaecologie. 
Tijdens haar werkzaamheden werd ze in toenemende mate geboeid door de wetenschap. Op 
een zonnige vrijdag in augsutus in 2008 zit zij tegenover Ben Willem die haar de vraag stelt ‘ik heb 
wel wat voor je, maar ben je bereid morgen naar Nijmegen te verhuizen?’. De VUSIS 1 studie was 
gestopt vanwege tegenvallende inclusiecijfers, ZonMW had net goedkeuring gegeven voor een 
doorstart in de vorm van de VUSIS 2. En zo kwam het dat zij enkele dagen later de arts-onderzoeker 
van de VUSIS 2 studie werd. Aanvankelijk coordineerde zij deze multicentrische studie naast haar 
werkzaamheden vanuit Nieuwegein. Per april 2009 nam ze afscheid van cluster Utrecht en ging 
zij werken als ANIOS in het Rijnstate Ziekenhuis te Arnhem. Gedurende 2010 werkte zij hier als 
fertiliteitsarts. In januari 2012 werd zij fulltime bewoner van dé tuin in het UMC St Radboud om dit 
proefschrift af te ronden. 
Inmiddels is zij op 1 juli 2012 begonnen met de opleiding tot gynaecoloog in het Jeroen Bosch 
Ziekenhuis. 
In haar vrije tijd bestijgt ze graag de racefiets of slaat ze een balletje op de tennisbaan of hockeyveld. 
Ze woont samen met Vincent Roos in Nijmegen.

